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Abstract 
 
The first and most conserved layer of plant innate immunity constitutes the 
perception of pathogen-associated molecular patterns (PAMPs) by pattern 
recognition receptors (PRRs). This type of immunity confers broad-spectrum disease 
resistance to a wide range of pathogens and is referred to as PAMP-triggered 
immunity (PTI). In Arabidopsis the leucin-rich repeat receptor kinases (LRR-RKs) 
FLS2 and EFR are the PRRs for the bacterial PAMPs flagellin and EF-Tu, 
respectively. Both form heteromeric complexes with the regulatory receptor- like 
kinase (RLK) BAK1. BAK1 is involved in brassinosteroide (BR) signalling via 
heteromerization with the BR receptor BRI1. In addition, BAK1 is also involved in 
cell death regulation. It is not known if BAK1 is able to differentially regulate these 
three pathways. In the case of BRI1 it was suggested that BAK1 plays a role as 
signal enhancer rather than being an intrinsic signalling component.  
Here, I showed that BAK1 is principally able to differentially regulate these three 
signalling pathways. The novel allele bak1-5 was strongly impaired in FLS2- and 
EFR-dependent PTI signalling pathways but displayed a wild-type-like signalling 
capacity in BR-signalling and BAK1-dependent cell death control. Bak1-5 plants 
expressed a full-length mutant protein with a single missense substitution located 
close to the active site of the intracellular kinase domain. This mutant variant of 
BAK1 showed an increased interaction with the three ligand-binding RKs FLS2, 
EFR, and BRI1. Intriguingly, BAK1-5 displayed a reduced kinase activity in vitro. 
Nevertheless, the kinase activity of BAK1-5 was required to suppress EFR-
dependent PTI-signalling in planta. These results strongly indicate a 
phosphorylation-dependent differential role of the regulatory RLK BAK1 in BR 
signalling, innate immunity and cell death control. 
Furthermore, I showed that BAK1 and its closest homolog BKK1 play a partially 
redundant role in PTI signalling. The strong impairment of PTI signalling in the 
double mutant bak1-5 bkk1-1 lead to compromised immunity against several adapted 
and non-adapted bacterial pathogens as well as to weakly virulent races of the 
obligate oomycete Hyaloperonospora arabidopsidis. 
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Chapter 1: General Introduction 
 
1.1. Introduction 
 
Plants are the principal energy source for almost all living organisms on earth. They 
are under constant pressure to defend themselves against pathogenic bacteria, fungi, 
oomycetes, insects and herbivores. In principle humans are in competition with plant 
pathogens for this energy source and need to protect crop plants against these 
pathogens. In the last centuries this has been mostly done by conventional breeding 
or applying pesticides to kill potential pathogens. However, in future these practices 
are not sustainable on their own as we will require a sustainable intensification of 
agriculture to manifest food security. On the one side pesticides lead to the loss of 
beneficial microbes and insects and are potentially harmful for human health.  On 
the other side resistances has developed in many plant pathogens either to applied 
chemicals or genetically encoded defence mechanisms. In order to overcome these 
problems and to improve current crop species we need to gain a detailed 
understanding of plants as biological systems in general and plant defence 
mechanisms in particular. Only this will enable us to make knowledge-based 
decisions on how to improve crops either by targeted conventional breeding, by 
genetic-modification or a combination thereof. 
Most plants are healthy most of the time or can at least minimize pathogen growth 
meaning that most pathogens are non-pathogenic on most plants (Thordal-
Christensen, 2003).  The simplest explanation for this fact is that the pathogen and 
the plant have different habitats. Second, the plant does not support the pathogen’s 
life style and therefore, the pathogen cannot express its pathogenicity factors or 
develop infection structures due to constitutively present barriers such as the bark, 
waxy cuticles or rigid cell walls (Nurnberger et al., 2004). These barriers are referred 
to as ecological or constitutive defences. However some pathogens can breach this 
constitutive defence layer and are then subject to the recognition close to or at the 
plasma membrane either directly or indirectly. At this stage the plant is able to 
perceive the pathogen as such by recognizing pathogen-associated molecular 
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patterns (PAMPs) or the disruption of its integrity by the pathogen via danger-
associated molecular patterns (DAMPs) (Boller and Felix, 2009). These extracellular 
molecules, collectively termed elicitors, are recognized by specific pattern-
recognition receptors (PRRs) and initiate an intracellular signalling cascade leading 
to PAMP-triggered immunity (PTI). However some pathogens are pathogenic on 
some plant species by masking their identity, evading recognition and/or suppressing 
PTI signalling using so called effectors. In the case of bacteria these effectors are 
mostly secreted via the type-three secretion system (T3SS) directly into the 
cytoplasm (Nomura et al., 2005). In other cases they are secreted by the pathogen 
into the apoplastic space and recently shown to be up-taken in a pathogen 
independent manner (Kale et al., 2010; Rafiqi et al., 2010). This leads to effector-
triggered susceptibility (ETS). Plants in turn developed another immune layer to 
recognize these effector molecules employing resistance (R) proteins. In this case 
the effector, which normally fosters the virulence of the pathogen betrays it, causing 
avirulence and leads to effector-triggered immunity (ETI) (Chisholm et al., 2006; 
Jones and Dangl, 2006). The recognition of effectors, which are avirulence (avr) 
factors in this case, by R-proteins can be direct or indirect. Some pathogens inject 
other effectors into the plant cytoplasm to suppress ETI and induce another cycle of 
ETS. This co-evolution of the recognition of the pathogen by the plant and the 
disturbance thereof by the pathogen is considered an “arms race”.  
Plants have a two-layered immune system whereby the first layer (PTI) recognizes 
infectious non-self or infected self characteristic of the action of a class of pathogens. 
In contrast the second layer (ETI) recognizes the presence of a specific pathogen 
race. Both immune layers are encoded in the germline and therefore referred to as 
innate immunity. Innate immunity is the only immune system in all living 
organisms; except for jawed vertebrates that possess an adaptive immune system in 
addition (Janeway and Medzhitov, 2002). Even though it is so widespread across 
kingdoms and uses similar molecular building blocks and mechanisms innate 
immunity is believed to be a result of convergent evolution (Ausubel, 2005; Zipfel 
and Felix, 2005).  
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1.2. PAMPs, DAMPs and PRRs 
 
It has been known for over 30 years that plants possess an excellent 
chemoperception system for (conserved) microbe-derived substances and to induce 
the production of anti-microbial compounds termed phytoalexins (Albersheim and 
Valent, 1978; Keen et al., 1972). Without knowing the molecular identity of these 
substances they were collectively referred to as general elicitors (Keen et al., 1972). 
The molecular identity of the first elicitor was proven to be heptaglucoside from cell 
wall preparations of the oomycete Phytophthora megasperma pv. glycinea (later 
renamed P. sojae pv glycinae) (Sharp et al., 1984a; Sharp et al., 1984b). In the 
following years, a range of elicitors from oligosaccharides, peptides to lipid moieties 
were shown to elicit a set of defence responses in plants (Boller, 1995). In recent 
years, a new concept has been adapted from the animal innate immunity field where 
it was suggested that the focus of the innate immune system is to discriminate 
between infectious non-self and non-infectious self (Medzhitov and Janeway, 1997). 
This discrimination takes place by recognizing PAMPs, which are defined as (i) 
being relatively invariant epitopes within molecules that are fundamental to the 
pathogens’ fitness, (ii) widely distributed within a class of microbes and (iii) absent 
from the host. This idea was extended to include infected, modified or infectious self 
by recognizing DAMPs, which can be defined as molecules of the potential host that 
are released by lytic enzymes or non-enzymatic activities of the pathogen 
(Matzinger, 2002).  Early examples of elicitors included DAMPs as 
oligogalacturonides that were thought to be released from the plant cell wall during 
pathogen attacks elicit host defence responses (Nothnagel et al., 1983). Overall, 
these elicitors (PAMPs and DAMPs) are recognized by plasma membrane- localized 
PRRs that in plants apart from two exceptions are transmembrane receptor kinases 
(RKs) or receptor-like proteins (RLPs) (Boller and Felix 2009). 
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1.2.1. Orphan elicitors 
 
Even though some elicitor/PRR pairs have already been identified, many orphan 
elicitors are still missing their corresponding PRR.  
 
1.2.1.1. Orphan fungal PAMPs 
 
Fungal cell wall components, such as ergosterol elicit defence responses at 
picomolar concentrations in tomato, tobacco and grapevine (Granado et al., 1995; 
Boller and Felix, 2009). Small secreted proteins like Sm1 and members of the 
cearto-platanin family cause defence responses on variety of monocots and/or dicots 
(Pazzagli et al., 1999; Djonovic et al., 2006). 
 
1.2.1.2. Orphan oomycete PAMPs 
 
Pep13 was the first epitope to be clearly defined as a PAMP in relation to plant 
defence (Brunner et al., 2002). It is a short 13-amino acid peptide of a conserved 
surface-exposed fragment within a calcium-dependent cell wall transglutaminase 
from the oomycete Phytophthora sojae that elicits defence responses in Solanaceae 
(Brunner et al., 2002). Recently, the cellulose binding elicitor lectin from 
Phytophthora parasitica var. nicotianae was shown to trigger defence responses in 
Arabidopsis and tobacco (Gaulin et al. 2006). The two cellulose binding domains, 
which are probably important for cell adhesion during infection, are sufficient for 
defence induction. Other elicitors from oomycetes are the fatty acid arachidonic acid, 
are small secreted proteins such as INF1 and other elicitins recognized by tobacco 
and other Solanaceae (Yu, 1995; Kamoun et al., 1997; Boller and Felix, 2009). 
 
1.2.1.3. Orphan bacterial PAMPs 
 
Plants recognise many different bacterial PAMPs. Lipopolysaccharides (LPS) are 
perceived by a range of plant species (Newman et al., 2007). The main PAMP 
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within LPS is the widely conserved lipid A, and its elicitor strength depends on its 
acetylation and phosphorylation pattern (Silipo et al., 2008). However, the core 
oligosaccharide and O-antigen structure are also recognised, potentially by a 
different perception system than for lipid A in Arabidopsis (Newman et al., 2007). 
Peptidoglycans (PGN) are a major cell-wall component of Gram-positive bacteria. 
PGN sugar chains longer than the disaccharide, but not the protein moieties are 
recognised as a PAMP in Arabidopsis (Gust et al., 2007). In several recent reviews it 
was suggested that LysM (lysin motif) containing receptor proteins could be the 
functional PRRs for PGN (Boller and Felix, 2009; Nicaise et al., 2009). 
Rhamnolipids were recently shown to induce defence responses in grapevine 
(Varnier et al., 2009). Nucleic acids of pathogens have long been known as potent 
immune elicitors in animals (Kawai and Akira, 2010). Only recently it was shown 
that unmethylated CpG-DNA elicits typical defence responses in Arabidopsis 
(Yakushiji et al., 2009). Bacteria also harbour many proteinaceous PAMPs. For 
example the cold shock protein (CPS) was shown to elicit defence responses in 
tobacco but not Arabidopsis cells (Felix and Boller, 2003). It was elegantly shown 
that functional indispensable amino acid residues in the highly conserved RNA and 
DNA-binding domain (RNP-1) were also essential for response elicitation and the 
core 22-amino acid peptide of the RNP-1 domain was identified as the 
corresponding PAMP (Felix and Boller, 2003). Also the secreted superoxide 
dismutase, Nep1-like proteins and harpins induce defence responses in several plant 
species (Nicaise et al., 2009). 
 
1.2.1.4. Orphan DAMPs 
 
Cutin monomers are released from the plant cell wall after pathogen attack by the 
enzymatic activity of cutinases and are recognized in micromolar concentrations 
(Boller and Felix, 2009). Plants potentially possess a positive feedback/forward loop 
as they secrete small peptides which are also perceived by cells in the surrounding 
non-attacked tissue (Ryan et al., 2007). Some of these peptides are synthesized as 
precursors and need activation by a protease before becoming fully active as for 
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example for systemin (McGurl et al., 1992). Other small peptide DAMPs, such as 
RAFL and HypSys are omnipresent in plant cell walls and were recently suggested 
to become activated by microbial proteases or by endogenous proteases after cell 
wounding (Boller and Felix, 2009; Pearce and Ryan, 2003). A subtilisin-like protein 
was recently identified as a novel peptide DAMP specific to soybean (Pearce et al., 
2010). As in the last case the production and recognition of most of these small 
peptide DAMPs seems to be limited to a small phylogenetic family and they may 
have evolved independently to fine-tune specific defence responses. These actively 
produced DAMPs that are produced in response to PAMP perception or wounding 
could be also seen as plant cytokines homologos to cytokines of the jawed vetebrate 
immune system.   
 
1.2.2. Known elicitor/PRR pairs 
 
It has been known nearly over 30 years that plants are able to respond to elicitors 
(Keen et al., 1972). In addition these elicitors were long known to be able to bind to 
high-affinity binding sites within the plant cell membrane (Nurnberger et al., 1994). 
However the first plant PRRs have been identified only in the last ten years.  
 
1.2.2.1. flg22/FLS2, the paradigmatic model pair 
 
Flagellin represents the best studied PAMP in plants. Flagellin is the building block 
of the eubacterial flagellum, which is essential for bacterial movement. The eliciting 
epitope flg22 was isolated from Pseudomonas syringae pv. tabaci (Pta) and 
corresponds to a highly conserved N-terminal domain (Felix et al., 1999). Flg22 
elicits responses in a wide variety of plant species from angiosperm to gymnosperms, 
suggesting that the corresponding perception system has evolved early in evolution 
(Albert et al. 2010). However, the recognition specificity is not necessarily the same 
for all species. Tomato for example is able to recognize a shorter version of the same 
epitope (flg15) whereas Arabidopsis is not (Bauer et al., 2001; Robatzek et al., 2007). 
Similarly, rice is able to recognize flg22 but is more responsive to full length 
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flagellin protein (Takai et al., 2008). This difference in recognition specificity is 
intrinsic to the respective receptor. Interestingly, flagellins with the same primary 
amino acid sequence where differentially recognized in rice based on their specific 
glycosylation status (Che et al., 2000; Tanaka et al., 2003; Fujiwara et al., 2004).  In 
addition several bacterial pathogens can evade flagellin recognition. For example, 
Xanthomonas campestris pv. campestris (Xcc) has within-species polymorphism in 
flg22, which leads to the inability of Arabidopsis to recognise the ‘disguised’ 
epitope (Sun et al., 2006). Although the biological relevance of this relative 
recognition on Xcc compatible host plants needs further investigation.  
The leucin rich repeat (LRR) RK FLS2 (Flagellin Sensing 2) was isolated by map-
based cloning as the corresponding PRR in Arabidopsis (Gomez-Gomez and Boller, 
2000). Further studies showed that flg22 binds directly to FLS2 and that this high-
affinity binding site is absent in fls2 knock-out mutant demonstrating that FLS2 is a 
bona fide receptor (Chinchilla et al., 2006). In recent years orthologous receptors 
were cloned and partially characterized from tomato, Nicotiana benthamiana and 
rice (Hann and Rathjen, 2007; Robatzek et al., 2007; Takai et al., 2008). FLS2 binds 
flg22 via its extracellular LRR domain, which most likely forms a horseshoe-like 
tertiary structure based on known LRR structures (Padmanabhan et al., 2009). 
Mutational and phylogenetic approaches suggested different parts of the 
extracellular LRR to be involved in ligand binding (Albert et al., 2010a; Boller and 
Felix, 2009; Dunning et al., 2007). Only crystallographic studies of the LRR domain 
in complex with flg22 will enable to clarify this controversy.  
The intracellular part of FLS2 has most of the characteristic structural elements of a 
Ser/Thr kinase and was shown to possess kinase activity (Gomez-Gomez et al., 
2001). 
 
1.2.2.2. elf18/EFR a Brassicaceae specifc pair 
 
The recognition of the bacterial elongation factor TU (EF-TU) is restricted to 
Brassicaceae (Kunze et al., 2004). The elicitor epitope could be narrowed down to 
the first 18 amino acids and requires N-acetylation for activity (Kunze et al., 2004). 
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Using a combination of reverse genetics and biochemical binding studies it was 
univocally shown that the LRR-RLK EFR (EF-Tu receptor) is the corresponding 
PRR in Arabidopsis (Zipfel et al., 2006). No orthologs from other species have been 
cloned so far. Interestingly EFR is a member of receptor-like kinases (RLK) 
subfamily XII the same as FLS2 (Shiu and Bleecker, 2001). As FLS2, EFR is highly 
glycosylated, however, EFR is far more sensitive to genetic disturbances in the 
protein folding, glycosylation and ER (endoplasmatic reticulum) quality control 
machinery (Haweker et al., 2010; Li et al., 2009; Lu et al., 2009; Nekrasov et al., 
2009; Saijo et al., 2009; von Numers et al., 2010). Recently it was shown that the 
extracellular LRR domain of EFR is the domain of elf18 perception (Albert et al., 
2010b). The expression of chimeric constructs encoding fusion proteins of the 
extracellular LRR of EFR fused to the intracellular kinase domain of FLS2 confer 
elf18 responsiveness to normally unresponsive N. benthamina (Albert et al., 2010b). 
Interestingly, the glycosylation status of the LRR seems to be important for peptide 
binding as mutations of a single predicted glycosylation site disables elf18 binding 
despite correct localization of the mutated protein to the plasma membrane 
(Haweker et al., 2010). 
 
1.2.2.3. axYs22/Xa21 a rice specific pair 
 
Xa21 (Xanthomonas oryzae pv. oryzae 21) resistant  was isolated by positional 
cloning form the wild rice species Oryza longistaminanta because of the broad-
spectrum resistance it confers to Xanthomonas oryzae pv. oryzae (Xoo) (Song et al., 
1995). It is the first LRR-RLK identified as being involved in disease resistance 
however the cognate ligand was unknown until recently (Lee et al., 2009). This 
ligand was long thought to be an effector molecule (AVR protein). However, it 
became apparent that a small sulfated secreted protein potentially involved in 
quorum sensing might rather be the recognized entity (Lee et al., 2006). Indeed a 
small tyrosin sulphated 17 amino acid long peptide from the small type-I secreted 
protein Ax21 (activator of Xa21-mediated immunity) was identified as the long-
missing ligand (Lee et al., 2009). Xa21 is part of a multi-gene family in rice (Song et 
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al., 1997).  One other gene family member called XA21D is able to confer partial-
resistance to Xoo (Wang et al., 1998). It is not clear if XA21D, a predicted 
extracellular LRR domain containing protein without transmembrane domain, is able 
to bind Ax21. Interestingly, Xa21 is closely related to FLS2 and EFR displaying a 
similar modular structure. As EFR, XA21 is sensitive to genetic disturbance in the 
ER quality control machinery (Park et al., 2010).  
 
1.2.2.4. Several PRRs for chitin? 
 
Chitin is a major component of the fungal cell wall and was first shown to possess 
elicitor activity in tomato cells (Felix, 1993). The cognate receptor CEBiP (chitin 
elicitor-binding protein) in rice was identified by biochemical binding assays, 
peptide sequencing, concomitant cloning and silencing of the coding gene (Kaku et 
al., 2006). CEBiP is a RLP with two extracellular LysM motifs, a single 
transmembrane domain and a cytoplasmic C-terminal tail without any known 
domain. It is likely that CEBiP requires additional signalling partner(s) to form a 
functional receptor complex (Kaku et al., 2006). Indeed OsCERK1 (chitin elicitor 
receptor kinase 1), a LysM-ontaining RLK, is required for full chitin responsiveness 
and directly interacts with CEBiP forming ligand-induced heteromeric complexes in 
vivo (Shimizu et al., 2010). The Arabidopsis ortholog of OsCERK1 has three LysM 
motifs and was previously found to be required for chitin responses (Miya et al., 
2007; Wan et al., 2008). CEBiP homologs are present in Arabidopsis and it was 
therefore hypothesized initially that AtCERK1 plays rather the role of a regulatory 
RLK then being the bona fide ligand-binding PRR (Zipfel, 2009). However, 
AtCERK1 was identified recently as a major chitin-binding protein in Arabidopsis 
and does not require any additional plant proteins for in vitro chitin binding (Iizasa 
et al., 2009; Petutschnig et al., 2010). In both studies AtCERK1 was able to bind not 
only chitin polymers but also oligomeric chitin with a degree of polymerization 
greater than five (Iizasa et al., 2009; Petutschnig et al., 2010). This is in good 
agreement with the previously observed recognition specificity of Arabidopsis (Wan 
et al., 2008). Importantly, AtCERK1 is also required for bacterial resistance 
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conferred by the recognition of unknown bacterial PAMP(s) (Gimenez-Ibanez et al., 
2009a; Gimenez-Ibanez et al., 2009b). These PAMP(s) might be structurally related 
to chitin and may bind to a similar site in the extracellular domain of AtCERK1. 
Alternatively, AtCERK1 could form heteromeric complexes whereby the complex 
composition would determine ligand specificity in a manner reminiscent of TLR 
heterocomplexes in the vertebrate innate immune system (Kawai and Akira, 2010).  
The latter hypothesis is supported by the fact that AtCEBiP is another chitin binding 
protein in Arabidopsis in addition to AtCERK1 (Petutschnig et al., 2010). 
 
1.2.2.5. Xylanase/Eix1/2 pair 
 
The fungal ethylene-inducing xylanase (EIX) is a strong elicitor of defence 
responses in many different plant species (Boller, 1995). A map-based cloning 
approach in tomato isolated two RLPs, LeEix1 and LeEix2, as potential EIX PRRs 
(Ron and Avni, 2004). Transient expression of both proteins confers EIX binding to 
N. tabacum cv BY2 but only Eix2 can confer EIX responsiveness (Ron and Avni, 
2004). LeEix1 and LeEix2 form heteromeric complexes in vivo and the over-
expression of LeEix1 dampens EIX-induced responses (Bar et al., 2010). This 
suggests that LeEix1 is a negative regulator of LeEix2-mediated responses or that 
LeEix1 is a ligand-scavenging receptor without signalling capacity.  
 
1.2.2.6. GBP a soluble PRR ?!? 
 
Heptaglucoside forms an integral part of oomycete cell walls and was the first 
characterized elicitor at the molecular level (Sharp et al., 1984a; Sharp et al., 1984b). 
Heptaglucans are only recognized by members of the Fabacae and biochemical 
studies in soybean identified a soluble high affinity glucan binding protein (GBP) as 
the potential PRR (Fliegmann et al., 2004). However, a genetic proof for the 
requirement of GBP for heptaglucan perception is still missing. Also how a soluble 
extracellular protein can induce intracellular signal cascades is still an open question. 
One hypothesis is that after ligand-binding GBP interacts with a RLK or RLP and 
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this interaction induces down-stream signalling. Clearly, more studies are needed 
clarify the mechanism of heptaglucan perception in plants.  
 
1.2.2.7. AtPeps and AtPEPR1/2 the first identified DAMP/PRR pairs 
 
The 23 amino acid long peptide AtPep1 (elicitor peptide 1) was isolated from 
untreated Arabidopsis leaves and shown to induce defence responses generally 
associated with PTI (Huffaker et al., 2006). It is part of a multi-gene family 
containing 6 potential paralogs. Several of them are induced by wounding, stress 
hormone and elicitor treatment (Huffaker et al., 2006; Huffaker and Ryan, 2007). All 
of them are produced as longer propeptides and require processing via an unknown 
mechanism before becoming elicitor active (Huffaker et al. 2006). The LRR-RLK 
AtPEPR1 (Pep1 receptor 1) was identified as an AtPep1 binding protein and bona 
fide PRR in Arabidopsis.  Atpepr1 mutant lines lost the high affinity AtPep1 binding 
site, and transient expression of AtPEPR1 made tobacco AtPep1-responsive 
(Yamaguchi et al., 2006). Careful phenotypic analysis showed that atpepr1 single 
mutants were not totally unresponsive to AtPep1 and its closest paralog AtPEPR2 
was identified as a partially redundant AtPep1 PRR (Krol et al., 2010; Yamaguchi et 
al., 2010). 
 
1.2.2.8. OGs and WAK1  
 
Plants sense disturbance of their self by the intruder. For example 
oligoglalacturonides (OG), representing lytic plant cell wall fragments, induce 
defence gene responses in soybean and many other plant species (Nothnagel et al., 
1983; Boller, 1995). Cell wall-associated protein kinases (WAKs) were 
hypothesised to constitute the respective PRR. WAK1 is able to bind OGs in vitro 
(Cabrera et al., 2008). Furthermore, heterologously expressed WAK1 and WAK2 
bind to de-esterized pectin oligomers in vitro and wak2 mutant plants are impaired in 
pectin-induced MPK3 activation (Kohorn et al., 2009). Using a domain swap 
approach it was demonstrated that a chimeric protein between the WAK1 
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ectodomain and the EFR kinase domain is able to recognize OGs and induce EFR-
specific responses after transient expression in N. benthamina (Brutus et al., 2010). 
By using reciprocal fusion proteins it was shown that elf18 treatment induces 
WAK1-specific responses. These experiments demonstrate that the WAK1 
ectodomain is able to perceive OGs and that the cytoplasmic kinase domain of 
WAK1 encodes downstream signalling specificity making WAK1 a prime PRR 
candidate for OGs.  
 
1.2.3. Potential PRRs 
 
1.2.3.1. non-RD kinase domains: Hallmark of PRRs ?!? 
 
Kinases, including RKs and RLKs, can be subdivided into RD and non-RD kinases 
depending on the conservation of the amino-acid residue preceding the core catalytic 
aspartate (D) residue in subdomain VIb of the kinase domain (Johnson et al., 1996; 
Nolen et al., 2004). Most RD kinases require auto-phosphorylation of the activation 
loop for full kinase activity. In contrast, non-RD kinases do not require 
phosphorylation of the activation loop to adopt an active confirmation (Nolen et al., 
2004). They are regulated by different mechanisms such as relief of auto-inhibition 
by C-terminal extensions (Kobe et al. 1996), Tyr phosphorylation in the P+1 loop 
(Mayans et al. 1998), or are constitutively active kinases (Nolen et al. 2001).  
Interestingly, several PRRs belong to the non-RD kinase class and this might be a 
hallmark of PRRs. 15 out of 18 PRRs belong to the non-RD class of protein kises 
even though members of this class are relatively infrequent in the genoms of animals 
and plants (Dardick and Ronald, 2006).  
 
1.2.3.2. Potential orphan PRRs 
 
While for many PAMPs the corresponding PRRs are still unknown, several RLKs 
and RLPs have been associated with defence responses and may potentially be 
orphan PRRs. For example, the two tomato RLPs Ve1 and Ve2 have been shown to 
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confer resistance to Verticillium dahliae and V. albo-atrum race 1 when expressed in 
potato (Kawchuk et al., 2001). However, in tomato only Ve1 was required and 
sufficient to confer resistance (Fradin et al., 2009). In Arabidopsis three LRR-RLPs 
were shown to be required for disease resistance to non-adapted bacterial or fungal 
pathogen (Ramonell et al., 2005; Wang et al., 2008a). Knock-out mutants of 
AtRLP30 and AtRLP13 are slightly more susceptible to the non-adapted bacterial 
pathogen Pseudomonas syringae pv phaseolicola (Pph) 1448A and a AtRLP30 YFP 
fusion protein localizes to the plasma membrane (Wang et al., 2008a). Mutants of 
AtRLP52 were shown to be more susceptible to the non-adapted fungal pathogen 
Erysiphe cichoracearum (Ramonell et al., 2005).  
Several RLKs represent potential PRRs. Recently the non-RD LRR-RLK NgRLK1 
from Nicotiana glutinosa was shown to interact with an elicitin from P. capsici in 
vitro and in a yeast-two hybrid assay (Kim et al., 2010). Surprisingly, not only the 
extracellular LRR-domain but also the intracellular kinase domain interacted with 
the elicitin. Therefore further studies are necessary to define NgRLK1 as a PRR per 
se such as testing its requirement for elicitin-induced responses and in vivo binding.  
In rice, map-based cloning identified the non-RD RLK Xa26 as a major component 
of the defence response against several Xoo strains (Sun et al., 2004). Rice cultivars 
lacking Xa26 were more susceptible to Xoo, and transgenic lines expressing Xa26 
gained broad spectrum resistance against several strains of Xoo (Cao et al., 2007; 
Sun et al., 2004). Interestingly, Xa26 is part of a multi-gene family and ectopic 
expression of another family member confers resistance to Xoo (Cao et al., 2007).  
This enumeration is far from being exhaustive as SNC2 (suppressor of npr1-1, 
constitutive 2), SNC4, RPG1 (barley stem rust resistance protein 1), Pi-d2 and many 
other RLPs and RLKs full fill similar criteria (Brueggeman et al., 2002; Chen et al., 
2006; Bi et al., 2010; Zhang et al., 2010). More studies are needed to identify 
potential cognate PAMPs and to demonstrate that these RLPs and RLKs are bona 
fide PRRs. 
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1.3. The importance of PTI in plant defence 
 
Early on it was shown that soybean seedlings pre-treated with elicitors from 
oomycete cell walls became resistant to a normally compatible race of P. 
megasperma pv. glycinea (Ayers et al., 1976). Several years later it was shown that a 
glucan preparation from the same pathogen was able to induce cross-kingdom 
resistance to several plant-viruses in different Nicotiana species (Kopp et al., 1989). 
Pre-treatment of tobacco with laminarin, a linear β-1,3 glucan isolated from brown 
algae but also part of land plant and fungal cell walls, was shown to induce 
resistance against the soft rot bacterial pathogen Erwinia carotovota (Klarzynski et 
al., 2000). As described above huge progress has been made in identifying the 
genetic and molecular bases of elicitor recognition. This enabled the detailed 
investigation of the contribution of elicitor recognition to plant defence. Using the 
paradigmatic PAMP/PRR pair flg22/FLS2 (see above) Boller and colleagues 
demonstrated that flg22 pre-treatment restricts the growth of the adapted pathogen P. 
syringae pv. tomato (Pto) DC3000 on Arabidopsis (Zipfel et al., 2004). Importantly, 
the authors were able to show that this induced resistance is dependent on the 
cognate PRR FLS2 defining a genetic basis for the observed phenomena (Zipfel et 
al., 2004). Furthermore, fls2 mutant plants are more susceptible to Pto DC3000 
when spray-inoculated suggesting a role of PTI in pre-invasive defence (Zipfel et al. 
2004). In addition, PTI is involved in non-host resistance as fls2 mutants are more 
susceptible to non-adapted bacterial pathogens such as Pph or Pta (de Torres et al., 
2006; Li et al., 2005). Silencing of NbFLS2 in N. benthamiana leads to increased 
resistance to several bacterial pathogens (Hann and Rathjen, 2007). Similarly, in 
Arabidopsis efr and cerk1 mutants are more susceptible to virulent and weakly 
virulent strains of Pto DC3000 (Gimenez-Ibanez et al., 2009a; Nekrasov et al., 2009; 
Saijo et al., 2009). As CERK1 is also involved in chitin perception cerk1 mutants are 
more susceptible to fungal pathogens such as Alternaria brassicicola and Erysiphie 
cichoracearum (Miya et al., 2007; Wan et al., 2008). In rice silencing of CEBiP 
increases the susceptibility to the fungal pathogen Magnaporthie oryzae (Kishimoto 
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et al. 2010). Recently it was demonstrated that PAMPs are able to induce systemic 
acquired resistance (SAR) also (Mishina and Zeier, 2007). 
The relatively little contribution of elicitor recognition, using single PRR mutants, to 
the overall resistance reported in most of these studies led to the postulate that PTI is 
a quantitative weaker response than ETI (Jones and Dangl, 2006). However, this 
neglects the possibility that mutants in multiple PRRs, blind to most elicitors, might 
be hyper-susceptible to normally non-adapted pathogens (PTI). This increase in 
susceptibility might be as large as the one observed for R-gene mutants infected with 
otherwise avirulent pathogens (ETI). In addition Xa21, which was previously 
defined as an R-protein (Song et al., 1995), is indeed a PRR that totally restricts the 
growth of otherwise virulent Xoo strains, clearly revoking the notion of quantitative 
differences between PTI and ETI (Lee et al., 2009). Similarly, the heterologous 
expression of EFR in tomato makes it resistant to the otherwise fully adapted 
pathogen Ralstonia solanacearum (Lacombe et al., 2010). 
 
1.4. Downstream events after ligand binding 
 
It is well known from studies on animal transmembrane receptor that the first event 
after ligand binding is a ligand-induced conformational change (Lemmon and 
Schlessinger, 2010; Rahimi and Leof, 2007). This conformational change leads to 
homo- and heteromerization with downstream signalling components enabling 
signal transduction from the outside into the cell. Even though a ligand-induced 
conformational change has not been demonstrated for plant PRRs it is assumed that 
it constitutes the first downstream signalling event.  
 
1.4.1. Oligomerization: BAK1 as a regulatory RLK  
 
BAK1 (BRI1 associated kinase 1), an LRR-RLK belonging to the subfamily II and 
also a member of the multi-genic SERK (somatic embryogensis related kinase) 
family, was recently shown to form ligand-dependent heteromeric complexes with 
several PRRs such as FLS2 and EFR in vivo and with AtPEPR1/2 in the yeast two 
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hybrid system (Chinchilla et al., 2007; Heese et al., 2007; Postel and Kemmerling, 
2009; Roux et al., submitted).  BAK1 was initially identified as a positive regulator 
of brassinosteroid (BR) responses, forming a ligand-dependent complex in vivo with 
the LRR-RK BRI1 (brassinosteroid insensitive 1), the main BR receptor (Li et al., 
2002; Nam and Li, 2002; Wang et al., 2005; Wang et al., 2008b). Over-expression of 
BAK1 suppresses weak bri1 alleles, and bak1 knock-out mutants are hypo-sensitive 
to BR and resemble weak bri1 alleles (Li et al., 2002; Nam and Li, 2002; Wang et 
al., 2008b). BAK1 is also involved in cell death control as bak1 knock-out mutants 
have a spreading lesion phenotype upon pathogen infection and display premature 
senescence phenotypes (He et al., 2007; Kemmerling et al., 2007). This loss of cell 
death control is aggravated in double-mutant combinations with its closest homolog 
BKK1(BAK1-LIKE1)/SERK4, and strong bak1 bkk1 allele combinations are seedling 
lethal even in sterile conditions (He et al., 2007; Jeong et al., 2010;). Additionally, 
BAK1 interacts with BIR1 (BAK1-interacting receptor like kinase 1), another LRR-
RLK, mutants of which also show constitutive un-controlled cell death (Gao et al., 
2009). Intriguingly, also other SERK-family members share (partially) functional 
redundant roles with BAK1 or amongst each other (Albrecht et al., 2008). In addition 
to BAK1, SERK1 and BKK1 also interact with BRI1 as positive regulators of BR 
responses (Karlova et al., 2006; He et al., 2007; Albrecht et al., 2008; Jeong et al., 
2010). Furthermore, SERK1 and SERK2 have redundant roles in male sporogenesis 
(Albrecht et al., 2005; Colcombet et al., 2005; Albrecht et al., 2008) and SERK1 was 
recently shown to be involved in organ separation in flowers (Lewis et al., 2010). 
Therefore it would be of great interest to investigate the role of other SERK-family 
members in PTI signalling and plant defence especially in higher order multiple 
mutants.  
Interestingly, bak1 mutants are not only compromised in the response to flg22, elf18 
and AtPep1 (Chinchilla et al., 2007; Heese et al., 2007; Krol et al., 2010) but also 
several other PAMPs such as HrpZ, lipopolysaccharides (LPS), and peptidoglycans 
(PGN) (Shan et al., 2008). Furthermore, BAK1-silenced N. benthamiana plants are 
less sensitive to the PAMPs INF1 and csp22 (Heese et al., 2007). This clearly 
suggests that BAK1 might form heteromeric complexes with other yet unknown 
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PRRs. However not all elicitor perception requires BAK1 as chitin responses are not 
compromised in bak1 mutant plants (Shan et al., 2008). 
Whereas it is clear genetically that BAK1 is a signal enhancer for both BR and PTI 
signalling. It is unclear how BAK1 regulates the different pathways mechanistically. 
It was recently suggested that BAK1 functions as a biochemical signal enhancer for 
the RD-kinase BRI1 by primarily increasing the kinase activity of BRI1 (Wang et al., 
2008). This conclusion is based on biochemical studies on the auto- and trans-
phosphorylation events revolving around BRI1-BAK1 followed by phenotypic 
analysis of BAK1 phospho-mimetic and phospho-dead mutants. Interestingly none 
of the mutant BAK1 alleles has a strong differential effect on PTI and BR signalling 
(Wang et al., 2008). It is unclear whether the BRI1-BAK1 model can be generalized 
to other RD- or non-RD kinases. For example, a recent study showed striking 
differences between FLS2-BAK1 complex formation (Schulze et al., 2010) and 
pervious insights into the BRI1-BAK1 complex (Wang et al., 2008). It was shown 
that FLS2 and BAK1 oligomerize and are phosphorylated within seconds of ligand 
addition (Schulze et al. 2010). Importantly, in contrast to the BAK1-BRI1 
interaction that requires the BRI1 kinase activity for full interaction (Wang et al., 
2008), FLS2-BAK1 phosphorylation but not complex formation is inhibited by pre-
treatment with the general kinase inhibitor K252a (Schulze et al., 2010). This 
demonstrates that complex formation between BAK1 and FLS2 is rather a 
requirement than a consequence of detectable phosphorylation.  
SERK-homologes in other plant species are potentially also involved in PTI as their 
transcripts are regulated by pathogens and defence-related hormones (Song et al., 
2008; Santos et al., 2009). Furthermore, the over-expression of OsSERK1 confers 
increased resistance to M. oryzae in rice whereas the suppression of LsSERK 
expression in lettuce renders plants more susceptible to Sclerotinia (Hu et al., 2005; 
Santos et al., 2009). This clearly suggests the functional conservation of SERK-
family members in plant defence.  
 
 
 
 34
 
 
1.4.2. Ion fluxes  
 
Seconds to minutes after elicitor treatment ion-fluxes occur across the plasma 
membrane that are easily recordable as growth medium alkalinisation and are often 
used as very early read-outs (Nurnberger et al., 2004). These ion fluxes coincide 
with a rise in cytoplasmic Ca2+ concentration (Jeworutzki et al., 2010). Interestingly, 
different elicitors give rise to different Ca2+-signatures (Aslam et al., 2009), that 
might encode elicitor specific down-stream responses. In the case of LPS, this 
[Ca2+]cyt rise is mediated by the cyclic nucleotide gated channel CNGC2 (Ali et al., 
2007). Pathogen-induced [Ca2+]cyt rise was recently shown to be blocked by adenylyl 
cyclase inhibitor alloxan suggesting a role of cNMPs signalling upstream of [Ca2+]cyt  
alterations (Ma et al., 2009) 
 
Figure 1.1: Multiple functions of BAK1 and other SERK family members 
a) Phylogenetic tree of the SERK protein family. Blue indicates subgroup one 
containing SERK1 and 2, red indicates subgroup two with SERK3 to 5. 
b) BAK1 regulates several important signaling pathways via the direct interaction 
with the ligand binding receptor BRI1, FLS2, EFR, PEPR1/2, and potentially 
unkown PRRs and other receptors (indicated by ???). 
See 1.4.1. for more details also. 
Figure adapted from Chinchilla et al. 2009 
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These different Ca2+ signatures are decoded by calcium binding proteins such as 
calcium dependent protein kinases (CDPKs), calmodulins, calicnerin B-like proteins 
(CBLs) and CBL-interacting protein kinases (CIPKs) (Dodd et al., 2010; Kudla et al., 
2010). Recently, several of these proteins have been implicated in PTI signalling. 
For example OsCIPK14/15 were shown to be positive regulators of EIX induced PTI 
responses in rice and to interact with several CBLs in the yeast two hybrid system 
(Kurusu et al., 2010).  AtCPK1 is rapidly induced transcriptionally after fungal 
elicitor treatment and is a positive regulator of plant resistance to different fungal 
pathogens (Coca and Segundo, 2010). Another study, mainly based on transient 
over-expression studies in Arabidopsis protoplasts identified AtCPK4/5/6/11 as 
major regulators of  flg22-induceed ROS-burst and gene expression downstream of 
calcium and partially independent of MAPK signalling (Boudsocq et al., 2010). This 
clearly demonstrates that calcium is major regulator of PTI. 
 
1.4.3. Phosphorylation and MAPK cascades 
 
Phosphorylation is the earliest measurable response after ligand-induced 
oligomerization (Felix et al., 1991; Schulze et al., 2010). Recent studies identified 
over 2000 constitutively phosphorylated proteins in rice and Arabidopsis (Nakagami 
et al., 2010). Two quantitative studies identified over 70 differentially 
phosphorylated proteins after elicitor treatment (Benschop et al., 2007; Nuhse et al., 
2007). In addition to transmembrane RLKs and calcium-regulated kinases (see 
above) the identity of several other kinases in PTI signalling is known. 
 
1.4.3.1.  Membrane-associated cytoplasmic RLKs regulate PTI signalling 
 
Several membrane-associated cytoplasmic RLKs have been recently implicated in 
PTI signalling (Lu et al., 2010; Zhang et al., 2010). BIK1 (Botrytis induced kinase 1) 
was originally identified as being transcriptionally induced by B. cineria (Veronese 
et al., 2006). Bik1 mutants are more susceptible to necotrophic fungi and more 
resistant to adapted bacterial pathogens Pto DC3000 due to elevated salicylic acid 
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(SA) levels. Interestingly, bik1nahG double mutants, without elevated SA levels, are 
slightly more susceptible to adapted Pto DC3000 than wild-type and nahG control 
plants (Veronese et al., 2006). Indeed, BIK1 was shown recently to be 
phosphorylated after elf18 and flg22 treatment, to interact constitutively with FLS2, 
EFR and potentially BAK1, and to dissociate from the receptor complex in a BAK1-
dependent manner after PAMP treatment (Lu et al., 2010; Zhang et al., 2010). 
Interestingly, mutations of potential phosphorylation sites in the activation segment 
of BIK1, an RD-kinase, abolish not only in vitro kinase activity but also all PAMP-
induced phosphorylation. These kinase dead BIK1 mutant proteins display a 
dominant negative effect on PTI signalling demonstrating the importance of BIK1 
mediated phosphorylation. Notably BIK1 and paralogous cytoplasmic kinases such 
as PBS1 (AvrPphB susceptible 1) and PBS1-like proteins (PBLs) are required for 
PTI signalling downstream of FLS2, EFR and CERK1 (Zhang et al., 2010). 
Importantly, BIK1 and PBLs do not seem to be required for MPK activation in 
response to flg22 (Zhang and Zhou, 2010). 
 
1.4.3.2. MAP kinase cascades in PTI signalling 
 
MAP (mitogen associated protein) kinase cascades are common signalling modules 
in cell signalling pathways. A complete MAP kinase cascade AtMEKK1-
AtMKK4/5-AtMPK3/6 leading to the activation of the transcription factors 
WRKY22/29 was suggested as a positive regulatory module of flg22 signalling 
mainly based on activation and expression studies of constitutively active kinases in 
protoplasts (Asai et al., 2002). However, recent reverse genetic studies demonstrated 
that AtMEKK1 is dispensable for the activation of AtMPK3/6, but is necessary for 
the activation of AtMPK4 (Ichimura et al., 2006; Nakagami et al., 2006; Suarez-
Rodriguez et al., 2006). The MPKKK upstream of AtMKK4/5 is currently unknown. 
The two MAPKKs AtMKK1/2 act upstream of MPK4 (Meszaros et al., 2006; Qui et 
al. 2008). The activation of AtMPK4 after flg22 treatment leads to the 
phosphorylation of MKS1, the release of MKS1 (MAP kinase substrate 1) and 
WRKY33 from the complex and transcriptional activation of defence genes such as 
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PAD3 (phytoalexin deficient 3) (Qui et al., 2008). How these two MAP kinase 
cascades are connected to PRRs at the plasma membrane is one of the fundamental 
questions to be answered. 
 
1.4.3.3. Phosphatases and other negative regulators 
 
Kinases and their targets are under negative regulation by phosphatases to attenuate 
and fine tune signalling. Recently, several phosphatases have been shown to interact 
with and negatively regulate MAP kinases involved in PTI signalling (Bartels et al., 
2010). The PP2C (protein phosphatase 2C)-type dual specific phosphatase AP2C1 
negatively regulates MPK4 and MPK6 and mutants thereof are more resistant to 
mites, but more susceptible to necrotrophic pathogens due to changes in defence 
hormone homeostasis (Schweighofer et al., 2007). Similarly, the MAP kinase 
phosphatases MKP1 (MPK phosphatase 1) and PTP1 (protein tyrosine phosphatase 
1) regulate MPK3/6 activity and double mutants are dwarf, resistant to Pto DC3000 
and overproduce the defence hormone SA (Bartels et al., 2009). Lately, MKP2 was 
shown to dephosphorylate MPK3/6 in vitro, to interact with both MPKs in vivo, and 
to regulate disease resistance as mpk2 mutants are more susceptible to necrotrophic 
fungus B. cinerea and more resistant to the soft rot bacteria R. sonacearum (Lee and 
Ellis 2007; Lumbreras et al., 2010). Whether, these phosphatases regulated PTI 
signalling still awaits further investigation. Importantly, phosphatases also regulate 
PRRs directly. The general kinase-associated protein phosphatase (KAPP) was 
shown to interact with FLS2 kinase domain in the yeast two-hybrid system and to 
negatively regulate FLS2 signalling (Gomez-Gomez et al., 1991). The rice PP2C 
XB15 (Xa21 binding partner 15) binds directly to the kinase domain of XA21, and 
negatively regulates XA21-mediated resistance by dephosphorylating XA21 (Park et 
al., 2008). Intriguingly, XA21 is also under negative regulations by phosphorylation 
as the ATPase XB24 leads to hyper-phosphorylation of XA21 in vitro and 
compromises Xa21-mediated resistance upon overexpression (Chen et al., 2010).  
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1.4.4. The oxidative burst 
 
Many elicitors induce a rapid transient oxidative burst within a few minutes of 
treatment (Nicaise et al., 2009). This involves the production of reactive oxygen and 
reactive nitrogen species (ROS and NOS, respectively) (Ma and Berkowitz, 2007). 
In Arabidopsis the oxidative burst is mainly mediated by the NADPH oxidase 
RbohD (respiratory burst oxidase homolg D) (Meszaros et al., 2006; Zhang et al., 
2007). The ROS-burst appears to be down-stream of the elicitor induced [Ca2+]cyt 
elevations and down-stream of or parallel to MAPK activation (Zhang et al., 2007; 
Boudsocq et al., 2010). Interestingly, it was shown elegantly that the potato NADPH 
oxidates RbohB is phosphorylated on two N-terminal residues after treatment with 
INF1 (Kobayashi et al., 2007). This phosphorylation is mostly mediated by 
StCDPK4/5 and required for full functionality in vivo. Interestingly, it was reported 
that Arabidopsis RbohD is differentially phosphorylated after flg22 treatment 
(Nuhse et al. 2007). As the flg22-induced ROS-production is strongly impaired in 
cpk4/5/6/11 quadruple mutant leaves, it is tempting to speculate that in Arabidopsis 
CPK4, 5, 6 and 11 play partially redundant roles in regulating RbohD via 
phosphorylation (Boudsocq et al., 2010).  
Even though the oxidative burst is a long-described phenomenon its biological 
mechanism and significance in PTI signalling is hardly elucidated. Whereas RbohB- 
silenced N. benthamiana plants are more susceptible to fungal and oomycete 
pathogens (Asai et al., 2008), only minor disease resistance related phenotypes have 
been reported for Arabidopsis rbohD mutants (de Torres et al., 2006; Galletti et al., 
2008; Mersmann et al., 2010). 
 
 1.4.5. Receptor endocytosis  
 
In recent years the importance of endocytosis of transmembrane receptors in animals 
was shown to extend beyond signal attenuation by depleting ligand binding sites at 
the plasma membrane (Murphy et al., 2009). It became apparent that receptors are 
able to signal from endosomes and that endosomal signalling can trigger different 
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physiological responses due to differential complex composition and regulation in 
comparison to plasma-membrane localized signalling (Murphey et al., 2009). FLS2 
was shown to be endocytosed in a ligand specific manner and FLS2 mutants with a 
reduced level of endocytosis display diminished flg22-responsivenes (Robatzek et 
al., 2006). However, it is not clear if FLS2 is able to signal from the endosomes as 
shown for BRI1 (Geldner et al., 2007). In the later case, treatment with the 
endocytosis inhibitor brefeldin A (BFA) leads to ligand-independent endosomal 
accumulation of BRI1 and contributes positively to BR-signalling (Geldner et al. 
2007). Recently, LeEix2 was shown to undergo ligand-induced endocytosis after 
transient expression in N. benthamiana (Bar and Avni 2009). This endocytosis and 
downstream signalling is blocked by co-expression of the EH (Eps15 homology) 
domain containing protein AtEHD2. Interestingly, AtEHD2 over-expression also 
blocks responses mediated by other defence related RLPs, such as CF4 
(Cladopsorium fulvum 4) and CF9 (Stergiopoulos and de Wit, 2009), but  not 
responses mediated by the RK FLS2 (Bar and Avni, 2009a, b). This suggests the 
existence of different endocytitic routes for PRRs depending on there molecular 
identity e.g. RLKs or RLPs. Recently, stomatal cytokinesis defective 1 (SCD1) was 
identified as an in vivo interaction partner for FLS2 by mass spectrometry analysis 
(Korasick et al., 2010). SCD1 is coexpressed with coatomers, dynamins and adaptins 
(ATTED-II, http://atted.jp) suggesting a potential role in trafficking of FLS2. 
Unfortunatley the authors did not investigate FLS2 endocytosis in this mutant. 
Nevertheless SCD1 is important for PTI signaling as scd1 mutants are less sensitive 
to PAMP application, manifested as reduced seedling growth inhibition and ROS 
production triggered by flg22 and elf18 (Korasick et al., 2010). scd1 mutant plants 
are also impaired in proper SA signaling leading to enhanced accumulation of PR1 
transcripts and hydrogen peroxide. Consistenly, scd1 mutant plants are more 
resistant to infection with syringe-infiltrated Pto DC3000 (Korasick et al., 2010).  
Clearly more detailed studies are required to explore the biological function and 
regulatory mechanisms of endosomal signalling in PTI. 
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1.4.6. Signaling from lipid microdomains !?! 
 
Lipid rafts are comprised of membranes organized through interactions between 
sterols and sphingolipids, and are thought to spatially control signaling through 
dynamic association of protein partners. Proteomic studies of lipid raft-associated 
proteins are achieved through the isolation of detergent resistant membranes 
(DRMs), as the tight association of lipids in microdomains reduces the deterget 
solubility of the contained proteins (Borner et al., 2005; Kierszniowska et al., 2009). 
The lipid raft hypothesis remains controversial, though DRMs have been studied by 
several groups (Mongrand et al., 2004; Borner et al., 2005; Morel et al., 2006; 
Fujiwara et al., 2009; Kierszniowska et al., 2009). Proteomic studies of DRMs 
potentially provide knowledge of protein associations, which might be direct or 
indirect, and thus can provide insight into function. PTI signaling could be facilitated 
by close proximity and association of proteins that are contained in the same DRMs. 
A recent study used quantitative proteomics to investigate flg22-induced changes in 
Arabidopsis DRM-associated proteins (Keinath et al., 2010). 64 proteins were 
enriched in DRMs upon PAMP elicitation, including FLS2, though unexpectedly not 
BAK1 (Keinath et al., 2010). DRM-associated differentially identified proteins 
include LRR-RLKs FERONIA (FER), HERCULES (HERK1), remorins, H+-
ATPases (AHA1, AHA2, AHA3, AHA4), Ca2+-ATPases (ACA8 and ACA10) and 
vacuolar ATPase subunit C DET3 (de-etiolated 3) (Keinath et al., 2010). AHA1, 
AHA2 and FER were previously 31 found to be phosphorylated in response to flg22 
treatment (Benschop et al., 2007; Nühse et al., 2007). Mutants of FERONIA, DET3 
and AHA1 were compromised for flg22-induced stomatal closure and concordantly 
had enhanced susceptibility to Pto DC3000 ΔAvrPtoΔAvrPtoB (Keinath et al., 2010). 
Interestingly, FER is involved in signaling for pollen tube reception (Escobar-
Restrepo et al., 2007), as well as cell elongation, where it functions with related 
RLKs HERCULES1 (HERK1) and THESEUS1 (THE1) (Guo et al., 2009). Given 
the promiscuous nature of this protein in several signaling pathways, FER could be a 
signaling adaptor, however a specific FLS2-FER interaction has been proven yet. A 
similar quantitative study was carried out to identify proteins differentially DRM 
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associated in response to the elicitor cryptogein in tobacco BY-2 cells (Stanislas et 
al., 2009). In this study a 14-3-3 protein required for ROS burst was identified, as 
well as several dynamin-related proteins that play a role in trafficking (Stanislas et 
al., 2009). 
 
1.4.7. Signalling regulation by E3 ligases 
 
In animals receptor endocytosis, receptor degradation and down-stream signalling is 
often regulated by ubiquitination (Kawai and Akira, 2010; Lemmon and 
Schlessinger, 2010). Several E3 ligases have been implicated in plant defence in 
general, and a subset specifically in PTI signalling (Trujillo and Shriasu, 2010). The 
three Arabidopsis paralogous E3 ligases PUB22/23/24 (plant U-box 22/23/24) 
negatively regulate PTI signalling downstream of several PRRs, as triple mutants are 
hyper-responsive to flg22, elf18 and chitin treatment and more resistant to the 
adapted bacterial and oomycete pathogens (Trujillo et al., 2008). Interestingly, PTI 
is also under positive regulation by ubiquitination. In rice, the E3 ligase OsXB3 
directly interacts with XA21 and is a specific phosphorylation target in vitro (Wang 
et al., 2006). Silencing of OsXB3 leads to compromised XA21-mediated resistance 
and coincides with reduced amounts of XA21 protein (Wang et al. 2006). This 
suggests that OsXB3 is involved in Xa21 homeostasis. 
 
1.4.8. Modulation of PTI signalling by small interfering RNAs 
 
Small interfering RNAs siRNAs are major regulators of cell signalling and were first 
shown to be implicated in plant development and antiviral defences (Voinnet, 2005; 
Chuck and O'Connor, 2010; Katiyar-Agarwal and Jin, 2010). Recently, however 
they were shown to regulate host-microbe interactions and PTI signalling (Katiyar-
Agarwal and Jin, 2010). Initial reports demonstrated that flg22 treatment 
downregulates auxin signalling via increased expression of the microRNA 
miRNA393 targeting the mRNA of the main auxin receptor TIR1 (transport inhibitor 
response 1) for degradation (Navarro et al. 2006). Also, mutants in the biogenesis 
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pathway of siRNAs, such as ago1, ago4, dcl1 and hen1, are compromised in PTI 
signalling and are more susceptible to adapted and non-adapted bacterial pathogens 
(Agorio and Vera, 2007; Navarro et al., 2008; Li et al., 2010).  
 
1.4.9. Transcriptional reprogramming 
 
PTI signalling cumulates into a massive transcriptional reprogramming observable 
already after 30 min (Navarro et al., 2004; Zipfel et al., 2006). This reprogramming 
comprises up to 3% of the Arabidopsis genome and significantly overlaps with the 
ETI transcriptome (Sato et al., 2010). Elf18 and flg22 induce the same set of genes, 
and ~30% or ~50% of those are also regulated by PGN or chitin, respectively (Zipfel 
et al., 2006; Gust et al., 2007; Wan et al., 2008). This highly significant overlap in 
transcriptional regulation by different PAMPs clearly suggests signal convergence 
after PAMP recognition. Furthermore, comparison of Arabidopsis whole-genome 
transcriptional changes following infection with non-adapted, adapted and non-
virulent bacteria identified over 800 PAMP-regulated genes (Thilmony et al., 2006; 
Truman et al., 2006). Ninety-six of them were up-regulated over a prolonged time 
period of 12 h post-infection by Pto DC3000 mutants defective in their type-III 
secretion system, as well as by four different PAMPs (flg22, elf18, LPS and HrpZ). 
Thus, these genes may represent the initial core PTI response (Truman et al., 2006).  
 
1.4.10. Stomatal closure an important PTI response 
 
Stomata are, in addition to natural wound sites, the major entry points for many plant 
pathogens. PAMP induced stomatal closure is therefore a very effective PTI 
responses to restrict pathogen growth (Melotto et al., 2008). LPS and flg22 treatment 
induce stomatal closure in Arabidopsis leaves and this relies on ABA (absicic acid) 
signalling components such as OST1 (open stomata 1), ABA3 (ABA deficient 3), 
RbohD and GPA1 (G protein alpha subunit 1) (Melotto et al., 2006; Zeng and He, 
2010; Mersmann et al., 2010). A recent study also suggests a predominant role of 
FLS2-dependent PTI signalling for growth restriction meditated by stomatal closure 
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during bacterial infection (Zeng and He, 2010). Stomatal opening is mostly driven 
by the uptake of anorganic cations and concomitant water influx. The two PM 
(plasma membrane) H+-ATPases AHA1 (autoinhibited H+-ATPase isofrom 1) and 
AHA2 are involved in generating the electrochemical gradient required (Merlot et al., 
2002) and were found to be differentially phosphorylated after elicitor treatment 
(Nuhse et al., 2007). It was shown recently that the negative defence regulator and 
effector target RIN4 (RPM1 interacting protein 4) interacts with AHA1 and AHA2, 
thereby directly promoting H+-ATPase activity and preventing stomatal closure (Lui 
et al. 2009). The finding that RIN4 interacts with MPK4 in vivo (Cui et al. 2010) 
makes it tempting to speculate that AHA1 and 2 are direct phosphorylation targets of 
MPK4 representing another layer of regulation.  
 
1.4.11. Callose deposition  
 
Callose deposition is the accumulation of β 1,3-glucans between the plasma 
membrane and the cell wall after elicitor treatment or attack by non-infectious 
pathogens (Nicaise et al. 2010). Callose deposition in Arabidopsis is mostly 
mediated by PMR4 (powdery mildew resistant 4), mutants thereof were originally 
identified as being more resistant to powdery mildew due to elevated SA levels 
(Nishimura et al., 2003). Surprisingly, the same mutant was later found to support 
more growth of T3SS deficient Pto DC3000 (Kim et al., 2005). Nevertheless, pmr4 
pad4 double mutants are slightly more susceptible to non-adapted bacterial Pph 
NPS3121 supporting the idea that callose deposition is important for pathogen 
growth restriction (Ham et al., 2007). Interestingly, callose deposition was linked to 
PAMP-induced glucosinolate production, secondary metabolites associated with 
microbial disease resistance (Clay et al., 2009; Bednarek et al., 2009).  
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1.4.12. Hormone signalling in relation to PTI and general defence  
 
SA, jasmonic acid (JA) and ethylene (ET) are the three major biotic stress hormones 
in plants. However, other hormones, e.g. auxin, ABA and gibberllic acid (GA), also 
influence disease-resistance outcomes (Robert-Seilaniantz et al., 2007). Traditionally, 
SA-dependent defences are implicated in the resistance against biotrophic and 
hemibiotrophic pathogens, whereas JA and ET signalling induces a different, 
sometimes antagonistic set of defence responses effective against necrotrophic 
pathogens, as well as herbivores (Glazebrook, 2005). 
Figure 1.2. Current model of the FLS2 signaling pathway in Arabidopsis 
FLS2 interacts constitutively with SCD1 and the RLCKs BIK1 and PBLs. BIK1 might 
also be associated with BAK1 in the resting state. Upon flg22 binding, a complex forms 
between FLS2, BAK1 and BIK1 almost instantaneously. Other SERKs, such as BKK1 
might also be part of the FLS2 complex. The RLKs FER and HERK as well as the proton 
pumps AHA1 and DET3 are present in flg22-induced detergent-resistant membranes 
where FLS2 resides. Following flg22 binding, multiple phosphorylation events occur 
rapidly. Upon phosphorylation, BIK1 is released from the complex. Flg22 perception 
leads to the activation of at least two MAPK cascades, both involved in the induction of 
defence gene expression. Flg22 binding also triggers a Ca2+-burst that might activate 
Ca2+- dependent protein kinases (CDPKs) and the NADPH oxidase AtRbohD required 
for the ROS burst. Arabidopsis CDPK4, 5, 6 1 and 11 act synergistically and 
independently of the MAPKs to induce defence gene expression. 
Figure and legend adapted from Segonzac et al. unpublished. 
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PAMP treatment or perception are able to increase SA levels and thereby promote 
local and systemic acquired resistance (Durrant and Dong, 2004; Mishina and Zeier, 
2007; Tsuda et al., 2008). In addition expression profiling experiments using mini-
arrays designed to analyse pathogen-responsive genes revealed the partial 
dependence of PTI-mediated gene induction on SA-signalling (Sato et al., 2007). 
Consequently, it was shown that mutations in the SA-signalling network reduce PTI 
induced defences (Tsuda et al., 2008). In a follow up study, Katagiri and co-workers 
recently used a network analysis approach to investigate the individual and 
combinatorial contributions to PTI signalling of  four hormone signalling/biogenesis 
mutants dde2, ein2, pad4 and sid2 (Tsuda et al., 2009). It became apparent that SA, 
JA and ET contribute mostly synergistically to flg22 induced PTI responses (Tsuda 
et al., 2009). This “wipe out and reconstitute stepwise” approach, starting from a 
higher order multiple mutant and adding individual genes until the wild-type genetic 
background is reconstituted, applied in this study (Katagiri and Tsuda, 2010) is very 
helpful to elucidate complex genetic interactions. However, it neglects potential 
pleiotrophic effects on the signalling capacity of these mutants making a clear 
contribution to signalling per se difficult. This was nicely illustrated in a recent 
study demonstrating that FLS2 is under the direct transcriptional control of ethylene 
responsive transcription factors EIN3 (ethylene insensitive 3) and EIL1 (EIN3-like 
1) even in the absence of elicitation (Boutrot et al., 2010).  Mutants in the ethylene 
signaling pathways, such as ein2 and etr1-1, display a constitutively reduced level of 
FLS2 leading to a reduced flg22-responsiveness (Boutrot et al., 2010). These results 
also suggest that elicitor induced ethylene synthesis (Paradies et al., 1980) might be 
part of a positive feedback loop downstream of flg22 perception by increasing FLS2 
transcription (Boutrot et al., 2010).  Importantly, ethylene contributes positively to 
the resistance to Pto DC3000 early in the infection process (Mersmann et al., 2010). 
However, ET most likely interferes with SA-dependent defences at later time points 
via the repression of SID2 (SA induced deficient 2) expression (Chen et al., 2009). 
These results add another layer of complexity, and warrants careful mutant 
phenotypic analysis combined with biochemical studies at different time-points 
during the infection process.  
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Auxin signalling is not only down-regulated by gene silencing (Navarro et al., 2006). 
SA also blocks auxin signalling by stabilizing auxin-response repressors (Wang et 
al., 2007; Kazan and Manners, 2009). Therefore auxin and SA possess antagonistic 
roles in defence signalling. Similarly, ABA behaves antagonistically to SA, as over-
expression of ABA biogenesis genes leads to lowered SA levels after pathogen 
infection and increased susceptibility to several bacterial pathogens (Fan et al., 
2009). In addition, bacterial pathogens actively promote ABA synthesis and 
signalling as a virulence mechanism (de Torres-Zabala et al., 2007).  In contrast, GA 
and cytokinins seem to promote SA signalling (Navarro et al., 2008; Choi et al., 
2010). It was elegantly shown that cytokinin enhances SA signalling via 
transcriptional co-activation mediated by physical interaction of SA- and cytokinin-
regulated transcription factors (Choi et al., 2010). Overall, the interplay between 
PAMP-induced hormone production and initially hormone levels, e.g. influenced by 
environmental conditions and life history, significantly influences disease-resistance 
outcome.  
  
1.5. Pathogens strike back: mechanisms to blur recognition and signalling 
 
Successful pathogens need to avoid and/or suppress recognition by the plant. They 
can disguise their identity by either changing or hiding the epitopes that are 
recognized by the plant (see 1.2). Alternatively, they can disturb intracellular 
signalling downstream of the recognition event. Collectively, molecules that are 
secreted by the pathogen to suppress recognition or signalling are called virulence 
effectors. 
 
1.5.1. Effectors preventing pathogen recognition before elicitor binding 
 
Plants release lytic enzymes into the apoplastic space either as an active defence 
process or after cell collapse (Stergiopoulos and de Wit, 2009). These enzymes 
include chitinases that digest fungal cell wall chitin polymers releasing small chitin 
oligomers that are recognised as elicitors by the plant cell (Silipo et al., 2010). 
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Fungal pathogens have developed two independent strategies to avoid this 
recognition event. The effector Avr4 from C. fulvum binds chitin and protects it 
from basic plant chitinases (van Esse et al., 2007; Westerink et al., 2002). Plants 
constitutively expressing Avr4 are hyper-susceptible to a variety of fungal pathogens 
and C. fulvum silenced for Avr4 is less virulent on tomato (van Esse et al., 2007). 
These results clearly demonstrate the importance of Avr4 during the infection 
process. Intriguingly, C. fulvum employs another apoplastic effector, Ecp6, that is 
able to scavenge small chitin oligomers thereby preventing binding to the cognate 
PRR (de Jong et al., 2010). Interestingly, Ecp6 also employs LysM domains for 
chitin binding similar to plant PRRs, such as CEBiP and CERK1 (de Jong et al., 
2010).  
 
1.5.2. Bacterial polysaccharides suppressing pathogen recognition  
 
Polysaccharides secreted by the bacteria fulfil different biological functions such as 
cell wall fortification, biofilm formation and cell-to-cell communication (Silipo et al., 
2010). Recently, two different classes of bacterial polysaccharides have been 
implicated in the suppression of plant defence. Cyclic glucans have been reported to 
interfere with host defence responses locally and even to be able to suppress defence 
responses in distant leaves (Rigano et al., 2007). The molecular mode of action, 
however, is still unknown. In contrast extracellular polysaccharides (EPS) have been 
shown to directly bind and chelate divalent cations such as Mg2+ and Ca2+ (Aslam et 
al., 2008). Bacterial mutant strains unable to produce EPS are less virulent and 
induced stronger defence responses than wild-type bacteria. In addition, pure EPS 
suppress the Ca2+-burst induced by several different PAMPs and purified EPS is able 
to bind Ca2+ directly (Aslam et al., 2008). This demonstrates that different types EPS 
have distinct function during the infections process. Some elicit defence responses 
whereas others are able to suppress those.  
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1.5.3. AvrPto and AvrPtoB the magic pair of T3SS effectors 
 
AvrPto and AvrPtoB seem to be “all-rounder” amongst effectors being implicated in 
the suppression of multiple signalling pathways (Dodds and Rathjen, 2010). Initially, 
it was demonstrated that AvrPto and AvrPtoB block PTI signalling upstream of 
MAP-kinase activation early on in the signalling cascade and this PTI suppression is 
important as bacterial mutant strains missing either one or both effectors are 
compromised in their virulence (He et al., 2006). Later AvrPto was reported to 
interact with the kinase domains of FLS2 and EFR and thereby quelling kinase 
activity and signalling (Xiang et al., 2008). However, all interaction studies were 
based on transient over-expression in Arabidopsis protoplasts and a later report 
showed that functionally impaired variants of AvrPto are still able to bind FLS2 
questioning the biological significance of the interaction (Shan et al., 2008). The 
authors showed instead that only functional AvrPto is able to interact with BAK1 
after transient over-expression in protoplasts and in the yeast two-hybrid system. 
Furthermore, AvrPto and AvrPtoB blocked the ligand-induced interaction between 
BAK1 and FLS2 or BRI1 (Shan et al., 2008). Importantly, plants constitutively 
over-expressing AvrPto show a bri1-like morphology more severe than bak1 null 
mutants and AvrPto also blocks BAK1-independent PTI pathways such as for chitin 
and NPP1 making it conceivable that AvrPto interferes with these pathways by 
interacting with other SERK-family members (Shan et al. 2008). In the case of 
AvrPtoB, an E3 ligase (Janjusevic et al., 2006), two additional targets were reported. 
AvrPtoB interacts with CERK1 in vivo and in the yeast two-hybrid system, mediates 
its poly-ubiquination in vitro, and induces its degradation via the vacuolar pathway 
in planta (Gimenez-Ibanez et al., 2009). Also, FLS2 was shown to interact with 
AvrPtoB and be poly-ubiquinated by it in vitro and in vivo (Gohre et al., 2008). This 
leads to the degradation of FLS2 via the 26S proteasome pathway. This finding was 
somehow surprising as the E3 ligase domain of AvrPtoB is not required for the 
suppression of FLS2-dependent responses (Gimenez-Ibanez et al. 2009).  
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1.5.4. MAP-kinases as effector virulence targets 
 
Two bacterial effectors have been shown recently to interfere with PAMP-induced 
MAP kinase activation downstream of PRRs. HopF2, an ADP-ribosyltransferase, 
blocks the PAMP-induced activation of MPK4 after transient over-expression in 
Arabidopsis protoplasts (Wang et al., 2010). This inhibition was indirect as HopF2 
interacts with several MAPKKs but not MAPKs in vitro and in protoplasts, 
including MKK5 an MAPKK previously not associated with MPK4 activation 
(Pitzschke et al., 2009a; Pitzschke et al., 2009b). Furthermore, HopF2 is able to 
ADP-ribosylate MKK5 in vitro and this enzymatic activity is required for the 
suppression of PTI responses by HopF2 (Wang et al., 2010). Interestingly, Desveaux 
and co-workers showed that the enzymatic activity of HopF2 and the in planta 
interaction partner RIN4 is required for its virulence function (Wilton et al., 2010). 
This suggests that either RIN4 is the major virulence target or that HopF2 targets 
MKK5 blocking MPK4 and thereby disturbing defence signalling via indirect 
manipulation of RIN4 (Cui et al., 2010; Wilton et al., 2010; Wang et al., 2010). 
Another bacterial effector, HopAI1, was shown to block MPK3 and MPK6 directly 
(Zhang et al., 2007). HopAI1 is a member of an effector family conserved widely 
among animal and plant pathogens (Li et al., 2007). HopAI1 has a protein 
phosphothreonine lyase activity that constitutively deactivates MPK3 and MPK6 by 
dehydroxylating a phospho-threonine in the activation loop preventing potential re-
phosphorylation (Zhang et al., 2007). 
 
1.5.5 Tricking plants into re-open the gates  
 
Plants close their stomata after elicitor recognition to prevent pathogen entry 
(Melotto et al., 2006; Melotto et al., 2008). However, some pathovars (pv) of P. 
syringae are able to trigger stomata re-opening using the non-protenaceous effector 
coronatine (Melotto et al., 2008; Melotto et al., 2006). Coronatine is a phytotoxin 
that structurally mimics the bioactive jasmonate JA-Ile. It binds directly to the 
corresponding JA receptor, the E3-ligase COI1 (Katsir et al., 2008). This most likely 
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leads to the degradation of transcriptional repressor proteins of the JAZ-family and 
activates the JA pathway (Chini et al., 2007; Thines et al., 2007; Katsir et al., 2008). 
Activation of the JA pathway inhibits SA signalling and further downstream NPR1 
(Nonexpresser of PR genses 1)-dependent ABA mediated stomatal closure (Zeng 
and He, 2010). Interestingly, the function of coronatine is not restricted to re-
opening stomata but extents to bacterial infection in the mesophylle space (Melotto 
et al., 2008). 
Recently, Xcc was shown to be able to re-open stomata (Gudesblat et al., 2009b). 
Xcc cells are able to communicate with each other during the infection process using 
a diffusible signal factor (DSF) that induces pathogenicity related gene expression. 
One of these gene products induces stomata re-opening after elicitor recognition. In 
addition, Xcc extracts block ABA-induced stomata closure and can complement the 
virulence defects of Pto strains unable to produce coronatine (Gudesblat et al., 
2009b). The molecular identity is unknown but is most likely distinct from 
coronatine (Gudesblat et al., 2009a). 
 
1.5.6. AvrPphB, a cysteine protease targeting multiple cytoplasmic RLKs 
 
AvrPphB was long known to target the cytoplasmic RLK PBS1 (Shao et al., 2003). 
PBS1 is guarded by RPS5 (Resistant to Pto 5) and the cleavage of PBS1 by 
AvrPphB induces ETI in a PBS1 kinase activity dependent manner (Shao et al., 
2003). However, the virulence function of AvrPphB was unknown until recently. In 
addition to PBS1, AvrPphB cleaves several other cytoplasmic kinases, such as PBLs 
and BIK1 (Zhan et al., 2010), that are involved in PTI signalling immediately 
downstream of several PRRs (Zhan et al., 2010; Lu et al., 2010). Most likely, the 
AvrPphB-mediated disappearance of these cytoplasmic RLKs leads to reduced PTI 
signalling capacity as single and double mutants in these kinases are compromised in 
PTI responses and PAMP induced resistance (Zhang et al., 2010).  
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1.5.7. PTI-suppressing effectors with targets of unknown function in PTI 
signalling 
 
The T3SS effector HopU1 is able to restrict flg22-induced callose deposition in 
transgenic Arabidospsis plants and ADP-ribosylates the RNA-binding protein GRP7 
(glycine rich protein 7) in vitro and in vivo (Fu et al., 2007). Mutants of GRP7 are 
also compromised in flg22- induced callose deposition and are hyper-susceptible to 
disarmed bacterial pathogens supporting a functional role of GRP7 in PTI signalling 
(Fu et al., 2007).  
The bacterial effector HopM1 targets the ARF GEF protein AtMIN7 (HopM 
interactor 1), a protein involved in vesicle trafficking, for ubiquination and 
proteasomal degradation (Nomura et al., 2006). AtMIN7 mutants are compromised 
in callose deposition triggered by a partially disarmed bacterial pathogen suggesting 
a role in vesicle trafficking leading to callose deposition (Nomura et al., 2006). 
However, the detailed functional involvements of both effector targets in PTI are 
currently under investigation.  
 
1.5.8. PTI-suppressing effectors without known targets  
 
Several bacterial, fungal, and oomycete pathogen effectors have recently been 
shown to be able to suppress PAMP-triggered responses, such as ROS burst 
production or callose deposition (Underwood et al., 2007; Sohn et al., 2007; Guo et 
al., 2009; Bos et al., 2010). However, in many cases the molecular details and 
mechanisms of PTI-suppression and its biological significance are still not known.  
 
1.6. From virulence to betrayal: ETI 
 
The second layer of plant inate immunity is based on the recognition of specific 
pathogen effector molecules by plant resistance proteins (Dangl and Jones, 2006). In 
the case of ETI these effectors are historically referred to as avirulence proteins as 
they betray the pathogen to the host creating an incompatible interaction (Dangl and 
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Jones, 2006). In general, these Avr gene/R gene interactions (Flor, 1971) are rather 
restricted to the pathovar/cultivar level (Nurnberger and Kemmerling, 2006). The 
recognition of pathogen effectors can be directly or indirectly and takes place in 
some cases extracellular but mostly intracellular and is under laboratory conditions 
often associated with localized cell death at the infection site termed hypersensitive 
response (HR) (Dodds and Rathjen, 2010). As for most known AVR protein/R 
protein interactions no physical interaction could be observed it was speculated that 
instead of directly interacting with the AVR protein the corresponding R-protein 
would rather guard the biochemical target of AVR and perceive perturbations 
thereof (Jones and Dangl, 2001). In this model the guardee is the virulence target of 
the effector in the absence of the corresponding R-protein (Chisholm et al., 2006). 
This model was extended recently to include AVR protein targets whose sole 
function it is to detect the pathogen. These targets are guarded by an R-protein but 
do not have any other function in defence signalling in the absence of the 
corresponding R-protein (van der Hoorn and Kamoun, 2008). This “decoy” model is 
in evolutionary perspective an extension of the “guard” hypothesis as insomuch the 
guardee can evolve into a decoy reducing multiple structural constrains, being 
functional in signalling, functional in AVR protein recognition and/or to avoid 
effector-mediated perturbation. Importantly, both models rely on indirect effector 
recognition linked to its intrinsic virulence activity. This makes it conceivable that 
several structurally distinct effectors can be recognized by a single R-protein via a 
common guradee/decoy maximizing the recognition potential while reducing fitness 
costs. 
 
1.6.1. R-proteins 
 
R-proteins fall into two major structural classes namely intracellular nucleotide 
binding domain (NB)-LRR proteins or extracellular LRR (eLRR) proteins. In both 
cases the LRR domain is believed to determine effector recognition specificity 
(Collier and Moffet, 2009). 
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1.6.1.1. eLRR R-proteins 
 
This class of R-proteins contains several tomato RLPs conferring resistance to 
specific C. fulvum races (Rivas and Thomas, 2005). For example Cf-2, Cf-4, Cf-5 
and Cf-9 R genes confer resistance to races carrying Avr2, Avr4, Avr5 and Avr9. 
These effectors are small poly-peptides secreted into the leaf apoplast during 
infection where they were shown to inhibit plant enzymes such as proteases and 
chitinases (Steriopoulos and de Wit, 2009). No direct interaction could be shown for 
any of these AVR proteins with their respective R-protein. In the case of Avr2 it was 
shown that its recognition event depends on the interaction with the cysteine 
protease Rcr3 but on its inhibition (Rooney et al., 2005). However, it is not clear if 
Rcr3 directly interacts with Cf-2 representing a bona fide guardee. 
 
1.6.1.2. NB-LRR R-proteins 
 
The largest class of R-proteins comprises NB-LRR R-proteins. The central 
nucleotide binding site is part of a larger NB-ARC domain which is also found in 
apoptosis related proteins from animals (Collier and Moffet, 2009). These domains 
are generally involved in ATP binding, hydrolysis and important for downstream 
signalling. In plants they can be divided in two subclasses that are correlated with 
the N-terminal characteristics of the R-protein and are speculated to be involved in 
down-stream signalling specificity (Lukasik and Takken, 2009). According to the 
identity of the  N-terminal domain, NB-LRR proteins are subdivided into coiled-coil 
(CC-)-NB-LRR proteins or  Toll and human interleukin-1 receptor (TIR) domain 
carrying NB-LRR proteins (Chisholm et al., 2006). The CC and TIR domains appear 
to function as homo- and hetero-dimerization regions, and also interact with 
upstream signalling parterns such as avirulence proteins, guardees or decoys (De 
Young and Innes, 2006; Lukasik and Takken, 2009). Therefore, in addition to the 
LRR-domain, the N-terminal domain also contributes to recognition specificity of 
AVR proteins (Dodds and Rajthen, 2010).  
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1.6.1.2.1. CC-NB-LRR proteins and their recognition events 
 
CC-NB-LRR proteins are mostly membrane associated, and include Arabidopsis 
RPM1, RPS2, tomato Prf and barley MLA10 (Intracellular mildew A 10) (Dangl and 
Jones, 2006). The two distinct R-proteins RPM1 and RPS2 interact with the same 
guardee RIN4 that inhibits their activation (Mackey et al., 2002; Axtell and 
Staskawicz, 2003; Mackey et al., 2003). However, in response to AVR perception 
both R-proteins detect different post-translational modifications of RIN4. The 
bacterial effector AvrRpt2 degrades RIN4, thereby activating RPS2 which leads to 
ETI and restriction of bacterial growth (Axtell and Staskawicz 2003; Mackey et al., 
2003). The two unrelated bacterial effectors AvrB and AvrRpm1 are recognized by 
RPM1 and this recognition event is associated with RIN4 phosphorylation (Mackey 
et al., 2002). This phosphorylation is an indirect effect of the effector function and in 
the case of AvrB potentially mediated by MPK4 (Cui et al., 2010).  
The tomato CC-NB-LRR protein Prf recognizes two distinct bacterial effectors 
AvrPto and AvrPtoB indirectly by forming a constitutive complex with its guardee 
the Ser/Thr kinase Pto (Mucyn et al,. 2006; Dodds and Rathjen, 2010). AvrPto and 
AvrPtoB are unrelated structurally and functionally but both elicit ETI by interfering 
with an oligomeric Prf-Pto complex, which potentially contains other Pto-family 
members such as Fen (Gutierrez et al., 2010; Dodds and Rathjen, 2010). AvrPto 
does not have any known enzymatic activity and displays a three-helix bundle fold 
with a characteristic omega loop important for interaction with Pto (Wulf et al., 
2004). AvrPto seems to stabilize the active kinase structure of Pto by interacting 
with an N-terminal loop and the P+1 loop (Xing et al., 2007). This induced 
conformational change was suggested to mediate Prf-dependent ETI. In the case of 
AvrPtoB the middle part of  the protein folds into a four-helix bundle and interacts 
with Pto via two similar interfaces compared with AvrPto. However, the primary 
amino acid sequence employed by either effector is very different (Dong et al., 
2009). AvrPtoB carries an E3 ligase domain in the C-terminus that is important for 
defence suppression as C-terminal deletion mutants are recognized in pto-tomato 
plants (Janjusevic et al., 2006). Interestingly, the recognition of this truncated 
 55
AvrPto was shown to be dependent on Prf and is mediated by direct interaction with 
Fen, a Pto homologe (Rosebrock et al., 2006). Fen is normally degraded by AvrPtoB 
via its E3 ligase activity and Pto is able to inactivate AvrPtoB by phosphorylation of 
a serine residue in the active site due to its stronger kinase activity (Ntoukakis et al., 
2009). These studies clearly exemplify the so called “arms-race” between pathogens 
and its potential host.  
Interestingly, the barley CC-NB-LRR MLA10 recognizes the fungal effector Avr10 
(Ridout et al., 2006) and this recognition leads to the translocation of MLA10 into 
the nucleus where it interacts with two WRKY transcription factors (Shen et al., 
2006). Notably, these transcription factors and their Arabidopsis homologs are 
negative regulators of basal immunity against bacterial and fungal pathogens, and 
are up-regulated transcriptionally after elicitor treatment (Shen et al., 2006). Thus 
the authors speculated that the interaction with the R-protein might lead to de-
repression of PTI signalling (Shen et al., 2006). Intriguingly, several other R-
proteins were shown to require a nuclear pool for ETI activation (Burch-Smith et al., 
2007; Wirthmueller et al., 2007).   
 
1.6.1.2.2. TIR-NB-LRR proteins and their recognition events 
 
TIR-NB-LRRs are cytoplasmic-and nuclear-localized proteins including Arabidopsis 
RPS4, flax L proteins and tobacco N protein (Gassmann et al. 1999, Dodds et al. 
2006, Whitham et al. 1994). RPS4 recognizes the bacterial effector AvrRPS4 via an 
unknown mechanism (Gassmann et al., 1999). In the case of the flax L R-proteins it 
was shown that different alleles of L proteins recognize different AvrL567 proteins 
via direct interactions at least partially mediated by the LRR domain (Dodds et al., 
2006).  The tobacco N protein recognizes the virus helicase domain p50 indirectly 
and forms a tertinary complex including the sulfurtransferase NRIP1 (Caplan et al. 
2008). The normally chloroplastic localized NRIP1 relocalizes to the cytoplasm and 
nucleus in the presence of p50 and is required for N-dependent ETI. However, it is 
questionable whether NRIP1 is the real guardee of N or mediates downstream 
signalling after p50 recognition.  
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1.6.2. Genetic requirement for ETI signalling 
 
Several R genes require SGT1 (Skyp1-Cullin-F-box protein), RAR1 (Required for 
MLA12 resistance 1) and HSP90 (Heat shock protein 90) for protein stability and/or 
signalling (Shirasu, 2010). RAR1, a CHORD domain containing protein, was 
initially identified as being essential for MLA function in barley (Shirasu et al., 
1999). SGT1 interacts with RAR1 in vivo and is required for signalling of several R-
proteins in different plant species (Austin et al., 2002; Azevedo et al., 2002). The 
third protein in the complex was shown to be the chaperone HSP90 that is required 
for full RPS2-mediated resistance (Takahasi et al., 2003). The RAR1-SGT1-HSP90 
chaperone complex functions in the stabilization, translocation and/or activation of 
NB-LRR proteins most likely in keeping them in a tight “signal-ready” confirmation 
before AVR protein recognition (Shirasu, 2009). 
In general the two major classes of plant R-proteins CC-NB-LRR and TIR-NB-LRR 
have a differential genetic signal transduction requirement of either NDR1 or EDS1-
PAD4-SAG101, respectively (Aarts et al. 1998, Wiermer et al. 2005). NDR1 (Non 
race-specific disease resistance) was initially identified as a locus in Arabidopsis 
required for the recognition of several bacterial avirulence proteins and resistance 
against incompatible Hyaloperonospera arabidopsidis (Hpa) races (Centruy et al. 
1995). NDR1 posses several potential transmembrane domains (Century et al., 1997) 
and is localized to the plasma membrane via a GPI-anchor (Coppinger et al., 2004). 
Its exact molecular function is currently unknown. Similarly the molecular functions 
of EDS1 (Enhanced disease susceptibility 1), PAD4 and SAG101 (Senescence-
associated gene 101) are unknown, however, all display structural similarities to 
lipases or lipid binding proteins (Wiermer et al. 2005). Furthermore, EDS1 was 
linked to reactive oxygen species and chloroplast related signalling (Wiermer et al., 
2005; Straus et al., 2010).  EDS1 and PAD4 were initially found to interact in the 
yeast two-hybrid system and in vivo (Feys et al., 2001). Mutant analysis suggested 
that EDS1 functions independently of PAD4 in the early events after AVR protein 
recognition, but later PAD4 and EDS1 function together in the amplification of 
defence responses (Feys et al., 2001). The structurally related protein SAG101 was 
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identified as an in vivo interaction partner of EDS1 and these interactions contribute 
to protein stability (Feys et al., 2005). Interestingly, EDS1, PAD4 and SAG101 not 
only contribute to ETI but play a partial redundant role in basal and non-host 
resistance to adapted and non-adapted bacterial, fungal and oomycete pathogens 
(Feys et al., 2005; Lipka et al., 2005).  
 
1.7. Prologue  
 
The following paragraph depicts literally the summary of my research project 
proposal written by myself at the beginning of my PhD. 
Pathogen-associated nolecular pattern (PAMP)-triggered immunity (PTI) can be 
seen as the first layer of defense in plants. However the signalling events 
downstream of PAMP perception are poorly understood and no comprehensive 
genetic screen has been published. Previously, a screen has been performed by Cyril 
Zipfel to identify EF-Tu insensitive (elfin) mutants.  Out of 167 elfin mutants, only 
one elfin mutant showed blocked or reduced responses to both flagellin and EF-Tu 
(the two most studied PAMPs in Arabidopsis).  This was surprising as the current 
model of PTI (PAMP-triggered immunity) signalling suggests an early conversion 
of signalling after flagellin and EF-Tu perception by their respective receptors.  
During the course of my PhD, I will first map-based clone and genetically confirm 
this exceptional elfin mutant, which appears to be defective in a positive regulator of 
PTI signaling. Furthermore, I will characterize the phenotype of the knockout and 
over-expression lines towards different PAMPs and a wide range of host and non-
host pathogens. I will also study the molecular function and interaction of the gene 
product in further detail, which will depend on the gene’s identity.  
To complement the aforementioned analysis of a positive regulator of PTI, I will use 
the FOX- (Full-length cDNA Over-eXpressing gene) hunting system to screen for 
negative regulators in the laboratory of Dr. Ken Shirasu in Japan (Riken, Yokohama). 
I will use the previously developed seedling growth inhibition screen to identify 
lines insensitive either to EF-Tu or flagellin.  Due to the fast identification of the 
genes involved, I will be able to select one or two interesting candidates which are 
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blocked in the response to both PAMPs. Those will be confirmed by re-
transformation of Arabidopsis thaliana with an over-expression construct. 
Furthermore, I will identify single/multiple mutants of the gene/gene family. Those 
will be analyzed in the same respect as mention before for the positive regulator.  
Finally, I will search for and analyze orthologs in other plant species and test their 
importance and evolutionary conservation in PTI signalling.   
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Chapter 2: Material and methods 
 
2.1.  Plant material and growth conditions 
 
2.1.1.  Arabidopsis thaliana 
 
2.1.1.1. Growth conditions 
 
The Arabidopsis plants were grown in controlled environment chambers on soil or 
MS salt medium (Duchefa), 1% sucrose and 1% agar with a 10 H or 16 H 
photoperiod at 20-22oC and 65 % humidity. The third backcross of bak1-5 with Col-
0 was used for all experiments.   
Table 2.1. List of Arabidopsis thaliana lines used in this study. 
Lines Description Reference 
Col-0 Columbia 0, wild-type reference 
line 
 
Ler Landsberg erecta ecotype, 
parental mapping line  
 
Ws-0 Wassilewskija 0   
Ws-eds1 EMS induced mutation in EDS1 
in the Wassilewskija 0 ecotype 
(Parker et al., 1996) 
psb27-1 knock-out of the D1 repair protein 
Psb27 
(Chen et al., 2006) 
ex1 knock-out mutant of Executer1 (Lee et al., 2007) 
ex2 knock-out mutant of Executer2 (Lee et al., 2007) 
ex1/2 Double knock-out mutant of 
Executer1 and Executer2 
(Lee et al., 2007) 
CSD2 OE Over-expression line of Cu/Zn 
Dismutase 2 
(Myouga et al., 2008) 
fls2 knock-out mutant of the PRR 
FLS2 
(Zipfel et al., 2004) 
efr knock-out mutant of the PRR (Zipfel et al., 2006) 
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EFR 
fls2 efr double knock-out mutant of FLS2 
and EFR 
(Nekrasov et al., 2009) 
bak1-4 knock-out mutant of BAK1 (Chinchilla et al., 2007) 
bak1-5 EMS-induced missense 
substitution mutant in BAK1, 
three times back-crossed to Col-0 
(Schwessinger et al., 
submitted) 
fls2 efr bak1-5 triple mutant generated by 
crossing fls2 efr with bak1-5 
 
bkk1-1 knock-out mutant of BKK1 (He et al., 2007) 
bak1-4 bkk1-1 double mutant generated by 
crossing bak1-4 with bkk1-1 
(Schwessinger et al., 
submitted) 
bak1-5 bkk1-1 double mutant generated by 
crossing bak1-5 with bkk1-1 
(Schwessinger et al., 
submitted) 
bak1-4 pBAK1::BAK1 bak1-4 expressing BAK1 under its 
own regulatory sequence 
(Schwessinger et al., 
submitted) 
bak1-4 pBAK1::BAK1-5 bak1-4 expressing BAK1-5 under 
its own regulatory sequence 
(Schwessinger et al., 
submitted) 
bak1-4 pBAK1::BAK1* bak1-4 expressing BAK1 
(D418N) under its own regulatory 
sequence 
(Schwessinger et al., 
submitted) 
bak1-4 pBAK1::BAK1-5* bak1-4 expressing BAK1-5 
(D418N) under its own regulatory 
sequence 
(Schwessinger et al., 
submitted) 
bri1-301 missense mutation in BRI1 (Xu et al., 2008) 
bri1-301 bak1-4 double mutant generated by 
crossing bri1-301 with bak1-4 
(Schwessinger et al., 
submitted) 
bri1-301 bak1-5 double mutant generated by 
crossing bri1-301 with bak1-5 
(Schwessinger et al., 
submitted) 
bak1-4 pBAK1::BAK1:Myc bak1-4 expressing cBAK1:Myc 
under its own regulatory sequence 
(Chinchilla et al., 2007) 
bak1-4 pBAK1::BAK1:HA3 bak1-4 expressing BAK1:HA3 
under its own regulatory sequence 
present study 
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bak1-4 pBAK1::BAK1-
5:HA3 
bak1-4 expressing BAK1-5:HA3 
under its own regulatory sequence 
present study 
bak1-4 pBAK1::BAK1:GFP bak1-4 expressing 
BAK1:GFPunder its own 
regulatory sequence 
present study 
bak1-4 pBAK1::BAK1-
5:GFP 
bak1-4 expressing BAK1-5:GFP 
under its own regulatory sequence 
present study 
 
2.1.1.2. Stable transformation of A. thaliana  
 
The transgenic Arabidposis plants were generated using floral dip method (Clough 
and Bent, 1998).  Briefly, flowering Arabidopsis plants were dipped into suspension 
culture of Agrobacterium tumefaciens Agl1 carrying the indicated plasmid. Plants 
carrying a T-DNA insertion event were selected either on MS media containing the 
appropriate selection or as soil grown seedlings by the spray application of PPT 
(Phosphinotricine, Duchefa). 
 
2.1.1.3. Generation of Arabidopsis F1 and F2 progeny 
 
Fine tweezers were used to emasculate an individual flower. To prevent self-
pollination, only flowers that had a well-developed stigma but immature stamen 
were used for crossing. Fresh pollen from three to four independent donor stamens 
was dabbed onto each single stigma. Mature siliques containing F1 seed were 
harvested and allowed to dry. Approximately five F1 seeds per cross were grown as 
described above and allowed to self pollinate. Produced F2 seeds were collected and 
stored. 
 
2.1.1.4. Arabidopsis seed sterilization 
 
For in vitro growth of Arabidopsis, seeds were sterilized. Approximately 50 - 100 
Arabidopsis seeds were put into a 1.5 mL tube. Tubes were put in a plastic rack. 100 
ml of 12% Sodium-hypochloride solution (chlorine bleach) were poured into a 
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beaker and put together with the seed into a desiccator. 10 mL of 37% HCl was 
directly added into the hypochloride solution so that yellow-grenish vapours were 
forming and the solution was bubbling heavily. The lid of the desiccator was closed 
immediately. This was left for 4 – 8 H. After the sterilization period, the desiccator 
was slightly opened under a fume hood for 5 min to let out the gas.  
 
2.1.2. Nicotiana benthamiana 
 
2.1.2.1. Growth conditions  
 
N. benthamiana plants were grown in controlled environment chambers at an 
average temperature of 24°C (range 18-26°C), with 45-65% relative humidity under 
long day conditions (16 H light).  
 
2.1.2.2. Transient transformation 
 
Agrobacteria cells from overnight cultures grown at 28°C in low-salt LB were 
harvested by centrifugation at 3500 rpm and resuspended in buffer containing 10 
mM MgCl2 to a final OD600nm of 0.3. The cultures were incubated at room 
temperature for 1 H and then hand-infiltrated on leaves of three to four week old N. 
benthamiana leaves using 1 mL needless syringe. All samples were taken 2 days 
post infiltration. 
 
2.2. PAMP assays 
 
2.2.1. PAMPs 
 
The following elicitors were used in this study: crab shell chitin (Sigma, UK), flg22 
peptide (CKANSFREDRNEDREV) (Peptron, South Korea), elf18 peptide (ac-
SKEKFERTKPHVNVGTIG) (Peptron, South Korea), and AtPep1 peptide 
(ATKWKAKQRGKEKVSSGRPGQHN) (Peptron, South Korea). 
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2.2.2. Seedling growth inhibition 
 
Fresh harvested seeds were surface sterilized, sown on MS media, stratified for 2 
days at 4oC in the dark and put in the light. Five-day-old seedlings were transferred 
into liquid MS with or without the indicated amount of peptide and incubated for 
eight further days. Dry weight of six replicates per treatment was measured using a 
precision scale (Sartorius) and blotted relative to untreated control. 
 
2.2.3. ROS burst assay 
 
Eight leaf discs (4 mm diameter) of at least four 3-4 week plants were sampled using 
a cork borer and floated over night on sterile water. The following day the water was 
replaced with a solution of 17 mg/mL (w/v) luminol (Sigma) and 10 mg/mL 
horseradish peroxidase (Sigma) containing 100 nM elf18 or 100 nM flg22. 
Luminescence was captured either using a Varioskan Flash (Thermo Scientific) 
multiplate reader or Photek camera (East Sussex, UK). The amount of relative light 
units might differ depending on the light capturing apparatus used. 
 
2.2.4. MAP kinase assay 
 
14-days-old seedlings were grown for five days on MS plates and than transferred to 
liquid MS. Triplicates of two seedlings each were treated with water, 100 nM elf18 
or 100 nM flg22 for 0, 5 and 15 min before being pooled for harvest. Seedlings were 
ground to fine powder in liquid nitrogen and solubilised in better lacus buffer [50 
mM Tris-HCl pH 7.5; 100 mM NaCl; 15 mM EGTA; 10 mM MgCl2; 1 mM NaF; 1 
mM Na2MoO4.2H2O; 0.5 mM NaVO3; 30 mM β-glycerophosphate; 0.1% IGEPAL 
CA 630; 100 nM calyculin A (CST); 0.5mM PMSF; 1 % protease inhibitor cocktail 
(Sigma)]. The extracts were centrifuged at 16,000 x g, the supernatant cleared by 
filtering through Miracloth and 4xLDS loading buffer (Invitrogen) added. 40 μg of 
total protein was separated by SDS-PAGE and blotted onto PVDF membrane 
(Biorad). Immunoblots were blocked in 5% (w/v) BSA (Sigma) in TBS-Tween 
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(0.1%) for 1-2 H. The activated MAP kinases were detected using anti-p42/44 
MAPK primary antibodies (1:1000, Cell Signaling Technology) overnight, followed 
by anti-rabbit-HRP conjugated secondary antibodies (Sigma). 
 
2.2.5. PAMP-induced defence gene induction 
 
14-days-old seedlings grown for five days on MS plates and than transferred to 
liquid MS were used for all gene induction studies. RNA was extracted using 
RNeasy Plant Mini kit (Qiagen) followed by DNase-treatment using Turbo DNA-
free (Ambion) and quantified with a Nanodrop spectrophotometer (Thermo 
scientific). cDNA was synthesized from 2.5 μg total RNA using SuperScript III 
reverse transcriptase (Invitrogen). SybrGreen master mix (Sigma) was used for 
qPCR reactions. 
For defence gene induction analysis a triplicate of two seedlings each was treated 
either with water, 100 nM elf18 or 100 nM flg22 for 0, 30, 60 and 180 min and 
pooled before harvesting. Gene expression of At2g17740 (DC1-domain containing 
protein), At5g57220 (CYP81F2) and At1g51890 (LRR-RLK) was monitored by 
qPCR analysis. The expression of each marker gene was normalized to the internal 
reference gene At4g05320 (UBQ10) and plotted relative to the Col-0 steady-state 
expression level. 
 
2.2.6. PAMP-induced ethylene production 
 
Plants were grown for 6 weeks before sampling 2 mm leaf strips from 4 plants per 
genotype. Ethylene assays were performed as described by Felix et al. (1999) using 
1 μM flg22, elf18 or AtPep1. 
 
2.2.7. Crude elicitor extract preparation 
 
Pta 6605 was grown O/N at 28oC in Kings B medium supplemented with 
appropriate antibiotics. Spun down at 4,000 x g for 15 min, washed with 1 volume 
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sterile water and re-suspended in 1/10 volume sterile water. The extract was boiled 
for 10 min at 95oC, spun down and supernatant applied at a final concentration of 
0.1 (v/v).  
A. brassicicola was grown on V8 plates containing 0.8 % agarose for 14-days at RT 
in the dark. Biomaterial was harvested by scraping the plate, washed, filtered 
through Miracloth and re-suspended in sterile water.  The extract was boiled for 10 
min at 95oC, spun down and supernatant applied at a final concentration of 0.1 (v/v).  
For Hpa crude elicitor extraction the following method was done. The aerial parts of 
3-4 week old Ws-0 eds1-1 infected (Hpa Emoy2, 7dpi) or non-infected plants were 
harvested and frozen in liquid nitrogen. 20 mL of cold sterile water was added and 
mixed vigorously by vortexing. The suspension was cleared of plant debris by 
filtering through Miracloth and enriched for heavier particles by centrifugation at 
300 rpm for 15 min. The supernatant was removed, the pellet resuspended in 3 mL 
of sterile water and heated at 95oC for 10 min. These suspensions were used in a 
concentration of 1:100.  
In the case of Albugo laibachii Alem1 and A. candida 20DD5 bio-samples were 
supplied by Eric Kemen (Sainsbury Laboratory, Norwich, UK). Crude elicitor 
extractions were performed as described for Hpa. 
 
2.3. BR assays 
 
2.3.1. Hypocotyl growth assay 
 
Freshly harvested seeds were surface sterilized and stratified in sterile water at 4oC 
for 4-6 days in the dark. Individual seeds were put on ½ MS containing 0.8% 
pythoagar (Duchefa) without hormone, with 100 nM BL or with 100 nM BRZ and 
left up-right in the dark at 20-22oC. Hypocotyl length was measured after 5-day 
incubation. 
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2.3.2. Root growth assay 
 
Freshly harvested seeds were surface sterilized and stratified in sterile water at 4oC 
for 4-6 days in the dark. Individual seeds were put on ½ MS containing 0.8% 
pythoagar (Duchefa) without hormone, with 0.1, 1 or 10 nM BL and left up-right in 
long day conditions at 20-22oC. Root length was measured after 7-day incubation. 
 
2.3.3. BR-responsive gene expression analysis 
 
14-days-old seedlings grown for five days on MS plates and than transferred to 
liquid MS were used for all gene induction studies. RNA was extracted using 
RNeasy Plant Mini kit (Qiagen) followed by DNase-treatment using Turbo DNA-
free (Ambion) and quantified with a Nanodrop spectrophotometer (Thermo 
scientific). cDNA was synthesized from 2.5 μg total RNA using SuperScript III 
reverse transcriptase (Invitrogen). SybrGreen master mix (Sigma) was used for 
qPCR reactions. 
For BR gene expression analysis a triplicate of two seedlings each was treated with 
either mock solvent control or 2.5 μM BRZ (Sigma) for 16 H over night. The next 
morning samples were further treated with mock solvent control or 200 nM 
brassinolide (SRICI) for another three hours before being pooled for harvesting. 
Gene expression of At2g40610 (EXP8) and At4g38850 (SAUR-ACI) was monitored 
by qPCR analysis. The expression of each gene was normalized to the internal 
reference gene At5g15400 (U-box containing protein) and plotted relative to the Col-
0 double mock treated expression level.  
 
2.4. Pathogen assays 
 
2.4.1. Bacterial spray-inoculation of Arabidopsis 
 
The Pto DC3000 or Pta 6605 strains were grown in overnight culture in Kings B 
medium supplemented with appropriate antibiotics. Cells were harvested by 
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centrifugation and pellets resuspended in sterile water to appropriate OD600 (0.2 for 
Pto DC3000 ΔAvrPto/ΔAvrPto and Pto DC3000 COR-; 0.02 for Pto DC3000). 
Immediately prior to spraying, Silwett L-77 was added to bacteria to 0.04 % (v/v). 
Bacteria were sprayed onto leaf surfaces until run-off and plants maintained at high 
humidity for 3 days. For syringe inoculation of Pta 6605, bacteria were similarly 
grown and harvested. Cell pellets were resuspended in sterile water to O.D. 600 0.002 
and infiltrated using a needleless syringe into 2 leaves each of 4 plants per genotype. 
Samples were taken using a cork-borer (2 mm) to cut leaf discs from 2 leaves per 
plant and 4 plants per genotype. Leaf discs were ground in water, diluted and plated 
on TSA with appropriate selection. Plates were incubated at 28°C and colonies 
counted 2 days later.  
 
2.4.2. H. arabidopsidis inoculation and scoring on Arabidopsis  
 
Hpa infections were performed as described by Tör et al., 2002. Spores were 
harvested from infected Ws-eds1 seedlings 7 days post-inoculation, suspended in 
cold water at a density of 5 x 104 spores/mL and spray-inoculated onto 7-day-old 
seedlings to the point of run-off. Inoculated seedlings were incubated at high 
humidity at 18°C for 7days then sporulation was assessed. The growth of the Hpa 
strains Cala2 and Emoy2 was assessed by counting the number of sporangiophores 
per cotyledon. The reproduction of the Hpa strain Emco5 infection was determined 
by vortexing sporulating seedlings in water and by quantifying spores using a 
haemocytometer. 
 
2.4.3. Bacterial spray-inoculation of N. benthamiana 
 
The Pta 11528 or P.syringae pv. syringae (Pss) B728a strains containing the broad 
host range vector construct pTD600 were grown in overnight culture in Kings B 
medium supplemented with appropriate antibiotics. Cells were harvested by 
centrifugation and pellets resuspended in sterile water to OD600 of 0.002. 
Immediately prior to spraying, Silwett L-77 was added to bacteria to 0.04 % (v/v). 
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Bacteria were sprayed onto leaves infiltrated the previous day with sterile water or 
Agrobacterium containing the indicated construct until run-off. Samples were taken 
using a cork-borer (2 mm) to cut leaf discs from 2 leaves per plant and 4 plants per 
genotype. Leaf discs were ground in water, diluted and plated on TSA with 
appropriate selection. Plates were incubated at 28°C and colonies counted 2 days 
later.  
 
2.4.4. Pathogens used in this study 
 
Table 2.2. Summary of pathogens used in this study. 
Pathogen Reference 
Pseudomonas strains 
Pta 11528  
Pta 6605  
Pss B728a  
Pto DC3000  
Pto DC3000 ΔAvrPto/ΔAvrPto (Lin and Martin, 2005) 
Pto DC3000 COR- (Melotto et al., 2006) 
Hyaloperonospora arabidopsidis isolates 
Cala2 (Holub, 2007) 
Emco5 (Holub, 2007) 
Emoy2 (Holub, 2007) 
Other oomycete pathogens 
Albugo laibachii Alem1 Eric Kemen, unpublished 
Albugo candida 20DD5 Eric Kemen, unpublished 
Fungal pathogen 
Botrytis cinerea 
Alternaria brassiciola 
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2.5. Molecular biological methods 
 
2.5.1. DNA methods 
 
2.5.1.1. Isolation of genomic DNA from Arabidopsis 
 
The extraction DNA extraction method yields relatively poor quality DNA sufficient 
for standard PCR. Aliquots were stored at -20° C. Small leaf samples of an area of 
about 25 mm2 was taken with a pair of tweezers and 400 μL of DNA extraction 
buffer were added. The tissue in the tube was crushed either using a grinder and blue 
pestles or by adding a small steel ball and shaking. The solution was centrifuged at 
maximum speed for 5 min in a microcentrifuge and 300 μL supernatant were 
transferred to a fresh tube. One volume of isopropanol was added to precipitate 
DNA and centrifuged at maximum speed for 5 min in a microcentrifuge. The 
supernatant was discarded carefully. The pellet was washed with 70% ethanol and 
dried. Finally the pellet was dissolved in 100 μL sterilized water and 1 μl of the 
DNA solution was used for a 20 μL PCR reaction mixture. 
 
2.5.1.2. PCR methods 
 
All PCR reactions were carried out in using a PTC-225 Peltier thermal cycler (MJ 
Research). 
 
2.5.1.2.1. Standard PCR 
 
This method was used when no sequence accuracy was required. Briefly; the PCR 
reaction mix contained 2 μL10 x reaction buffer, 0.6 μL 10 mM of each primer, 0.4 
μL 2 mM dNTP mix, 0.1 μL Taq polymerase (NEB), 13.6 μL dH2O and 1 μL of the 
DNA template solution. A typical Standard PCR thermal profile is shown below. 
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Table 2.3. Standard PCR thermal profile. 
 
Stage Temperature (oC) Time period No. of cycle 
Initial denaturation 94 3 min 1 x 
Denaturation 94 15 sec  
Anealing 50-60 15 sec 25 – 40 x 
Extension 72 1 min per kb  
Final extension 72 10 min  1 x 
 
2.5.1.2.1. Colony PCR 
 
The previously described PCR conditions were used with slight adjustments 
(2.5.1.2.1.). Instead of the DNA template a small pipette tip of colonies showing 
antibiotic resistance were added to each reaction and the volume was adjusted 
adding 1 μL of dH
2
O. Additionally, the samples were heated for 10min at 94oC 
before the first cycle. Each colony was streaked out onto a fresh LB plate containing 
the appropriate antibiotic selection 
 
2.5.1.2.3. Hi-fidelity PCR 
 
This method was used when sequence accuracy was required. Briefly; the reaction 
mix contained 2 μL 2 mM dNTP mix, 1 μL 2 mM of each primer, 4 μL 5 x hifidelity 
buffer, 0.6 μL DMSO, 1 μL of the template cDNA and, 11.2 μL dH2O and 0.2 μL 
Phusion polymerase (Finzyme). The mix was kept on ice and put in the thermocycler 
when it reached 98oC. A typical hi-fidelity PCR thermal profile is shown below. 
Table 2.4. Hi-fidelity PCR thermal profile. 
 
Stage Temperature (oC) Time period No. of cycle 
Initial denaturation 98 1 min 1 x 
Denaturation 98 10 sec  
Anealing 55-62 15 sec 20 – 30 x 
Extension 72 20 sec per kb  
Final extension 72 5 min  1 x 
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2.5.1.2.4. Targeted mutagenesis PCR 
 
This method was used to introduce a desired mutation within a DNA sequence. 
Briefly; the reaction mix contained 4 μL 2 mM dNTP mix, 2.5 μL 2 mM of each 
primer, 10 μL 5 x GC-rich buffer, 1.5 μL DMSO, 1 μL of the template plasmid (25 
μg/ μl) and, 28.25 μL dH2O and 0.75 μL Phusion polymerase (Finzyme). The mix 
was kept on ice and put in the thermocycler when it reached 98oC. A typical targeted 
mutagenesis PCR thermal profile is shown below. 
Table 2.5. Targeted mutagenesis PCR thermal profile. 
 
Stage Temperature (oC) Time period No. of cycle 
Initial denaturation 98 1 min 1 x 
Denaturation 98 10 sec  
Anealing 55 15 sec 12 x 
Extension 72 20 sec per kb  
Final extension 72 5 min  1 x 
 
The PCR reactions were brought to room temperature and 1 μl DpnI per reaction 
was added. Reactions were incubated O/N at 37oC and 5 μl used to transform E. coli 
DH5α. 
 
2.5.1.2.5. DNA sequence verification 
 
Dideoxy DNA sequencing reactions were carried out in a final volume of 10 μL 
containing 80-100 ng template DNA, 0.5 μL of 3.2 μM, 1.5 μL 5x buffer and 1 μL 
ABI Big Dye Terminator Ready Reaction Mix (Perkin Elmer, Massachusetts, USA). 
The PCR cycle conditions were: initial denaturation step at 96°C for 1 min, 
denaturation at 96°C for 10 sec, annealing at 50°C for 5 sec and elongation at 60°C 
for 4 min (35 cycles total). Sequencing was carried out on a 377 or 3700 ABI 
PRISMTM Dye-Deoxy Terminator Cycle Sequencer (Perkin Elmer, Massachusetts, 
USA) in the Genome centre (John Innes Centre). Sequences were analysed using the 
software package VNTI version 11 (Invitrogen).   
 72
2.5.1.2.6. Agarose gel electrophoresis 
 
DNA fragments were separated by electrophoresis in horizontal agarose gels. The 
gels were prepared in 1 x TAE (40 mM Tris, 20 mM NAOAc, 1 mM EDTA, pH7.9) 
including 1 μg/ml ethidium bromide (Sigma) for visualization purposes. The 
concentration of agarose varied between 0.8-2% (w/v) depending on the sizes of the 
DNA fragments to be separated but 1% (w/v) gels were normally used for analytical 
purposes. DNA samples were prepared by adding 0.1 vol of 10 x loading buffer 
(50% (w/v) glycerol, 50 mM EDTA, 10 x TAE, 0.25% (w/v) 64 bromophenol blue, 
0.25% (w/v) xylene cyanol) and were loaded into the wells of the gel submerged in 1 
x TAE. Gels were run at 10-100 V until the desired separation was achieved. 
Analytical gels were photographed on a short wavelength UV transilluminator 
(gelDoc 1000, Biorad). 
 
2.5.1.2.7. DNA purification from agarose gel pieces 
 
DNA was visualised on a long wavelenght UV transilluminator (TM40, UVP) and 
the desired fragment was excised using a razor blade. Fragments were purified using 
QIAquick spin columns (Qiagen) following the manufacturer’s instructions. 
 
2.5.1.2.8. bak1-5 marker design 
 
For bak1-5 homozygous mutant identification a dCAPS marker was designed using 
dCAPS Finder 2.0 (Neff et al., 2002). The genomic region around the bak1-5 
mutation was PCR amplified using Taq polymerase (Qiagen). The corresponding 
product was cut with RsaI (NEB) and bak1-5 derived PCR products contained an 
additional RsaI site in addition to the internal restriction control site.  
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2.5.1.3. Cloning 
 
The desired DNA sequences were amplified by hi-fidelity PCR (2.5.1.2.3) using the 
appropriate template and primers. All sequences were verified in the primary 
plasmid (2.5.1.3.1-3) by DNA sequencing analysis (2.5.1.2.5). Secondary plasmids 
(2.5.1.3.4-5) were verified by restriction analysis (2.5.1.3.8). 
 
2.5.1.3.1. Blunt end cloning 
 
The blunt end DNA fragment was ligated into the pCR-Blunt-II-TOPO (Invitrogen) 
primary vector combining 0.5 μL vector solution, 0.5 μL 6 x buffer salt solution, 
0.5-2 μL of DNA fragment solution and making it up to 3 μL using sterile dH2O. 
The reaction was left for 30 min at RT. The whole reaction volume was used to 
transform E. coli DH5α. 
 
2.5.1.3.2. Gateway entry vector cloning 
 
The DNA fragment containing a CACC at the 5’-end was ligated into the pENTRD-
TOPO (Invitrogen) entry/primary vector combining 0.5 μL vector solution, 0.5 μL 6 
x buffer salt solution, 0.5-2 μL of DNA fragment solution and making it up to 3 μL 
using sterile dH2O. The reaction was left for 30 min at RT. The whole reaction 
volume was used to transform E. coli DH5α. 
 
2.5.1.3.3. IN-Fusion cloning 
 
The DNA fragments were amplified with primers carrying the following extension: 
5’-AAGTTCTGTTTCAGGGCCCG- for the forward primer and 5’-ATGGTCT 
AGAAAGCTTTA- for the reverse primer. The destination vectors pOPINM and 
pOPINF were linearised previously using KpnI (NEB) and HindIII (NEB). 50 ng of 
purified insert and 100 ng of linearised destination vector were mixed in a total 
volume of 10 μl sterile dH2O. The reaction mix was added to a well of dry-down In-
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Fusion reaction powder and mixed by pipetting up and down. The reaction was 
incubated at 42oC for 30 min and terminated by adding 40 μL TE immediately 
afterwards. Up to 30 μL of the reaction volume was used to transform E. coli DH5α.  
 
2.5.1.3.4. Classical “cut and paste” cloning 
 
The DNA fragments of interest (inserts) were released from the primary vector 
(2.5.1.3.1) using appropriated restriction enzymes. The secondary vector was also 
pre-digest with appropriate restriction enzymes creating compatible ends. For DNA 
ligation 2 μL purified insert, 6 μL purified linearised vector, 1 μL ligase buffer and 1 
μL of T4 DNA ligase were combined in one reaction tube, mixed and incubated at 
16oC O/N. The whole reaction volume was used to transform E. coli DH5α. 
 
2.5.1.3.5. Gateway LR reaction 
 
LR Gateway reaction was used to introduce the insertion of the entry vector into a 
destination vector that was either from the pGWB or pEarleygate series (Earley et al., 
2006; Nakagawa et al., 2007). The reaction mix contained 50-150 ng of the entry 
vector (2.5.1.3.2), 200-250ng of the destination vector, TE buffer pH 8.0 up to a 
final volume of 4 μL, and 1 μL of the LR Clonase II mix (Invitrogen). The reaction 
was vortexed shortly and incubated for 4-6 H at RT. The reaction was stopped 
adding 1 μL of Proteinase K (Invitrogen) and incubating samples for 15min at 37oC. 
Normally, 2 μL of the reaction volume was used to transform E. coli DH5α. 
 
2.5.1.3.6. Vector map generation 
 
Vector maps of primary and secondary plasmids were generated using VNTI version 
11 (Invitrogen). In silico digests were performed to identify appropriated 
endonucleases for restriction analysis (2.5.1.3.8). 
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2.5.1.3.7. Transformation of bacteria by heat-shock 
 
For transformation an aliquot of DH5α (Home made by Karen Morehouse) cells 
were mixed with indicated amount of ligation or plasmid solution and left on ice for 
10-30 min. The cells were heat shocked at 42oC for 1-2 min and immediately chilled 
on ice for another 5min. The cells were re-suspended in 750 μL of liquid LB and 
incubated while shaking at 300 rpm at 37oC for 1-2 H. The solution was plated on 
LB-agar plates containing the appropriate antibiotic selection 
 
2.5.1.3.8. Transformation of bacteria by electroporation 
 
Prior to electroporation, electro-competent bacterial cells were thawed on ice for 5 - 
10 min. The desired amount of desalted plasmid up to 5 μL was added to 20 μL of e 
electrocompetent cells. Cells were transformed in an electroporation cuvette with a 
width of 1 mm in a Bio-Rad electroporator (Bio-Rad, Hercules, CA, USA). The 
settings were 1800 V with a capacity of 25 μF, over 200 Ω resistance. Cells were 
recovered from the cuvette by adding 1 mL of liquid LB medium and transferring 
the suspension to a sterile Eppendorf tube. The bacteria were incubated while 
shaking at 300 rpm for 1-2 H in the case of E. coli at 37oC and for A. tumefaciens at 
28°C. The bacterial solution was plated on LB-agar plates containing the appropriate 
antibiotic selection. 
 
2.5.1.3.9. Plasmid miniprep 
 
Single colonies corresponding to positive colony PCR results were incubated O/N in 
5 mL LB containing the appropriate antibiotics and spun down for 10 min at 4,000 
rpm. Plasmids were extracted from the bacterial cell pellet using QIAprep spin 
miniprep kits (Qiagen) following the manufacturers protocol.  
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2.5.1.3.10. Restriction analysis 
 
The reaction mix for the plasmid restriction contained 200-400 ng of the plasmid, 1 
μL of 10 x reaction buffer, 0.5 μL of each of the cutting enzymes (NEB), and was 
incubated for 1.5 H at 37oC. The product was analyzed by agarose gel 
electrophoresis. 
 
2.5.1.3.11. Plasmids used in this study 
 
Table 2.6. Summary of plasmids used in this study. 
 
Name Insert/Description Backbone Reference 
Plant expression vectors 
p35S::GUS:YFP-HA GUS pEarleygate103  
p35S::cFoxR1 CDS At5g15850 pEarleygate100  
p35S::cFoxR2 CDS At2g18300 pEarleygate100  
p35S::cFoxR3 CDS At2g12290 pEarleygate100  
p35S::cFoxR4 CDS At5g24660 pEarleygate100  
p35S::cFoxR5 CDS At1g68520 pEarleygate100  
p35S::cFoxR6 CDS At1g26920 pEarleygate100  
p35S::cFoxR7 CDS At3g59940 pEarleygate100  
p35S::cFoxR8 CDS At5g20790 pEarleygate100  
p35S::cFoxR9 CDS At5g03230 pEarleygate100  
p35S::cFoxR10 CDS At2g42280 pEarleygate100  
p35S::cFoxR11 CDS At2g41310 pEarleygate100  
p35S::cFoxR1:YFP-HA CDS At5g15850 pEarleygate103  
p35S::cFoxR2:YFP-HA CDS At2g18300 pEarleygate103  
p35S::cFoxR3:YFP-HA CDS At2g12290 pEarleygate103  
p35S::cFoxR4:YFP-HA CDS At5g24660 pEarleygate103  
p35S::cFoxR5:YFP-HA CDS At1g68520 pEarleygate103  
p35S::cFoxR6:YFP-HA CDS At1g26920 pEarleygate103  
p35S::cFoxR7:YFP-HA CDS At3g59940 pEarleygate103  
p35S::cFoxR8:YFP-HA CDS At5g20790 pEarleygate103  
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p35S::cFoxR9:YFP-HA CDS At5g03230 pEarleygate103  
p35S::cFoxR10:YFP-HA CDS At2g42280 pEarleygate103  
p35S::cFoxR11:YFP-HA CDS At2g41310 pEarleygate103  
p35S::cFoxR9-H1 CDS At5g60680 pEarleygate100  
p35S::cFoxR9-H2 CDS At2g28400 pEarleygate100  
p35S::cFoxR9-H3 CDS At3g45210 pEarleygate100  
p35S::cFoxR9-H1:YFP-
HA 
CDS At5g60680 pEarleygate103  
p35S::cFoxR9-H2:YFP-
HA 
CDS At2g28400 pEarleygate103  
p35S::cFoxR9-H3:YFP-
HA 
CDS At3g45210 pEarleygate103  
pBAK1::BAK1 genomic region of BAK1 
including 1.5 kb upstream 
sequence 
pGWB2 entry clone 
(Kemmerling et 
al., 2007) 
pBAK1::BAK1-5 derivate of 
pBAK1::BAK1 
pGWB2  
pBAK1::BAK1* derivate of 
pBAK1::BAK1 
expressing 
BAK1(D418N) 
pGWB2  
pBAK1::BAK1-5* derivate of 
pBAK1::BAK1-5 
expressing BAK1-
5(D418N) 
pGWB2  
pBAK1::BAK1:HA3 genomic region of BAK1 
including 1.5 kb upstream 
sequence 
pepiGreenB(HA)  
pBAK1::BAK1-5:HA3 derivate of 
pBAK1::BAK1:HA3 
pepiGreenB(HA)  
pBAK1::BAK1:GFP genomic region of BAK1 
including 1.5 kb upstream 
sequence 
pepiGreenB(GFP)  
pBAK1::BAK1-5:GFP derivate of pepiGreenB(GFP)  
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pBAK1::BAK1:GFP 
pBAK1::BAK1:Myc   (Chinchilla et al., 
2007) 
pFLS2::FLS2:Myc   (Robatzek et al., 
2006) 
pFLS2::EFR:HA3   gift of Vladimir 
Nekrasov 
Sainsbury 
Laboratory UK 
p35S::BRI1:HA3   gift of Freddy 
Boutrot 
Sainsbury 
Laboratory UK 
pCERK1::CERK1:HA3   (Gimenez-Ibanez 
et al., 2009) 
E.coli expression vector 
pGST:BAK1 BAK1 CD (256-615aa) pGEX-4T1 primary vector 
(Karlova et al., 
2009) 
pGST:BAK1-5 derivate of pGST:BAK1 pGEX-4T1  
    
pGST:BAK1* derivate of pGST:BAK1 
expressing BAK1 
(D418N) CD 
pGEX-4T1  
pGST:BAK1-5* derivate of pGST:BAK1-
5 expressing BAK1-5 
(D418N) CD 
pGEX-4T1  
pMBP:EFR EFR CD (682-1031aa) pOPINF  
pMBP:EFR* derivate of pMBP:EFR 
expressing EFR* 
(D849N) CD 
pOPINF  
pMBP:FLS2 FLS2 CD (840-1173aa) pOPINF  
pMBP:FLS2* derivate of pMBP:FLS2 
expressing FLS2* 
pOPINF  
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(D977N) CD 
pMBP:BRI1 BRI1 CD (814-1196aa) pOPINF  
pMBP:BRI1* derivate of pMBP:BRI1 
expressing BRI1* 
(D977N) CD 
pOPINF  
pHis6:FLS2 see above pOPINM  
p His6:FLS2* see above pOPINM  
p His6:BRI1 see above pOPINM  
p His6:BRI1* see above pOPINM  
 
2.5.2. RNA methods 
 
2.5.2.1. Isolation of total RNA from Arabidopsis 
 
RNA was extracted using RNeasy Plant Mini kit (Qiagen) following the 
manufactures protocol. RNA quality was evaluated by agarose gel electrophoreses.  
 
2.5.2.2. Reverse transcription PCR 
 
This method was used to generate single stranded cDNA from total RNA. All 
reactions mixes were always kept on ice if not indicated otherwise. Briefly; the 
reaction mix contained 2.5 μg total RNA, 2 μL 2 mM oligo(dT)15 , 4 μL 2 mM 
dNTP and was made up with sterile dH2O to a final volume of 13 μL. The reaction 
mix was heated for 5 min at 65oC and put on ice immediately for 1-5 min. The 
contents of the tube were collected by brief centrifugation. 7 μL of the second 
reaction mix  were added containing 4 μL First-Strand buffer, 1 μL 0.1 M DTT, 1 
μL RNase OUT (Invitrogen) and 1 μL SuperScript III RT polymerase (Invitrogen). 
The reactions were vortexed briefly, spun down and incubated at 50oC for 50 min. 
The reactions were terminated by heating at 70oC for 15 min and kept at -20oC for 
storage. 
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2.5.3. Protein methods 
 
2.5.3.1. General protein methods 
 
2.5.3.1.1. SDS-polyacrylamide gel electrophoresis 
 
The reagents and SDS-polyacrylamide gel preparation methods were followed 
according to Laemmli, 1970. Gels were run in Mini PROTEAN III gel tanks (Bio-
Rad) filled with Tris-glycine electrophoresis buffer (25 mM Tris, 250 mM glycine 
(electrophoresis grade, pH 8.3, 0.1% SDS). The gel electrophoresis was performed 
in a continuous buffer system at 2.1 - 3.4 mA cm/gel. All gels included a molecular 
size marker 10-250 K Bio-Rad Precision Plus Marker (Bio-Rad). Electrophoresis 
was continued until the loading dye band migrated out of the gel. 
 
2.5.3.1.2. Western Blot 
 
Two Watmann papers and sponges per gel were equilibrated for 5 min in pre-chilled 
transfer buffer (25 mM Tris, 192 mM glycin, 20% (v/v) methanol, pH 8.3). The 
PVDF membrane (BIO-RAD) was activated for 1 min in methanol. The sandwich 
and device were assembled according the manufacture’s protocol (BIO-RAD). The 
membrane was facing the anode and the gel the cathode. The transfer took place at 
4oC overnight at 30 V or for 2 H at 95 V.  
 
2.5.3.1.3. Coomassie stain 
 
The proteins in the gel or on the membrane were visualized by coomassie staining. 
The gel was transferred to a tray containing coomassie stain solution (0.5% (w/v) 
bromophenol blue R-250, 50% (v/v) methanol, and 7.5% (v/v) glacial acetic acid), 
agitated at RT for 30 min, and de-stained three times under agitation for 30min with 
coomassie de-stain (20% (v/v) methanol, 5% (v/v) acetic acid). 
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2.5.3.1.4. Immunoblotting  
 
PVDF transfer membrane containing immobilised, denatured proteins were blocked 
for one hour at room temperature with 0.1% TBST buffer (0.5 M NaCl, 200 mM 
Tris-HCl, 0.05% (v/v) Tween-20, 0.2% (v/v) Triton X-100, pH 7.5) containing 5% 
dried skimmed milk powder (w/v) with gentle agitation on a platform shaker. This 
step prevents nonspecific binding by blocking potential binding sites with irrelevant 
protein. After removal of the blocking solution, the membrane was washed for 2 min 
with TBS buffer. The membrane was then incubated with the primary antibodies 
directed against the target protein with 0.1% TBST buffer containing 5% dried 
skimmed milk powder (w/v) for 1 H at RT or O/N at 4oC. The membrane was 
washed three times for 15 min each with 0.1% TBST buffer. The membrane was 
than incubated for 1 H at RT with 0.1% TBST buffer containing 5% dried skimmed 
milk powder (w/v) and secondary anti-bodies that are directed against the anti-
immunoglobulin of the primary antibody and covalently coupled to horseradish 
peroxidase (HRP). The membrane was washed three times for 15 min each with 
0.1% TBST buffer. Detection of the peroxidase signal of the secondary antibody-
HRP conjugate was performed with ECL (Amersham Biosciences), or SuperSignal 
West Femto (Pierce) chemiluminescent detection reagent for Western blotting. The 
membrane was exposed onto ECL Hyperfilm (Amersham Biosciences). Film 
exposure ranged from 30 sec to 20 min. The film was aligned to the membrane and 
the protein standards were marked on the film to confirm the relative molecular 
weight of the signal. 
Primary antibodies were diluted in 0.1% TBST buffer containing 5% dried skimmed 
milk powder (w/v) solution to the following concentration: anti-GFP (AMS 
Biotechnology) 1: 5000; anti-BAK1 1:500; anti-HA-HRP (Santa Cruz) 1: 2000; 
anti-FLS2 1:1000; anti-BRI1 1:1000.  
Secondary antibodies were diluted in 0.1% TBST buffer containing 5% dried 
skimmed milk powder (w/v) solution to the following concentration: anti-rabbit-
HRP (Sigma) 1:5000 or anti-rabbit-HRP (Ebioscience) 1:5000. 
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2.5.3.1.6. Antibodies 
 
Polyclonal anti-BAK1 antibodies were generated by immunizing rabbits with a 
synthetic peptide [DSTSQIENEYPSGPR] derived from the C-terminus of BAK1 
(Schulze et al., 2010).  
Polyclonal anti-FLS2 antibodies were generated by immunizing rabbits with a 
synthetic peptide [KANSFREDRNEDREV] derived from the C-terminus of FLS2. 
(Chinchilla et al., 2006). 
Polyclonal anti-BRI1 antibodies were generated by immunizing rabbits with a 
synthetic peptide [IDSQSTIRSIEDGGFS] derived from the C-terminus of BRI1. 
Antibodies (final bleed) were affinity purified against the peptide (Eurogentec). 
 
2.5.3.1.6. HPLC and Mass Spectrometry 
 
Protein samples were prepared for the mass spectrometry analysis as described 
previously (Ntoukakis et al., 2009). LC-MS/MS analysis was performed using a 
LTQ-Orbitrap mass spectrometer (Thermo Scientific) and a nanoflow-HPLC system 
(nanoAcquity, Waters Corp.) as described previously (Ntoukakis et al., 2009). The 
entire TAIR9 database was searched (TAIR9 33596 sequences; 13487687 residues) 
(www.arabidopsis.org) using Mascot (with the inclusion of sequences of common 
contaminants such as keratins and trypsin). Parameters were set for ±5 ppm peptide 
mass tolerance and allowing for methionine oxidation and two missed tryptic 
cleavages. Carbiodomethylation of cysteine residues was specified as a fixed 
modification and oxidized methionine and phosphorylation of serine, threonine or 
tyrosine residues were allowed as variable modifications. Scaffold (v2_06_01, 
Proteome Software Inc., Portland, OR) was used to validate MS/MS based peptide 
and protein identifications. Peptide identifications were accepted if they could be 
established at greater than 95.0% probability as specified by the Peptide Prophet 
algorithm.  Protein identifications were accepted if they could be established at 
greater than 95.0% probability and contained at least 2 identified peptides.   
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2.5.3.1.7. Quantificaiton of total protein concentration 
 
In order to determine the total protein concentration of plant extracts, the Bio-Rad 
Protein Assay (Bio-Rad) was used. 10 μL of total 1:20 diluted total was added to the 
990 μL of the 1:5 diluted Bio-Rad protein assay solution. The reaction was mixed 
thoroughly at room temperature. To determine the protein concentration of the 
sample, the OD595nm was measured using a MBA2000 spectrophotometer (Perkin 
Elmer) and compared to a BSA (Sigma) standard curve. 
 
2.5.3.2. In vitro protein analysis 
 
2.5.3.2.1. Recombinant protein purification 
 
Recombinant fusion proteins were produced in E. coli BL21 (Novagen), extracted 
using BugBuster reagent (Novagen) containing 1 μL/mL Benzoase (Novagen), 1 
KU/mL Lysozyme (Novagen) and 150 μL/mL protease inhibitor cocktail set II 
(Novagen) and the soluble fraction was used to enrich for fusion proteins. GST-
tagged fusion proteins (GST-BAK1, GST-BAK1*, GST-BAK1-5, GST-BAK1-5*) 
were enriched using Glutathione Sepharose Fast Flow (GE Healthcare) according to 
the manufactures protocol. MBP-tagged fusion proteins (MBP-BRI1, MBP-BRI1*, 
MBP-FLS2, MBP-FLS*, MBP-EFR, MBP-EFR*) were enriched using Amylose 
Resin (NEB) according to manufactures protocol. His-tag fusion proteins (His-BRI1, 
His-BRI1*, His-EFR, His-EFR*) were enriched using His-Bind Resin (Novagen) 
according to the manufactures protocol. After elusion fusion proteins were adjusted 
to the same concentration in 10% glycerol solution and stored at -20oC until usage.  
 
2.5.3.2.2. Radioactive in vitro kinase assays 
 
The fusion proteins were incubated in 30 μL kinase buffer (50 mM Tris, pH 7.5, 10 
mM MgCl2, 10 mM MnCl2, 1 mM DTT) in the presence of 1 μM unlabeled ATP 
and 183 kB of [32P]-γ-ATP for 30 min at 30oC with shaking at 900 rpm. The 
 84
reactions were stopped by adding 2xLDS loading buffer (Invitrogen). The 
phosphorylation status of fusion proteins was analyzed by audioradiography after 
separation of one-fourth of the in vitro kinase assay by SDS-PAGE followed by 
western blotting, if not indicated otherwise. Incorporated [32P]-groups were 
visualised exposing the membrane onto ECL Hyperfilm over night (Amersham 
Biosciences).  In autophosphorylation assays 1 μg fusion protein for MBP- and 
GST-tagged proteins and 5 μg for His-tagged proteins was incubated with 1 μg of 
MBP (Fluka). In transphosphorylation assays 1 μg of each fusion protein was used.  
 
2.5.3.2.3. Non-radioactive in vitro kinase assays 
 
The fusion proteins were incubated in 30 μL kinase buffer (50 mM Tris, pH 7.5, 10 
mM MgCl2, 10 mM MnCl2, 1 mM DTT) in the presence of 3 mM unlabeled ATP 
for 30 min at 30oC with shaking at 900 rpm. The reactions were stopped by adding 
2xLDS loading buffer (Invitrogen). The phosphorylation status of fusion proteins 
was analyzed by immunoblot analysis or HPCL-MS/MS analysis. 
 
2.5.3.2.4. Immunoblot phosphorylation site analysis 
The indicated amount of fusion proteins (GST-BAK1, GST-BAK1*, GST-BAK1-5, 
GST-BAK1-5*) were separated by SDS-PAGE and blotted onto PVDF membrane 
(Biorad). The immunoblots were blocked in 5% (w/v) BSA (Sigma) in TBS-Tween 
(0.1 %) for 1-2 H. Phospho-Serine/Threonine sites were detected using anti-p-Thr 
(1:1000, Cell Signaling Technology) overnight, followed by anti-mouse-HRP 
conjugated secondary antibodies (1:5000, Sigma). Phospho-Tyrosine sites were 
detected using anti-p-Tyr (1:2000, Cell Signaling Technology) overnight, followed 
by anti-rabbit-HRP conjugated secondary antibodies (1:5000, Sigma). 
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2.5.3.3. In vivo protein analysis 
 
2.5.3.3.1. Protein extraction and immunoprecipitation in N. benthamiana 
 
Leaves were ground to fine powder in liquid nitrogen and 5 mL extraction buffer [50 
mM Tris-HCl pH 7.5; 150 mM NaCl; 10 % glycerol; 10 mM DTT; 10 mM EDTA; 1 
mM NaF; 1 mM Na2MoO4.2H2O; 1% (w/v) PVPP; 1% (v/v) P9599 protease 
inhibitor cocktail (Sigma); 1% (v/v) IGEPAL CA-630 (Sigma)] added. Samples 
were cleared by centrifugation at 16.000 x g for 15 min at 4oC and adjusted to 2 
mg/mL total protein concentration. Immunoprecipitation were performed on 1.5 mL 
total protein by adding 20 µL GFPTrap-A beads (Chromotek), 20 µL anti-HA 
sepharose beads (Roche), or   20 µL true-blot anti-rabbit Ig beads (Ebioscience) in 
combination with 15 µL antibody and incubation at 4oC for 3-4 H. Beads were 
washed 4 times with TBS containing 0.5% (v/v) IGEPAL CA-630, 
immunoprecipitates eluted with 30 μL 2xLDS (Invitrogen) and heating at 70oC for 
10 min.  
 
2.5.3.3.1. Protein extraction and immunoprecipitation in A. thaliana 
 
Frozen tissue was ground to fine powder in liquid nitrogen and extraction buffer [50 
mM Tris-HCl pH 7.5; 150 mM NaCl; 10 % glycerol; 5 mM DTT; 2mM EDTA; 1 
mM NaF; 1 mM Na2MoO4.2H2O; 1 mM PMSF (Sigma); 5 mM Na3VO4, 1 % (v/v) 
P9599 protease inhibitor cocktail (Sigma); 1 % (v/v) IGEPAL CA-630 (Sigma)] 
added. Samples were cleared by centrifugation at 16.000xg for 15 min at 4oC and 
adjusted to 2 mg/mL total protein concentration. Immunoprecipitations were 
performed on 1.5 ml total protein by adding 20 µL GFPTrap-A beads (Chromotek), 
20 µl anti-HA sepharose beads (Roche), or   20 µL true-blot anti-rabbit Ig beads 
(Ebioscience) in combination with 15 µL antibody and incubation at 4oC for 3-4 H if 
not indicated otherwise. Beads were washed 4 times with TBS containing 0.5% (v/v) 
IGEPAL CA-630, immunoprecipitates eluted with 50 µL 2xLDS (Invitrogen) and 
heated at 70oC for 10 min.  
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2.6. Cellular biological methods 
 
2.6.1. Confocal laser scanning microscopy 
 
Nicotiana benthamiana leaf tissue transiently over-expressing the indicated proteins 
were analysed by CLSM employing the Leica SP5 Confocal Microscope (Leica 
Microsystems, Wetzlar, Germany). After excitation at 488 nm, eYFP emission and 
remaining autofluorescence were detected using the PI (>660 nm) filter set. All 
samples were imaged with the 40x objectives. Pictures were taken giving an average 
of four scans.  
 
2.7. Antibiotics used in this study 
 
Final concentrations of 50 μg/mL, 25 μg/mL, 100 μg/mL, 100 μg/mL and 50 μg/mL 
were used for kanamycin, gentamycin, carbenicillin, rifampicin and spectinomycin 
(all Duchefa) for bacterial cultures, respectively. For the selection of Arabidopsis 
transgenic lines, 50 μg/mL, 40 μg/mL or 10 μg/mL of kanamycin, hygromycin, or 
phosphinothricin (all Duchefa) respectively, were used. All antibiotic solutions were 
filtersterilized using 22 μm micro filter. 
 
2.8. Media used in this study 
 
All recipes are for the scale of 1 L. 
 
LB 
 10 g tryptone, 5 g yeast extract, 10 g NaCl, pH 7.0. For solid 
 Medium, 10g agar was included. 
 
King’s B 
 20 g Peptone, 1.5g Heptahydrated Magnesium Sulfate, 1.5g Potassium 
 Hydrogen Phosphate, 10mL glycerol. pH7.0. For solid medium, 10 g 
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 agar was included. 
 
MS 
 4.3 g MS salts, 0.59 g MES, 0.1 g myo-inositol, 1 ml of 1000x MS 
 vitamin stock, 10 g sucrose pH was adjusted to 5.7 with KOH . For solid 
 medium, 8 g phyto-agar was included. 
 
2.9. Primers used in this study 
 
Table 2.7. Primers used in this study. 
 
Primer name 5' to 3' sequence 
BAK1_4_F_GT CATGACATCATCATCATTCGC 
BAK1_4_R_GT ATTTTGCAGTTTTGCCAACAC 
BKK1-1_F_GT TGGCTCAGAAGAAAACCACAG 
BKK1-1_R_GT CTGCTCCACTTCTGTTTCCAC  
BRI1-301_F_GT CATCGAAATCTTGTGCCTCTT 
BRI1-301_R_GT GAACGTAACCCGGTGTACCA 
BAK1_dCAPS_F_GT AAGAGGGCTTGCGTATTTACATGATCAGT 
BAK1_dCAPS_R_GT GAGGCGAGCAAGATCAAAAG 
EFR_KD_F AAGTTCTGTTTCAGGGCCCGGCCAGTGATGGTAACCCATC 
EFR_KD_R ATGGTCTAGAAAGCTTTACATAGTATGCATGTCCGTATTTAACATC 
FLS2_KD_F AAGTTCTGTTTCAGGGCCCGGAAAATTCATCAGAGTCCTCATTACCG 
FLS2_KD_R ATGGTCTAGAAAGCTTTAAACTTCTCGATCCTCGTTACGATC 
BRI1_KD_F AAGTTCTGTTTCAGGGCCCGGGTAGAGAGATGAGGAAGAGACG 
BRI1_KD_R ATGGTCTAGAAAGCTTTATAATTTTCCTTCAGGAACTTCTTTTATAC 
BAK1_+1445_FBsmBI CGTCTCGAATTCTGTCGTGAAAAGGGCACTAA 
BAK1_nostop_R_Bam
HI GGATCCTCTTGGACCCGAGGGGTAT 
BAK1_(C408Y)_F GAGGGCTTGCGTATTTACATGATCATTACGACCCAAAGATTATTCATCGAGATGTG 
BAK1_(C408Y)_R CACATCTCGATGAATAATCTTTGGGTCGTAATGATCATGTAAATACGCAAGCCCTC 
BAK1_(D416N)_F CCCAAAGATTATTCATCGAAATGTGAAAGCTGCAAATATTTTGTTG 
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BAK1_(D416N)_R CAACAAAATATTTGCAGCTTTCACATTTCGATGAATAATCTTTGGG 
EFR_(D848N)_F GACCCTGTAGCTCACTGTAATATTAAGCCAAGCAACA 
EFR_(D848N)_R TGTTGCTTGGCTTAATATTACAGTGAGCTACAGGGTC 
FLS2_(D997N)_F GGTTTTCCCATCGTTCATTGTAATCTGAAGCCAGCTAATATACTC 
FLS2_(D997N)_R GAGTATATTAGCTGGCTTCAGATTACAATGAACGATGGGAAAACC 
BRI1_(D1009N)_F GTCCGCATATCATCCACAGAAACATGAAATCCAGTAATGTGTTG 
BRI1_(D1009N)_R CAACACATTACTGGATTTCATGTTTCTGTGGATGATATGCGGAC 
FoxR1_Fstart CACCATGTTGAAAGTAGAGAGTAACTGGG 
FoxR1_Fstop TCAGAATGATGGAACAATTCCATATC 
FoxR1_Fnostop GAATGATGGAACAATTCCATATC 
FoxR2_Fstart CACCATGTTGGAAGGTCTTGTCTCTCA 
FoxR2_Rstop TTAGTAATGAAAACCGAGGCTAG 
FoxR2_Rnostop GTAATGAAAACCGAGGCTAGATG 
FoxR3_Fstart CACCATGTAACAATCAGCGAGAGTTTG 
FoxR3_Rstop TCAACACCATTCGTAATGTGAA 
FoxR3_Rnostop TTTCTTCACATTACGAATGGTGT 
FoxR4_Fstart CACCATGGGGAAAGGAGGAAACTATG 
FoxR4_Rstop CTACGGAGAGGCAGAGGCA 
FoxR4_nostop CGGAGAGGCAGAGGCAG 
FoxR5_Fstart CACCATGATGAAAAGTTTGGCTAGTGC 
FoxR5_Rstop TTAGTGAGCAACACCAATTGAAG 
FoxR5_Rnostop GTGAGCAACACCAATTGAAGA 
FoxR6_Fstart CACCATGGCTGAAACATCTGATGTATCG 
FoxR6_Rstop CTACATGAACAGCTCAGACTGCAG 
FoxR6_Rnostop CATGAACAGCTCAGACTGCAGC 
FoxR7_Fstart CACCATGGGAGTGTCAAAGAAGAAATC 
FoxR7_Rstop TCAAACGTAGATTGAAGAACACG 
FoxR7_Rnostop AACGTAGATTGAAGAACACGAGA 
FoxR8_Fstart CACCATGTCGACTTTGGAATCTCCAT 
FoxR8_Rstop TTAGACACATGCCGCCGTTA 
FoxR8_Rnostop GACACATGCCGCCGTTACTAG 
FoxR9_Fstart CACCATGGCGTCAAGGAAGCTTTT 
FoxR9_Rstop CTAATCCTGAAACCCAATCTTCTC 
FoxR9_Rnostop ATCCTGAAACCCAATCTTCTCC 
FoxR10_Fstart CACCATGGATTCAAATAATCATCTCTACG 
FoxR10_Rstop CTATATTGACTTCTTCTCCTTGTTCATA 
FoxR10_Fnostop TATTGACTTCTTCTCCTTGTTCATACA 
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FoxR11_Fstart CACCATGGTAATGGAAACAGAGTCAAAGT 
FoxR11_Rstop TCAGACCGAGGTTGTGATATCA 
qFRK1_F ATCTTCGCTTGGAGCTTCTC  
qFRK1_R TGCAGCGCAAGGACTAGAG  
qAt1g51890_F CCAGTTTGTTCTGTAATACTCAGG  
qAt1g51890_R CTAGCCGACTTTGGGCTATC  
qAt2g17740_F TGCTCCATCTCTCTTTGTGC  
qAt2g17740_R ATGCGTTGCTGAAGAAGAGG  
qAt5g57220_F AATGGAGAGAGCAACACAATG  
qAt5g57220_R ATACTGAGCATGAGCCCTTTG  
qAt2g46400_F TCAACCAAGACAAGAACAT  
qAt2g46400_R GTTCTCAATCTCATGGTTAG  
qUBQ10_F AGATCCAGGACAAGGAGGTATTC  
qUBQ10_R CGCAGGACCAAGTGAAGAGTAG  
qAt1g80460_F GCTGCTCCTAATGCTGTTGTC  
qAt1g80460_R GATTCAGGCTGATCTGATGG  
qAT5G15400_R TGCGCTGCCAGATAATACACTATT 
qAT5G15400_R TGCTGCCCAACATCAGGTT 
qSAUR-ACI_F GAGGATTCATGGCGGTCTATG 
qSAUR-ACI_R GTTAAGCCGCCCATTGGAT 
qEXP8_F CAACCATCACCGTCACAGCTA 
qEXP8_R TGAAGAGGAGGATTGCACCAA 
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Chapter 3: FOX-hunting for novel regulators of PTI signalling 
 
3.1. Objectives 
 
Several lines of evidence suggest the presence of a negative regulatory signalling 
network controlling plant defence. Firstly, treatment of tomato suspension cell 
cultures with the broad spectrum phosphatase inhibitor calyculin A mimics the 
medium alkalinisation and change in phosphorylation pattern induced by xylanase 
(Felix et al., 1994), leading to the hypothesis that PTI signalling is under constant 
negative regulation by phosphatases. Secondly, treatment with the protein synthesis 
inhibitor cyclohexamide (CHX) elicits similar gene expression as seedlings treated 
with flg22 (Navarro et al., 2004), suggesting the presence of unstable negative 
regulators, which are rapidly degraded after defence elicitation. Thirdly, PAMP 
treatment induces the expression of several transcription factors that have been 
shown to negatively regulate PTI signalling (Shen et al., 2006; Xu et al., 2006; 
Journot-Catalino et al., 2006). Lastly, it became a paradigm that plant hormones de-
repress signalling pathways that are normally constitutively suppressed (Berleth et 
al., 2004; Vert et al., 2005; Raghavendra et al., 2010). At the beginning of this study 
only few negative regulators of PTI signalling were known in Arabidopsis. One is 
the kinase-associated protein phosphatase (KAPP), which negatively regulates many 
different RLKs (Gomez-Gomez et al., 2001; Ding et al., 2007). However its specific 
role in PTI signalling is unclear. Further downstream several WRKY transcription 
factors negatively regulate basal resistance against biotrophic and hemibiotrophic 
pathogens (Shen et al., 2006; Xu et al., 2006; Journot-Catalino et al., 2006). 
Comparatively, in animal innate immunity many negative regulators are known 
ranging from Toll-like receptor homologs, inactive signalling molecule mimetics, 
phosphatases, to ubiquitin ligases and lyases (Liew et al., 2005). I therefore 
hypothesized the existence of additional unknown negative regulators of PTI 
signalling in Arabidopsis. In order to identify such negative regulators I followed 
two independent approaches. Both are based on the assumption that the constitutive 
over-expression of a negative regulator leads to insensitivity to the applied stimulus. 
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This approach was previously successfully used to identify negative/positive 
regulators of ABA signalling or salt stress/tolerance such as AtPP2CA or OST1/2, 
respectively (Kuhn et al., 2006; Conti et al., 2008).  
For the forward genetic approach I went to RIKEN Plant Science Centre Yokohama 
(Japan) to screen the Full-length cDNA Over-eXpressing gene (FOX) hunting 
system library (Ichikawa et al., 2006) for lines that lost elf18 or flg22-induced 
seedling growth inhibition (SGI). In this FOX system, a normalized full-length 
Arabidopsis cDNA library containing initially over 15,000 independent cDNAs 
under the control of the constitutive CaMV (cauliflower mosaic virus) 35S promoter 
was transformed into Arabidopsis plants. On average 2.6 cDNA clones are 
integrated in each individual plant representing 1.2 independent cDNAs (Ichikawa et 
al., 2006). This library was chosen due to several potential advantages; (i) the 
identity of the over-expressed gene(s) can be obtained easily by PCR sequencing 
using vector-specific primers and (ii) lines showing intermediate phenotypes can be 
re-screened easily within the same generation.  
The reverse genetic approach was based on the hypothesis that genes commonly 
down-regulated by several PAMPs are potential negative regulators of PTI 
signalling.  Transcription profile analyses identified 15 genes down-regulated after 
elf18, flg22, and chitin treatment of Arabidopsis seedlings (Zipfel et al., 2004; Wan 
et al., 2007). Eleven of those were screened for loss of flg22-triggered ROS-burst 
after transient over-expression in N. benthamiana.  
These two independent approaches identified eleven candidate genes with potential 
regulatory function in PTI signalling. Interestingly, several of these candidates are 
implicated in chloroplastic ROS homeostasis or signalling. However, no clear link 
between previously published chloroplastic ROS homeostasis signalling mutants and 
PTI signalling could be observed.  
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3.2. Results and Discussion 
 
 
3.2.1. Identification of potential regulators of PTI signalling in a forward 
genetic screen using the FOX-hunting system library 
 
I performed the forward genetic screen using the FOX-hunting system (Ichikawa et 
al., 2006) during a short-term stay at the RIKEN Plant Science Centre, Yokohama  
 
Table 3.1. 39 FoxF candidate lines after two successive rounds of screening. 
Uncoloured, yellow, and blue underlined rows indicate FoxF lines identified in the  
flg22-induced SGI assay, elf18-induced SGI assay or in both, respectively. n.a. not 
available 
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(Japan). I screened approximately 12,000 individual T2 lines for reduced sensitivity 
to elf18- or flg22-induced SGI. In the first round the SGI of 12-14 day-old seedlings 
in the presence of 50 nM elf18 or 65 nM flg22 was compared qualitatively with  
wild-type or respective receptor mutant control. Three replicates per treatment and 
line were used. In this initial screen I identified 150 potential candidates. All 
candidate lines were re-screened in the same generation (T2) using eight replicates 
per treatment confirming 39 lines (Table 3.1). None of these lines showed a total 
PAMP insensitivity. The inserted gene was initially identified by database searches 
and later confirmed by PCR and sequence analysis of genomic DNA using vector-
specific primers (Table 3.1). This was clearly an advantage of the Fox-hunting 
system and the corresponding candidates are called FoxF (F for forward). We 
requested these 39 T2 lines from RIKEN, Yokohama, in order to re-screen them 
more quantitatively upon my return to The Sainsbury Laboratory. Unfortunately, I 
did not obtain many T2 seeds for these 39 candidates and had to progress one 
generation for seed amplification. I therefore isolated individual antibiotic resistant 
T2 transformants.  For every candidate identified in the T2 generation (Table 3.1) I 
measured the responsiveness of three independent T3 progeny lines in the flg22- or 
Figure 3.1. Three FoxF6 T3 lines are partially insensitive to PAMP-induced SGIA. 
SGI of Col-0, FoxF6 #1-3, FoxF8, FoxF12, Fox20 and FoxF22 in the presence of either 
50 nM elf18 or 65 nM flg22. Fresh weight is represented relative to untreated control. 
Results are average ± s.e (n=6). 
This is a representative graph for the T3 re-screening process of all 39 FoxF candidate 
lines. For candidates with responsiveness similar to Col-0 the result of only one T3 line 
is shown. 
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elf18-induced SGI assay. An illustration thereof is shown in Figure 3.1. The 
candidate line FoxF6, but not FoxF8, FoxF12, FoxF20 and FoxF22, was confirmed 
in the T3 generation (Figure 3.1). Using this approach I could confirm seven 
candidates in the T3 generation (Table 3.2). In addition I included FoxF1 and FoxF8 
for further characterization as they showed the strongest phenotype in the T2 but 
loss thereof in the T3 generation (Figure 3.1 and data not shown). Interestingly, 
relative high genomic instability through generations was reported for this FOX-
hunting system library (Minami Matsui, personal communication). It is therefore 
conceivable that the expression of the corresponding gene was silenced in the T3 
generation leading to the loss of the previous observed phenotype. To demonstrate 
the causative role of the FoxF candidate, optimally, I should have performed 
expression analysis of the inserted gene in combination with linkage analysis using a 
backcross to Col-0 or segregation analysis in subsequent generations. However, I did 
not work further with the original Fox lines due to several known disadvantages 
such as multiple insertions and gene-silencing over generations. Alternatively, I 
intended to test all candidates by independent re-transformation and phenotyping of 
independent over-expression lines. For this purpose I amplified the full-length 
coding sequence of all identified FoxF genes (Table 3.2) and cloned them under the 
35S promoter in a binary vector. I created one clone without epitope tag and one 
clone with C-terminal YFP-HA tag for future localization studies. In parallel I 
ordered publicly available T-DNA insertion lines for all candidates and of up to 
three closest homologs from stock centres. I genotyped individual plants by PCR to 
identify homozygous insertion mutants and started to investigate the transcript level 
Table 3.2. Table of final nine FoxF lines identified after three rounds of screening.  
Green underlined rows indicate FoxF lines carrying gene insertions coding for proteins 
with shown or predicted chloroplastic localization 
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of the corresponding genes by RT-PCR (data not shown). However, due to time 
limitation I was not able to progress beyond this stage in the project. 
 
3.2.2. Initial phenotypic analysis of a small mutant collection in genes related to 
plastidic ROS signalling and homeostasis 
 
Interestingly, the cDNA within the T-DNA insertion fragments of five out of these 
eight candidates encoded for proteins that are known or predicted to localize to the 
chloroplasts (Table 3.2). Most of those are related to ROS signalling or homeostasis. 
For example, Psb27 (FoxF8) was previously shown to be involved in the repair 
cycle of the D1 the major subunit of the photosystem II (PS II) reaction centre (Chen 
et al., 2006; Nowaczyk et al., 2006). It is believed that singlet-oxygen is generated 
through energy transfer from excited chlorophyll to oxygen at the reaction centre of 
PS II (Kim et al., 2008). As D1 is one of the most highly turned-over proteins in 
plants, inhibition of the repair mechanism could lead to the generation of excessive 
energy, photo-inhibition and generation of increased amounts of singlet oxygen 
(Apel and Hirt, 2004). We therefore requested mutants impaired in singlet oxygen 
signalling such as ex1 (executer 1), ex2 and ex1/2 (Lee et al., 2007). CSD2 (CuZn-
superoxide dismutase 2) (FoxF1) is involved in the dissipitation of excessive energy 
promoted by the water-water cycle in the chloroplasts (Asada, 1999). It catalyzes the 
conversion of superoxide anions to hydrogen peroxide and is required for normal 
plant development as csd2 null mutants are lethal (Rizhsky et al., 2003). It is also 
noteworthy that CSD2 is upregulated post-transcriptionally by compatible pathogens 
(Navarro et al., 2008) and chloroplastic hydrogen peroxide antagonizes singlet 
oxygen signalling (Laloi et al., 2006). We therefore requested CSD2 over-expression 
lines (Myouga et al., 2008).   
First, I performed flg22- and elf18-induced SGI assays, but no difference was 
observed for any of the mutant or over-expression lines (Figure 3.2 A-B). Similarly, 
no difference was observed for ROS-burst either induced by flg22 or chitin (Figure 
3.2 C-D). Finally, I performed spray-infection assays with Pto DC3000 and Pto 
DC3000 Cor-, that is not able to produce coronatine (Melotto et al., 2006). I 
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Figure 3.2. Mutants in chloroplastic ROS-production or signalling are not 
impaired in PTI-signalling but compromised in defence to bacterial pathogens. 
A. SGI of Col-0, ex1, ex2, ex1/2, psb27-1 and CSD2 OE in the presence of the 
indicated concentration of flg22. Fresh weight is represented relative to 
untreated control. Results are average ± s.e (n=6). 
B. SGI of Col-0, ex1, ex2, ex1/2, psb27-1 and CSD2 OE in the presence of the 
indicated concentration of elf18. Fresh weight is represented relative to 
untreated control. Results are average ± s.e (n=6). 
C. ROS burst in leaves of Col-0, ex1, ex2, ex1/2, psb27-1 and CSD2 OE induced 
by 100 nM flg22. Fresh weight is represented relative to untreated control. 
Results are average ± s.e (n=6). 
D. ROS burst in leaves of Col-0, ex1, ex2, ex1/2, psb27-1 and CSD2 OE induced 
by 500 μg/ml chitin. Fresh weight is represented relative to untreated control. 
Results are average ± s.e (n=6). 
E. Four-week-old plants (Col-0, fls2, fls2 efr, fls2 ex1, ex2, ex1/2 and CSD2 OE) 
were spray-inoculated with Pto DC3000 (OD600= 0.02). 
F. Four-week-old plants (Col-0, fls2, fls2 efr, fls2 ex1, ex2, ex1/2 and CSD2 OE) 
were spray-inoculated with Pto DC3000 Cor- (OD600= 0.2). 
Bacterial counts were carried out at 3 days post-inoculation (3 dpi). Results are 
average ± s.e. (n=4).  
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performed up to six independent infections for each strain and the results between 
experiments were variable to a certain degree. A description of the general tendency 
observed for each mutant is given. 
The psb27-1 and ex1/2 mutant plants were as susceptible as WT (Figure 3.2 E-F and 
data not shown). Ex2 mutants were more susceptible to Pto DC3000 in 4 out of 6 
independent experiments and more strikingly to Pto DC3000 Cor- in 3 out of 3 
experiments (Figure 3.2 E- F). CSD2 over-expression lines were more susceptible in 
2 out of 4 experiments (Pto DC3000) and 2 out of 3 experiments (Pto DC3000 Cor-). 
On the contrary ex1 was more resistant especially to Pto DC3000 in 3 out of 6 
experiments (Figure 3.2 E-F).  This suggests that these genes are implicated in the 
defence response as such, even though these mutants or over-expression lines are not 
impaired in PTI-signalling measured as PAMP-induced ROS-burst or SGI. 
Interestingly, singlet oxygen was previously shown to rapidly induce SA production 
and to partially require EDS1 for signalling (Ochsenbein et al., 2006). In addition, in 
tobacco chloroplastic-generated ROS plays an important role in cell-death induced 
by over-expression of the constitutive active NtMEK2DD or by the non-host pathogen 
Xanthomonas campestris pv. vesicatoria (Liu et al., 2007; Zurbriggen et al., 2009). 
The change in disease resistance observed in ex1, ex2 and CSD2 OE lines could 
therefore, be potentially explained by differential activation of ETI responses 
triggered by weakly recognized effectors.   
 
3.2.3. Reverse genetic approach to identify potential PTI-signalling regulators 
using transient over-expression in N. benthamiana 
 
I hypothesised that genes down-regulated by several PAMPs could represent 
negative regulators of PTI-signalling. Analysis of publicly available micro-array 
data identified 15 genes down-regulated at either 30 or 60 min after treatment with 
flg22, elf18 or chitin (Zipfel et al., 2006; Wan et al., 2008). We focused our efforts 
on genes that were not implicated in auxin signalling as the research group of Prof. 
Jonathan Jones (The Sainsbury Laboratory) was working on the hormonal aspect of 
plant defence signalling (Navarro et al., 2006; Robert-Seilaniantz et al., 2007). The 
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resulting eleven genes were called FoxR1 to 11 (R for reverse) (Table 3.3). I 
amplified the full length coding sequence of each FoxR gene and cloned it under the 
35S promoter. I created one clone without epitope tag and one clone with C-terminal 
YFP-HA tag for potential localization studies. To test their possible involvement in 
PTI signalling I transiently over-expressed all eleven genes with and without C-
terminal fusion tag in N. benthamiana. I investigated the impact of the over-
expressed gene on PAMP-induced ROS-burst production 3 dpi (days-post 
infiltration). The expression of the tagged variants were verified by Western-blot 
analysis (data not shown). After several rounds of screening I could identify three 
genes that influenced PAMP-induced ROS-burst consistently in several independent 
experiments. The over-expression of the two bHLH transcription factors FoxR2 and 
FoxR10 increased the flg22-induced ROS-burst production compared with the 
negative control GUS:YFP-HA as shown for FoxR10 in Figure 3.3 A. In contrast, 
over-expression of FoxR9   lead to a dramatic reduction in flg22-induced ROS-
production (Figure 3.3 B). Interestingly, FoxR2 is closely related to three paralogous 
transcription factors, BEE (BR enhanced expression) 1-3, that together positively 
regulated BR responses (Friedrichsen et al., 2002). Additionally, plants over-
expressing BEE1 are not only BR hypersensitive but also show a reduced 
responsiveness to exogenous ABA application (Friedrichsen et al., 2002). FoxR2 
might be potentially involved in hormone signalling and thereby influence PTI 
signalling.  
Table 3.3. The eleven FoxR genes commonly down-regulated by efl18, flg22 and 
chitin. 
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I also investigated the localization of the C-terminal YFP-HA fusion proteins after 
transient over-expression in N. benthamiana (Figure 3.3 C). As expected 
FoxR2:YFP-HA and FoxR10:YFP-HA localized to the nucleus whereas the 
GUS:YFP-HA control was distributed between nucleus and cytoplasm. Surprisingly, 
FoxR9:YFP-HA seemed to localize to “vesicle-like” structures forming aggregates 
(Figure 3.3 C). The expression of full length fusion protein was confirmed by 
Western blot analysis (data not shown) indicating that the protein was not degraded. 
For further analysis I created stable transgenic over-expressing lines. In addition, I 
ordered publicly available T-DNA insertion lines for all three candidates and up-to 
three closest homologs from stock centres. I genotyped by PCR individual plants to 
Figure 3.3. Three FoxR genes influence flg22-induced ROS burst and localize to 
distinct sub-cellular locations after transient over-expression in N. benthamiana. 
A. The over-expression of FoxR10 leads to enhanced flg22-induced ROS-burst in 
N. benthamiana. ROS burst in leaves of N. benthamiana transiently over-
expressing GUS:YFP-HA, FoxR10 or FoxR10:YFP-HA induced by 100 nM 
flg22 at 3 dpi. Results are average ± s.e. (n=8). 
B. The over-expression of FoxR9 leads to the abolishment of flg22-induced ROS-
burst in N. benthamiana. ROS burst in leaves of N. benthamiana transiently 
over-expressing GUS:YFP-HA, FoxR9 or FoxR9:YFP-HA induced by 100 nM 
flg22 at 3 dpi. Results are average ± s.e. (n=8). 
C. FoxR2:YFP-HA and FoxR10:YFP-HA localized to the nucleus whereas 
FoxR9:YFP-HA aggregates in “vesicle-like” structures after transient over-
expression. Confocal images of N. benthamiana leaves 2 dpi transiently over-
expressing GUS:YFP-HA, FoxR2:YFP-HA, FoxR10:YFP-HA or FoxR9:YFP-
HA, respectively. Scale bar represents 50 μm.  
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identify homozygous insertion mutants and started to investigate the transcript level 
of the corresponding gene by RT-PCR (data not shown). However, due to time 
limitation I was not able to progress beyond this stage in the project. 
 
3.1.4. Initial phenotypic characterization of FoxR9 and its three closest 
homologs using the transient over-expression system N. benthamiana 
 
FoxR9 is part of a plant-specific 13-member gene family in Arabidopsis, which is 
characterized by the Pfam protein domain DUF584. FoxR9 forms an out-group with 
its three closest homologs FoxR9-H1 (At5g60680.1), FoxR9-H2 (At2g28400.1) and 
FoxR9-H3 (At3g45210.1) (Figure 3.4 A).  They are highly conserved showing up to 
60% identity at the amino acid level (Figure 3.4 B). I therefore tested if transient 
over-expression of any of these close homologs could interfere with flg22-induced 
ROS-burst in N. benthamiana.  Indeed the over-expression of any of the three 
homologs was able to suppress the flg22-induced ROS-burst (Figure 3.4 C). Similar 
to FoxR9:YFP-HA also the C-terminal YFP-HA fusion proteins of its three closest 
homologs accumulated in “vesicle-like” aggregates (Figure 3.4 D). The expression 
of full length fusion protein was confirmed by Western blot analysis (data not 
shown) indicating that the protein is not degraded. Finally, I tested if the abolished 
ROS-burst after transient over-expression of FoxR9 correlates with compromised 
resistance of N. benthamiana to bacteria. To this end I syringe-infiltrated water or 
Agrobacterium-suspensions carrying plasmids coding for FoxR9:YFP-HA or as 
negative control GUS:YFP-HA. The following day, leaves were spray-infected with 
either P. syringae pv. tabaci 11528 or P.syringae pv. syringae B728a.  Interestingly, 
the pre-infiltration with Agrobacterium on its own seemed to induce defence 
responses leading to enhanced resistance as leaves expressing GUS:YFP-HA were 
more resistant to both compatible pathogens at 2 dpi (day-post infection) (Figure 3.4 
E). Nevertheless, both bacterial strains were more virulent on leaves expressing 
FoxR9:YFP-HA compared to leaves expressing GUS:YFP-HA control (Figure 3.4 E). 
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Figure 3.4. FoxR9 and its closest homologs suppress plant defences after transient 
over-expression in N. benthamiana. 
A. FoxR9 forms an out-group with its three closest homologs. Phylogenetic tree of 
FoxR9 and its twelve homologs in Arabidopsis. 
B. FoxR9 and its three closest homologs are highly conserved especially in the C-
terminus part. Alignment of FoxR9 and its three closest homologs.  
C. FoxR9 and its closest homologs suppress PAMP-induced ROS-burst after 
transient over-expression in N. benthamiana. ROS burst in leaves of N. 
benthamiana transiently over-expressing GUS:YFP-HA, FoxR9 or FoxR9:YFP-
HA, FoxR9-H1, FoxR9-H1:YFP-HA, FoxR9-H2, FoxR9-H2:YFP-HA, FoxR9-
H3 or FoxR9-H3:YFP-HA induced by 100 nM flg22 at 3 dpi. Results are 
average ± s.e. (n=8). 
D. FoxR9:YFP-HA FoxR9-H1:YFP-HA, FoxR9-H2:YFP-HA and FoxR9-
H3:YFP-HA aggregate in “vesicle-like” structures after transient over-
expression. Confocal images of N. benthamiana leaves 2 dpi transiently over-
expressing FoxR9:YFP-HA, FoxR9-H1:YFP-HA, FoxR9-H2-YFP-HA or 
FoxR9-H3-YFP-HA, respectively. Scale bar represents 25 μm 
E. Over-expression of FoxR9:YFP-HA leads to increased susceptibility of N. 
benthamiana to two adapted bacterial pathogens. Leaves expressing the 
indicated construct were spray-infected with either P. syringae pv. tabaci 11528 
or P. syringae pv. syringae B728a and sampled 2 dpi. See text for experimental 
details. 
Bacterial counts were carried out at 3 days post-inoculation (3 dpi). Results are 
average ± s.e. (n=4).  
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This shows that the over-expression of FoxR9 in N. benthamiana blocks defence 
signalling and leads to an enhanced susceptibility to two adapted bacterial pathogen.  
As the effect of three FoxR9 homologs on ROS production was similar to that of 
FoxR9, it is tempting to speculate that some of these proteins fulfil a similar and 
partial redundant role in PTI-signalling.  However, all conclusions are based on 
results obtained after transient over-expression of Arabidopsis genes in N. 
benthamiana.  Therefore further studies in Arabidopsis are needed to investigate the 
potential role of FoxR9 and its close homologs in PTI signalling.  
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Chapter 4: bak1-5, a novel BAK1 allele, strongly impaired in PTI 
signalling and plant defence 
 
4.1. Objectives 
 
PAMP-triggered immunity is often described as the first layer of plant defence. In 
recent years some progress has been made in the elucidation and characterization of 
molecular events immediately downstream of ligand-binding to the corresponding 
PRR (Boller and Felix, 2009). However when I started my PhD only very few PRRs 
and even less immediate downstream signalling components were known 
(Schwessinger and Zipfel, 2008). In Arabidopsis, the only three known PRRs were 
FLS2, EFR and potentially CERK1 (Zipfel, 2008). It was recently shown that BAK1 
interacts with FLS2 in a ligand-dependent manner and that it is required for late and 
early flg22-triggered responses (Heese et al, 2007; Chinchilla et al., 2007). 
Furthermore, bak1 T-DNA insertion mutant alleles were known to be impaired in 
early but not late elf18-triggered responses, such as elf18-induced SGI (Chinchilla et 
al., 2007). A MAP-kinase cascade including MPK 3, 4 and 6 was known to be 
downstream of elf18, flg22 and chitin perception regulating a common core set of 
PTI-induced and -repressed genes (Schwessinger and Zipfel, 2008). In addition, 
several WRKY transcription factors were shown to be implicated in this 
transcriptional reprogramming. In order to elucidate novel signalling components or 
regulators we performed a forward genetic screen using the well described elf18-
induced SGI (Nekrasov et al., 2009). Within this screen we identified a unique 
mutant being strongly impaired in both flg22 and elf18-triggered SGI. 
Here, I show that elfin 27-6 is a novel allele of BAK1 harbouring a single mis-sense 
substitution in the 10th exon. First I demonstrate that the mutation within the coding 
region of BAK1 is causative for the observed SGI phenotypes using a combined 
approach of reconstitution in the null mutant background and allelism tests. In a 
detailed phenotypic characterization using the back-crossed mutant I show that 
bak1-5 is compromised in all early and late responses triggered by elf18 and flg22 
tested. This strong impairment in PTI signalling leads to enhanced susceptibility to 
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bacterial pathogens. Next, I demonstrate the importance of BKK1, the closest 
homologe of BAK1, in PTI signalling. The novel bak1-5 bkk1-1 double mutant is 
more strongly impaired in flg22- and elf18-triggered PTI signalling then either 
single mutant. This strong impairment in PTI signalling leads to enhanced 
susceptibility to bacterial pathogens and biotrophic oomycetes. Overall, my results 
suggest that BAK1 and BKK1 play a partially redundant role in PTI signalling of 
known and yet unknown PRRs. 
 
4.2. Results 
 
4.2.1. Identification of elfin27-6, an elf18- and flg22-insensitive mutant  
 
In order to discover new PTI signalling components, in collaboration with several 
other lab members I performed a forward genetic screen using a Col-0 EMS (ethyl- 
methanesulfonate) mutagenised population. On wild-type seedlings elf18 normally 
triggers severe growth retardation (Zipfel et al., 2006). However, mutants of the 
corresponding receptor EFR, of the protein folding and maturation machinery 
(Haweker et al., 2010; Li et al., 2009; Lu et al., 2009; Nekrasov et al., 2009; Saijo et 
al., 2009; von Numers et al., 2010) or of signalling components are impaired in this 
inhibition and identified as bigger seedlings. After three reiterative rounds of 
screening and identification of EFR mutant alleles by sequence analysis, I identified 
a single mutant allele out of 103 non-efr elfin mutants that was not only impaired in 
elf18-triggered SGI but also totally insensitive to flg22 (Figure 4.1 A). Importantly, 
this mutation was not specific to the SGI assay as both elf18- and flg22-triggered 
ROS burst was also strongly impaired in elfin27-6 (Figure 4.1 B). Next, we went on 
to determine if the observed phenotype was due to a single mutation event. For this 
purpose we analysed the F2 segregating population of a Col-0 x elfin27-6 cross 
using SGI triggered by concomitantly application of 50 nM elf18 and 50 nM flg22. 
At these peptide concentrations, 24 out of 98 seedlings displayed an enhanced 
growth phenotype suggesting a single recessive causative mutational event. 
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Furthermore, this suggests a mutation in an important component shared between 
both EFR- and FLS2- dependent signalling pathways. 
                              
 
4.2.2. Map-based cloning of elfin 27-6  
 
I chose a map-base cloning approach to identify the causative mutation in elfin27-6. 
Therefore, I generated a mapping population by crossing elfin 27-6 with Ler-0. I 
screened a segregating F2 population in SGI assay using 100 nM elf18, a 
concentration at which both Col-0 and Ler-0 displayed severe growth retardations 
compared to elfin27-6.  At this high peptide concentration elfin27-6 segregated as a 
single recessive locus. Rough-mapping on 20 elf18-insensitive individuals combined 
with bulk segregant analysis linked the mutation to the molecular marker 
CER451534 on the lower arm of Chromosome IV. I generated a bigger mapping 
population for high resolution mapping, which confirmed initial results and located 
the mutation 4.2 cM south of CER451534 (Figure 4.2 A). BAK1 (At4g33430) is 
located in close proximity to the identified location and bak1 mutants were known to 
be impaired in flg22-, but not elf18-induced SGI (Chinchilla et al., 2007). Therefore 
BAK1 was a prime candidate for targeted sequence analysis. Indeed sequencing of 
the whole genomic locus of BAK1 identified a single mis-sense substitution in the 
Figure 4.1. elfin27-6 is strongly impaired in FLS2- and EFR-dependent PTI 
signalling. 
A. elfin27-6 is impaired in seedling growth inhibition triggered by 60 nM elf18 or 
flg22. Fresh weight is represented relative to untreated control. Results are 
average ± s.e (n=6). 
B. elfin27-6 is strongly impaired in the ROS-burst triggered by 100 nM elf18 or 
100 nM flg22. Results are average ± s.e (n=8). [c = water control]  
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10th exon. The guanine at position 1223 of the coding sequence was exchanged with 
an adenine  (Figure 4.2 A), which represents the most commonly observed 
substitution for EMS mutagenesis (Kohalmi and Kunz, 1988). Next we tested 
whether this missense mutation affected the accumulation of the BAK1 protein in 
elfin27-6 plants. To this end, we performed immunoblot analysis using anti-BAK1 
antibodies on total protein extracts from Col-0, elfin27-6 and bak1-4, a previously 
described T-DNA insertion null allele (Chinchilla et al., 2007). Full length mutant 
BAK1 protein accumulated in elfin 27-6 to similar level as the wild-type protein 
(Figure 4.2 B). In contrast the corresponding band was almost completely missing in 
bak1-4 null mutant (Figure 4.2 B). Therefore the strong impairment of elfin27-6 in 
elf18- and flg22-induced SGI is most likely due to expression of the mutated BAK1-
5 protein. I therefore renamed elfin27-6 as bak1-5. 
Interestingly, the mis-sense substitution in bak1-5 leads to the single amino acid 
change C408Y in subdomain VIa of the cytoplasmic kinase just preceding the 
catalytic triad (Figure 4.2 C). The corresponding Cys residue is conserved in all 
Figure 4.2.  elfin27-6 is bak1-5, a novel allele of BAK1. 
A. elfin27-6 carries a single mis-sense mutation in the 10th exon of BAK1. 
Schematic representation of relative marker positions and observed 
recombination rates in a Ler-0 x elfin27-6 F2 mapping population. 
B. BAK1-5 accumulates to wild-type levels. Immunoblot of total protein from Col-
0, elfin27-6 and bak1-4 using anti-BAK1 antibody. Immunoblot, upper panel; 
Coomassie colloidal blue stained membrane, lower panel. 
C. The Cys408 residue mutated in BAK1-5 mutated is conserved in all AtSERK 
family members but not in all RLKs. Alignment of kinase subdomains VIa, VIb 
and VII of AtSERKs, AtBRI1, AtCLV1, AtFLS2, AtEFR and OsXA21. The 
star indicates the Cys to Tyr change in BAK1-5. 
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SERK family members and in ~17% of all RLKs in Arabidopsis thaliana (Figure 4.2 
C, data not shown).  
 
4.2.3. bak1-5 a novel semi-dominat allele of BAK1  
 
To confirm that the C408Y mutation in BAK1-5 is causative for the observed strong 
impairment in elf18- and flg22-triggered responses, I first transformed the null 
mutant bak1-4 with the genomic locus of BAK1 or bak1-5 under the control of its 
own regulatory sequence. In the T2 generation I selected transgenic lines with 
similar expression levels compared to wild-type (Figure 4.3 A) and tested their 
responsiveness to elf18 and flg22 as measured by PAMP-triggered ROS production. 
As expected, the wild-type transgene was able to complement the compromised 
flg22- and elf18-induced oxidative burst of bak1-4 (Figure 4.3 B-C). Consistently, 
transgenic plants expressing bak1-5 were strongly impaired in flg22- and elf18-
induced oxidative burst, and thus phenocopied the bak1-5 mutant (Figure 4.3 B-C).  
This clearly demonstrates that not any mutations closely linked to the genetic locus 
of BAK1 but actually the mutation in BAK1 is causative for the observed phenotypes 
of bak1-5.  
Initial experiments with high concentrations of flg22 and elf18 in the SGI assay 
suggested that bak1-5 was a recessive mutation. However, I wanted to test for 
potential subtle semi-dominant effects of the mutant bak1-5 protein on the wild-type 
protein using heterozygous plants. For this purpose we performed an allelism 
analysis using Col-0, bak1-4 and bak1-5. Initially, I tested the effect of the bak1-5 
mutation on the flg22-triggered ROS burst. Confirming previous results bak1-5 and 
importantly bak1-5 x bak1-4 heterozygous F1 plants displayed a near abolishment of 
the ROS-burst (Figure 4.4 A). 
In the case of bak1-5 x Col-0 heterozygous F1 plants only a slight delay in the onset 
of the flg22-induced ROS-burst could be observed but no clear reduction in the 
amplitude (Figure 4.4 A). We obtained similar results for the flg22-induced SGI. 
Heterozygous F1 bak1-5 x Col-0 plants displayed an intermediate phenotype 
between bak1-5 and Col-0 seedlings (Figure 4.4 B). Next we tested the contribution 
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of BAK1-5 to elf18-triggered responses. Consistently with all previous observations, 
bak1-5 x bak1-4 heterozygous F1 plants phenocopied bak1-5 mutants in both elf18-
induced ROS-production and SGI (Figure 4.4 C-D). More importantly, bak1-5 x 
Col-0 heterozygous F1 plants were markedly compromised in their elf18 induced 
ROS-burst. Furthermore, these plants were partially insensitive to low concentration 
of elf18 (10 nM) in the SGI, growing more than Col-0 or bak1-4 seedlings. This 
careful investigation clearly demonstrates the semi-dominant nature of the bak1-5 
Figure 4.3. BAK1-5 is causative for the bak1-5 phenotype. 
A. Expression of BAK1 and BAK1-5 in transgenic plants in the bak1-4 
background. Immunoblot of total protein from Col-0, bak1-4 pBAK1::BAK1, 
bak1-4 pBAK1::BAK1-5 and bak1-4 using anti-BAK1 antibody. Immunoblot, 
upper panel; Coomassie colloidal blue stained membrane, lower panel. 
B. The bak1-5 mutation is causative for the reduced flg22-induced ROS burst. 
Total ROS production after 35 min in leaves of Col-0, bak1-4, bak1-5, bak1-4 
pBAK1::BAK1, and bak1-4 pBAK1::BAK1-5 after treatment with 100 nM flg22. 
Results are average ± s.e. (n=8).  
C. The bak1-5 mutation is causative for the compromised elf18-induced ROS 
burst. ROS burst in leaves of Col-0, bak1-4, bak1-5, bak1-4 pBAK1::BAK1 and 
bak1-4 pBAK1::BAK1-5 plants treated with 100 nM elf18. Results are average ± 
s.e. (n=8). 
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mutation. This also suggests that bak1-5 has a semi-dominant negative effect on the 
endogenous wild-type BAK1 most likely in a dose-dependent manner interfereing 
with the function of the wild-type protein via protein-protein interaction. 
Intriguingly, the semi-dominant effect of bak1-5 was more pronounced in the case of 
EFR-dependent signalling pathway.  
 
 
 
Figure 4.4. bak1-5 is a semi-dominant allele. 
A. The flg22-induced ROS burst is delayed but not reduced in bak1-5 x Col-0 F1 
plants. ROS burst in leaves of Col-0, bak1-4, bak1-5, bak1-5 x Col-0 F1 and 
bak1-5 x bak1-4 F1 plants treated with 100 nM flg22. Results are average ± s.e. 
(n=8). 
B. bak1-5 x Col-0 F1 seedlings are slightly impaired in the flg22-triggered SGI. 
SGI of Col-0, bak1-4, bak1-5, bak1-5 x bak1-4 F1 and bak1-5 x Col-0 F1 in the 
presence of 40 nM flg22. Fresh weight is represented relative to untreated 
control. Results are average ± s.e (n=6). 
C. The elf18-induced ROS burst is significantly compromised in bak1-5 x Col-0 
F1 plants. ROS burst in leaves of Col-0, bak1-4, bak1-5, bak1-5 x Col-0 F1 and 
bak1-5 x bak1-4 F1 plants treated with 100 nM elf18. Results are average ± s.e. 
(n=8). 
D. bak1-5 x Col-0 F1 seedlings are slightly impaired in the elf18-triggered SGI. 
SGI of Col-0, bak1-4, bak1-5, bak1-5 x bak1-4 F1 and bak1-5 x Col-0 F1 in the 
presence of 10 nM elf18. Fresh weight is represented relative to untreated 
control. Results are average ± s.e (n=6). 
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4.2.4. bak1-5 is strongly impaired in PTI signalling 
 
The initial phenotypic characterization of bak1-5 suggested a strong impairment in 
all elf18- and flg22-triggered responses. In order to obtain a precise overview of the 
impairment in PTI signalling and to illustrate potential differences to the previous 
described bak1-4 null allele (Chinchilla et al., 2007; Heese et al. 2007), I performed 
a detailed comparative phenotypic analysis using Col-0, bak1-4 and bak1-5 mutant 
plants.  
Previous reports showed that bak1-4 was not impaired in elf18-triggered SGI 
(Chinchilla et al., 2007). I was able to recapitulate these results as only bak1-5 
seedlings were impaired in the elf18-triggered SGI (Figure 4.5 A). Interestingly, 
bak1-5 was also more strongly impaired in flg22-induced SGI at high peptide 
concentrations of 1μM compared to bak1-4 (Figure 4.5 A). Similarly, I found that 
the ROS-burst induced by flg22 and elf18 treatment was strongly reduced in bak1-5 
leaves (Figure 4.5 B), whereas leaves of the null mutant bak1-4 showed only a 
delayed and slightly reduced oxidative burst (Figure 4.5 B), as previously reported 
(Chinchilla et al., 2007; Heese et al., 2007).  
Next, I analysed the impact of bak1-5 on the activation of MAP kinases by flg22 and 
elf18. Consistent with previous observations, the activation of MPK3, 4 and 6 after 
flg22 and elf18 treatment was delayed and reduced in bak1-4 seedlings (Figure 4.5 
C). Surprisingly, the activation of these MPKs by flg22 and elf18 was differentially 
regulated in bak1-5 seedlings. The activation of MPK3 and 6 by flg22 and elf18 was 
also delayed, but the level of activation ultimately reached levels similar to that 
observed in wild-type seedlings at 15 min. Notably, MPK4 was not activated at all 
during the time-course of the experiment (Figure 4.5 C).  
Since MPK activation is linked to PAMP-induced transcriptional reprogramming 
(Fiil et al., 2009; Boudsocq et al., 2010), I then assessed whether PAMP-induced 
gene expression was also affected in bak1-5 seedlings using three different PTI 
marker genes (He et al., 2006) over a 3 hours time course experiment. The induction 
of the three genes by flg22 and elf18 was partially impaired in bak1-4 over the time-
course although this effect was minor or absent at certain time-points (Figure 4.5 D). 
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In contrast, after flg22 or elf18 treatment the transcript levels of all three PTI-marker 
genes were drastically reduced in bak1-5 over the time-course (Figure 4.5 D). 
Interestingly, the steady-state expression of the marker genes was already lower in 
bak1-5 when compared to wild-type (Figure 4.5 D, Figure 4.6).  
My results clearly demonstrate that bak1-5 plants were strongly affected in all flg22 
and elf18 responses measured. Strikingly, the new allele bak1-5 was more strongly 
impaired in PTI signalling than the null allele bak1-4 suggesting a mis-regulation of 
Figure 4.5. bak1-5 is strongly impaired in EFR- and FLS2-dependent PTI 
signalling. 
A. bak1-5 is strongly impaired in flg22- and elf18 induced SGI even at high 
peptide concentrations. SGI of Col-0, bak1-4 and bak1-5 in the presence of 
1μM flg22 or 1μM elf18. Fresh weight is represented relative to untreated 
control. Results are average ± s.e (n=6). 
B. bak1-5 is strongly impaired in flg22- and elf18-induced ROS burst. ROS burst 
in leaves of Col-0, bak1-4, bak1-5 after treatment with 100 nM flg22 (left) or 
elf18 (right). Results are average ± s.e. (n=8).  
C. Differential MPK activation in bak1-5 after flg22 and elf18 treatment. The 
kinetics of kinase activation in seedlings of Col-0, bak1-4 and bak1-5 treated 
with either 100 nM flg22 (left) or elf18 (right) as shown by immunoblot 
analysis using an anti-p44/42-ERK antibody. Individual MPKs are identified by 
molecular mass and indicated by arrows. Immunoblot, upper panel; Coomassie 
colloidal blue stained membrane, lower panel. 
D. Defence gene induction by flg22 and elf18 is strongly impaired in bak1-5. Gene 
expression of At2g17740 (left), CYP81F2 (At5g57220) (middle) and At1g51890 
(right) in seedlings of Col-0, bak1-4 and bak1-5 treated with 100 nM flg22 or 
100 nM elf18 was measured by qPCR analysis. Results are average ± s.e. (n=3). 
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PTI signalling. This effect was particularly apparent with EFR-dependent responses, 
as bak1-4 null mutants were not affected in elf18-triggered late responses, whereas 
bak1-5 mutants were. 
 
4.2.5. The absence of BKK1 in bak1-5 bkk1-1 double mutant drastically 
enhances the impairment in PTI signalling 
 
Next, in collaboration with Milena Roux I wanted to test if BKK1, the closest 
homolog of BAK1, is also implicated in PTI signalling. bkk1 single mutant plants 
were previously reported not to be impaired in PTI signalling (Albrecht et al., 2008; 
Heese et al., 2007). However, the investigation of more subtle or redundant roles 
was precluded by the seedling lethality of the bak1-4 bkk1-1 double mutant due to 
uncontrolled cell death (He et al., 2007). Fortunately, we were able to overcome this 
technical limitation using bak1-5 bkk1-1 double mutant, which is fully viable (see 
Chapter 5). This allowed us to perform a detailed analysis of the role of BKK1 in 
FLS2- and EFR-dependent signalling pathways.  
The double mutant bak1-5 bkk1-1 showed strikingly reduced responses to both flg22 
and elf18 in all assays conducted. Remarkably, only a negligible ROS-burst was 
triggered in leaves of bak1-5 bkk1-1 double mutants by either flg22 or elf18 
Figure 4.6.   Reduced steady-state defence genes expression in bak1-5. 
Gene expression of At2g17740 (left), CYP81F2 (middle) and At1g51890 (right) in 
seedlings of Col-0, bak1-4 and bak1-5 was measured by qPCR analysis. Results are 
average ± s.e. (n=3). 
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Figure 4.7. BAK1 and BKK1 are required for EFR- and FLS2-dependent PTI 
signalling.  
A. bak1-5 bkk1-1 plants are totally impaired in flg22- and elf18- induced ROS 
burst. Total ROS production after 35 min in leaves of Col-0, bak1-5, bkk1-1, 
and bak1-5 bkk1-1 after treatment with 100 nM flg22 (upper panel) or 100 nM 
elf18 (lower panel). Results are average ± s.e. (n=8). 
B. MAPK activation is nearly totally abolished in bak1-5 bkk1-1 seedlings after 
flg22- or elf18-treatment. The kinetics of kinase activation in seedlings of Col-
0, bak1-5, bkk1-1, and bak1-5 bkk1-1 treated with either 100 nM flg22 (upper 
panel) or 100 nM elf18 (lower panel) as shown by immunoblot analysis using 
an anti-p44/42-ERK antibody. Individual MPKs are identified by molecular 
mass and indicated by arrows. Immunoblot, upper panel; Coomassie colloidal 
blue stained membrane, lower panel. 
C. Near total abolishment of flg22- or elf18-induced defense gene expression in 
bak1-5 bkk1-1 seedlings. Gene expression of CYP81F2 (upper panel), 
At1g51890 (middle panel) and At2g17740 (lower panel) in seedlings of Col-0, 
bak1-5, bkk1-1, and bak1-5 bkk1-1 treated with 100 nM flg22 or 100 nM elf18 
was measured by qPCR analysis. Results are average ± s.e. (n=3). 
D. bak1-5 bkk1-1 plants are strongly impaired in flg22- and elf18-induced ethylene 
production. Ethylene production in Col-0, bak1-5, bkk1-1 and bak1-5 bkk1-1 
leaves after mock, 100 nM flg22, 100 nM or elf18 treatments. Results are 
average ± s.e. (n=6). Ethylene assays were performed by Delphine 
Chinchilla (University of Basel). 
E. bak1-5 bkk1-1 seedlings are totally insensitive to flg22- and elf18-triggered SGI 
even at high peptide concentrations. SGI triggered by elf18 or flg22 in Col-0, 
bak1-5, bkk1-1 and bak1-5 bkk1-1 seedlings. Fresh weight is represented 
relative to untreated control. Results are average ± s.e (n=6).
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treatment (Figure 4.7 A). This was even lower than in bak1-5 mutant leaves. bkk1-1 
single mutant displayed no impairment in the ROS-burst triggered by either PAMP 
(Figure 4.7 A). We then tested the sensitivity of bak1-5 bkk1-1 double mutant in 
other PTI signalling responses, which show a different temporal behaviour. First, we 
tested MAP kinase activation after flg22 and elf18 treatment. As previously shown 
the activation of MPK3 and 6 was reduced and delayed in bak1-5 seedlings in 
comparison to wild-type and bkk1-1 (Figure 4.7 B). Intriguingly, only residual 
MAPK activation in response to flg22 and elf18 could be detected in bak1-5 bkk1-1 
seedlings over the time course assayed (Figure 4.7 B).  
Next we tested if this near total impairment in early PTI signalling extended to 
PAMP-triggered gene induction of three independent marker genes (He et al., 2006) 
over a 3 hours time course. Indeed in bak1-5 bkk1-1 double mutant seedlings the 
expression levels were hardly changed by either flg22 or elf18 treatment and even 
lower than in bak1-5 single mutant (Figure 4.7 C). In contrast in bkk1-1 seedlings 
the expression level of all three marker genes was nearly indistinguishable from wild 
type (Figure 4.7 C).  
An increase in ethylene biosynthesis can be measured within 2 hours of treatment 
with flg22 or elf18 (Felix et al., 1999; Kunze et al., 2004). We were able to 
recapitulate these results and measured a clear flg22- or elf18-induced production of 
ethylene in Col-0 and bkk1-1 plants (Figure 4.7 D). In contrast, this was significantly 
reduced in bak1-5 leaves; and only marginal ethylene production could be measured 
in bak1-5 bkk1-1 in response to flg22 or elf18 (Figure 4.7 D). Interestingly, the ROS 
burst and ethylene production triggered by flg22 and elf18 was sometimes higher in 
bkk1-1 leaves than in Col-0 leaves, which may be explained by the weak constitutive 
cell death and early senescence of this mutant (He et al., 2007; Jeong et al., 2010). 
Finally we tested SGI as a late PTI signalling response. As shown in Figure 4.7 E, 
elf18- and flg22-triggered SGI in bkk1-1 seedlings was comparable to wild-type at 
all concentrations tested (Figure 4.7 E).  In contrast bak1-5 and bak1-5 bkk1-1 
seedlings were totally impaired in the SGI triggered by flg22. Notably, the only 
partial impairment in elf18-triggered SGI of bak1-5 seedlings was even further 
decreased in bak1-5 bkk1-1 seedlings (Figure 4.7 E).  
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In summary, we showed that loss of BKK1 further decreased early and late responses 
of bak1-5 to elf18 and flg22 unravelling a partially redundant role of BKK1 in PTI 
signalling. 
 
 
4.2.6. BAK1 and BKK1 play partially redundant roles in DAMP-induced PTI 
signalling 
 
It was recently shown that BAK1 is also involved in PTI induced by AtPep1 (Krol et 
al. 2010). bak1-4 null mutant shows a reduced sensitivity to AtPep1 and BAK1 
interacts with the two corresponding ligand-binding receptors AtPEPR1/2 in a 
targeted yeast-two hybrid approach (Postel et al. 2009). Therefore, in collaboration 
Figure 4.8. BAK1 and BKK1 are partially redundant in AtPep1-triggered DTI-
signalling. 
A. bak1-5 bkk1-1 leaves nearly totally impaired in AtPep1-induced ROS burst. 
Total ROS production after 35 min in leaves of Col-0, bak1-5, bkk1-1, and 
bak1-5 bkk1-1 after treatment with 100 nM AtPep1. Results are average ± s.e. 
(n=8). 
B. Total impairment of AtPep1-triggered ethylene production in bak1-5 bkk1-1 
plants. Total Ethylene production after 3 hours in Col-0, bak1-5, bkk1-1 and 
bak1-5 bkk1-1 leaves after mock or 100 nM AtPep1 treatments. Results are 
average ± s.e. (n=6). Ethylene assays were performed by Delphine 
Chinchilla (University of Basel). 
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with Milena Roux I tested if AtPEPR1/2-dependent signalling was also 
compromised in bak1-5 and if BKK1 plays a similar role as in PTI signalling. We 
were able to reproduce the attenuated AtPep1-induced ROS burst in bak1-4 (Figure 
4.8 A). Consistently with observations made for flg22 or elf18-induced PTI-
signalling, the AtPep1-triggered ROS burst was further decreased in bak1-5 leaves, 
and almost completely abolished in bak1-5 bkk1-1 (Figure 4.8 A). The partially 
redundant role of BKK1 was even more evident in AtPep1-induced ethylene 
production as bak1-5 leaves still generated reduced but measurable amounts of 
ethylene whereas bak1-5 bkk1-1 double mutant leaves were totally unresponsive 
(Figure 4.8 B). bkk1-1 plants were not affected in their responsiveness to AtPep1 
(Figure 4.8 A-B). These experiments demonstrate that BAK1 and BKK1 play 
partially redundant roles in AtPep1-induced PTI-signalling. 
 
4.2.7 BAK1 and BKK1 are required for disease resistance against bacterial 
pathogens 
 
After having clearly demonstrated the importance of BAK1 and BKK1 for PTI 
signalling and shown the strong impairment of it in bak1-5 single and bak1-5 bkk1-1 
double mutants in collaboration with Milena Roux I tested how this impairment in 
PTI signalling would impact general disease resistance.  
We first spray-inoculated plants with the highly virulent hemibiotrophic bacterium 
Pto DC3000. As reported previously (Zipfel et al., 2004; Nekrasov et al., 2009),  fls2 
and fls2 efr plants were hyper-susceptible to this strain upon spray-inoculation 
(Figure 4.9 A). The bak1-4 and bkk1-1 mutants however exhibited wild-type 
susceptibility levels (Figure 4.9 A). In contrast, leaves of bak1-5, fls2 efr bak1-5 and 
bak1-5 bkk1-1 allowed higher growth of Pto DC3000, comparably to fls2 efr (Figure 
4.9 A). 
PTI defects can be detected more sensitively with weakly virulent bacterial strains 
lacking effector molecules, such as AvrPto and AvrPtoB, or the phytotoxin 
coronatine, that are involved in PTI suppression (Melotto et al., 2006; Xiang et al., 
2008; Goehre et al., 2008; Shan et al., 2008; Nekrasov et al., 2009). As shown in 
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Figure 4.9 B, efr and fls2 single mutants where already more susceptible to spray-
inoculation with Pto DC3000 ΔAvrPto/ΔAvrPtoB while bak1-4 and bkk1-1 plants 
were not. This increased susceptibility was even more pronounced in fls2 efr double 
mutant plants and importantly in bak1-5 single mutants.  Interestingly, bak1-5 bkk1-
1 double and fls2 efr1 bak1-5 triple mutant leaves supported even slightly more 
growth of Pto DC3000 ΔAvrPto/ΔAvrPtoB (Figure 4.9 B). Indeed, Pto DC3000 
ΔAvrPto/ΔAvrPtoB grew to similar levels in bak1-5 bkk1-1 and fls2 efr1 bak1-5 as 
the isogenic wild-type Pto DC3000 in Col-0 plants, showing that the these mutations 
almost completely restored the virulence defect associated with the loss of AvrPto 
and AvrPtoB. This pattern was even more pronounced when infecting with the Pto 
DC3000 COR- strain. This strain grew already to much higher numbers in fls2 efr 
Figure 4.9. BAK1 and BKK1 are required for resistance to adapted and non-
adapted bacterial pathogens. 
A. Four-week-old plants (Col-0, fls2, efr, fls2 efr, fls2 efr bak1-5, bak1-4, bak1-5, 
bkk1-1 and bak1-5 bkk1-1) were spray-inoculated with Pto DC3000 (OD600= 
0.02). 
B. Four-week-old plants (Col-0, fls2, efr, fls2 efr, fls2 efr bak1-5, bak1-4, bak1-5, 
bkk1-1 and bak1-5 bkk1-1) were spray-inoculated with Pto DC3000 
ΔAvrPto/ΔAvrPto (OD600= 0.2). 
C. Four-week-old plants (Col Col-0, fls2, efr, fls2 efr, fls2 efr bak1-5, bak1-4, 
bak1-5, bkk1-1 and bak1-5 bkk1-1) were spray-inoculated with Pto DC3000 
COR- (C) (OD600=0.2). 
D. Four-week-old plants (Col-0, fls2, efr, fls2 efr, fls2 efr bak1-5, bak1-4, bak1-5, 
bkk1-1 and bak1-5 bkk1-1) were syringe-inoculated with P. syringae pv. tabaci 
6605 (OD600=0.002) 
Bacterial counts were carried out at 3 days post-inoculation (3 dpi). Results are 
average ± s.e. (n=4).  
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when compared to Col-0, bak1-4 or bkk1-1 (Figure 4.9 C). bak1-5 plants were 
similarly hyper-susceptible as fls2 efr, while this strain reproducibly colonized bak1-
5 bkk1-1 and fls2 efr1 bak1-5 leaves to an about 10-fold higher level (Figure 4.9 C), 
reaching again levels comparable to the ones observed with isogenic wild-type Pto 
DC3000 in Col-0 leaves (Figure 4.9 C). Thus, BAK1 and BKK1 both contribute to 
the basal resistance to Pto DC3000 mediated by FLS2, EFR and other yet unknown 
PRRs.  
We then tested if BAK1 and BKK1 play a role in the non-host resistance against the 
non-adapted bacterium P. syringae pv. tabaci 6605 (Pta 6605) , which partially 
depends on FLS2 (Li et al., 2005) (Figure 4.9 D). Growth in bak1-4 and bkk1-1 
reached similar low levels as wild-type Col-0, while the fls2 and fls2 efr mutant were 
significantly more susceptible, supporting up to 2 logs more bacterial growth than 
Col-0 (Figure 4.9 D). The bak1-5, bak1-5 bkk1-1 and fls2 efr1 bak1-5 mutants were 
as susceptible to this non-adapted strain as the fls2 single and fls2 efr double mutant 
(Figure 4.9 D). This suggests that the contribution of PTI to the non-host resistance 
to Pta 6605 is mostly mediated by FLS2 and is therefore also compromised in the 
absence of functional BAK1 and BKK1.  
 
4.2.8. BAK1 and BKK1 are required for disease resistance against oomycete 
pathogens 
 
Next we wanted to know if this strong impairment of basal and non-host resistance 
in bak1-5 bkk1-1 is also applicable to biotrophic pathogens. Therefore Nick Holten  
(HRI, Warwick, UK) assessed the role of BAK1 and BKK1 in resistance to the 
obligate biotrophic oomycete pathogen Hpa. We first performed infections with the 
virulent isolate Emco5 that causes abundant sporangiophores and spore formation 
within 7 days after inoculation (dai) on Arabidopsis Col-0 seedlings (McDowell et 
al., 2005). In comparison to Col-0, we observed a decreased sporulation on bak1-4 
seedlings (Figure 4.10 A), probably due to their increased cell death phenotype upon 
infection (Kemmerling et al., 2007). In contrast, no decrease in the number of spores 
could be observed in bak1-5, bkk1-1 or bak1-5 bkk1-1 (Figure 4.10 A). The absence 
 119
of noticeable phenotype of bak1-5 bkk1-1 seedlings could be due to the already high 
susceptibility of Col-0 to Hpa Emco5 that may mask a contribution of PTI. We thus 
decided to perform infections with Hpa isolates that are only moderately virulent on 
Col-0 seedlings. Sporulation of the Hpa isolate Cala2 on Col-0 seedlings is rare due 
to RPP2-based resistance (Holub et al., 1994). Indeed, we observed only occasional 
conidiophore formation on Col-0 seedlings inoculated with Hpa Cala2 that never 
resulted in sporulation (Figure 4.10 B).  In contrast, bak1-5 and bkk1-1 seedlings 
Figure 4.10. BAK1 and BKK1 are required for resistance to the obligate biotrophic 
oomycete pathogen Hyaloperonospora arabidopsidis. 
A. Infection of Col-0, bak1-4, bak1-5, bkk1-1 and bak1-5 bkk1-1 seedlings with H. 
arabidopsidis Emco5. Spores were counted at 7 days post-inoculation (7 dpi). 
Results are average ± s.e. (n=12).  
B. Infection of Col-0, bak1-4, bak1-5, bkk1-1 and bak1-5 bkk1-1 seedlings with H. 
arabidopsidis Cala2. Conidiophores were counted at 7 dpi. Results are average 
±s.e. (n=40).  
C. Infection of Col-0, bak1-4, bak1-5, bkk1-1 and bak1-5 bkk1-1 seedlings with H. 
arabidopsidis Emoy2. Conidiophores were counted at 7 dpi. Results are average 
± s.e. (n=40).  
All infections and disease scoring was performed by Nick Holten (HRI, Warwick, UK). 
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appeared reproducibly more susceptible to this isolate and this enhanced 
susceptibility was even more pronounced in bak1-5 bkk1-1 seedlings (Figure 4.10 B). 
Additionally, infection with another weakly virulent isolate, Hpa Emoy2, where 
resistance in Col-0 is provided by RPP4 (Holub et al., 2008), revealed a similar 
pattern. Consistently, bak1-5 bkk1-1 seedlings support the growth of about double 
the number of conidiophores than Col-0 (Figure 4.10 C). As observed with the 
highly virulent isolate Emco5, bak1-4 seedlings were less susceptible to the Hpa 
isolates Cala2 and Emoy2 (Figure 4.10 B-C), as expected due to their deregulated 
cell death upon infection.  
These results revealed a redundant role for BAK1 and BKK1 in resistance to the 
obligate biotrophic oomycete Hpa. 
 
4.3. Discussion 
 
4.3.1. bak1-5 a novel semi-dominant allele of BAK1 leads to a strong 
impairment in FLS2- and EFR-dependent PTI signalling 
 
bak1-5 was isolated in a screen designed to identify regulators of EFR-dependent 
PTI signalling based on their reduced elf18-sensitivity in an SGI assay (Nekrasov et 
al., 2009). It came as a surprise to identify a novel BAK1-allele within such a screen 
as previously described null  bak1 mutant alleles were not impaired in elf18-induced 
SGI (Chinchilla et al., 2007; Hesse et al., 2007). However, several lines of evidence 
univocally demonstrate that the bak1-5 mutation causes the observed phenotypes: (i) 
bak1-5 plants need to express a full-length or truncated version of BAK1 in order to 
exert an elf18-insensitivity in the SGI assay as the expression of no BAK1 protein in 
the null allele does not confer elf18-insensitivity. Indeed full length bak1-5 mutant 
protein is expressed in bak1-5 plants (Figure 4.2 B). (ii) Expression of the bak1-5 
mutant protein in the bak1-4 null mutant background phenocopied bak1-5 plants 
(Figure 4.3 and 4.4). And (iii) BAK1-5 has a dose-dependent dominant-negative 
effect on the endogenous wild-type BAK1 as plants heterozygous for the bak1-5 
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mutation are partially compromised in their flg22- and elf18-responsiveness (Figure 
4.4).   
It has been previously reported that bak1 null alleles in Arabidopsis are 
compromised in early and late responses to flg22 but only in early responses to elf18 
(Chinchilla et al., 2007). In contrast bak1-5 mutant plants were compromised in 
elf18-induced SGI, a late response (Figure 4.1).  This observation prompted me to 
perform a comprehensive comparative phenotypic analysis between bak1-4 and 
bak1-5 mutant plants in respect to their elf18- and flg22-responsiveness (Figure 4.5). 
Bak1-5 mutants were more strongly compromised in flg22- and elf18-induced ROS-
burst, defence gene expression and SGI (Figure 4.5). The differential and stronger 
effect of bak1-5 compared to bak1-4 was more apparent for EFR-dependent 
responses. This might be due to the relatively small impairment of EFR-dependent 
responses in bak1-4 and the concomitant greater ability to observe a differential 
behaviour. Alternatively, it could be that bak1-5 has per se a greater impact on EFR- 
compared to FLS2-dependent signalling. Interestingly, heterozygous BAK1/bak1-5 
plants show more consistent and stronger impairment in elf18-triggered responses 
than flg22-triggered responses supporting the later hypothesis (Figure 4.4.).  This 
and several additional observations suggest that PTI signalling is differentially mis-
regulated in bak1-5 plants.  
The flg22- and elf18-induced activation of MPK3, 4 and 6 was reduced and delayed 
in bak1-4 seedlings (Figure 4.5 C). In contrast, in bak1-5 seedlings the activation of 
MPK3 and 6 was only delayed but after 15 min reached similar activation levels as 
observed for Col-0 (Figure 4.5 C). Importantly, MPK4 was not activated at all in 
bak1-5 seedlings during the time-course of the experiment. This might suggest that 
proper MPK4 activation is required for full PTI signalling challenging its previously 
ascertained role as a negative regulator of defence signalling (Petersen et al., 2000; 
Qui et al., 2008a). Interestingly, bir1-1 mutants also display a strong impairment of 
flg22-induced MPK4 but not MPK3 and MPK6 activation (Gao et al., 2008). This 
specific impairment of MPK4 in bir1-1 was only observed under non-permissive 
temperature and was fully reverted at 27oC, a temperature at which bir1-1 mutant 
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plants are fully viable (Gao et al., 2008). This might suggest a differential regulation 
of BIR1 in the bak1-5 mutant background. 
Intriguingly, the basal transcript levels of three unrelated PTI marker genes was 
markedly reduced in bak1-5 plants (Figure 4.6). Therefore, the activity of negative 
regulators of PTI signalling might be constitutively higher in bak1-5 plants leading 
to repression of defence genes. Alternatively, assuming that MPK4 is a negative 
regulator of PTI signalling another hypothesis is also conceivable. In bak1-5 plants, 
defence signalling might be weakly constitutive leading to the activation of a 
postulated negative feedback loop (Schwessinger and Zipfel, 2008) thereby down-
regulating basal defence gene expression. Both hypotheses require bak1-5 to 
actively manipulate PTI signalling.  
 
4.3.2. BAK1 and BKK1 have a partially redundant role in FLS-, EFR- and 
AtPEPR1/2-dependent PTI signalling 
 
The transcripts of SERK1-4 are up-regulated in response to PAMP or pathogen 
treatments (Postel et al., 2009), supporting a potential role for these SERKs in plant 
immunity. Yet, no other serk single mutant apart from bak1 is affected in flg22- or 
elf18-triggered responses (Chinchilla et al., 2007; Heese et al., 2007). However, 
several SERK-family members share (partially) redundant roles in different 
signalling pathways with BAK1 or amongst each other (Chinchilla et al., 2009). For 
example, BKK1, the closest homolog of BAK1, has a partially redundant role in cell 
death control (He et al., 2007; de Jonge et al., 2010). Strong bak1 bkk1 double 
mutant alleles are seedling lethal under sterile conditions (He et al., 2007). Even 
weak allele combinations have strong developmental phenotypes, such as early 
senescence making them unamenable for PTI signalling analysis. So in order to test 
if BKK1 has a partially redundant role with BAK1 in PTI signalling I took 
advantage of the fact that bak1-5 bkk1-1 mutants are not impaired in cell death 
control (see Chapter 5). Bak1-5 bkk1-1 mutants were more strongly impaired in all 
flg22- and elf18-induced responses tested than either single mutant (Figure 4.7). In 
some assays such as flg22- and elf18-induced ROS production bak1-5 bkk1-1 plants 
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even phenocopied receptor mutant plants (Figure 4.7 A). This demonstrates that 
BAK1 and BKK1 function in a partially redundant manner in FLS2- and EFR-
dependent signalling. Additionally, BAK1 and BKK1 are also involved in DAMP-
signalling as bak1-5 bkk1-1 mutants are nearly totally impaired in AtPep1-induced 
ROS-burst and ethylene production (Figure 4.8). Therefore, BAK1 and BKK1 might 
be the most important SERK family members for FLS2-, EFR- and AtPEPR1/2-
dependent signalling. Though, additional analysis of serk1 bak1-5, serk2 bak1-5 and 
higher order mutants might reveal subtle roles of other SERK-family members in 
PTI signalling. 
 
4.3.3. BAK1 and BKK1 are required for immunity to hemi-biotrophic and 
obligate biotrophic pathogens 
 
The role of BAK1 and to a larger extent BKK1 in plant disease resistance is unclear. 
An unambiguous analysis of the role of BAK1 and BKK1 in Arabidopsis disease 
resistance is hindered by the constitutive and pathogen-induced cell death phenotype 
of bak1 and bkk1 single and double null mutants (He et al., 2007; Kemmerling et al., 
2007; Jeong et al., 2010). Accordingly, bak1-4 plants exhibited pronounced chlorotic 
lesions upon infection with the hemibiotrophic bacterium Pto DC3000, but were not 
more susceptible to this bacterium (Kemmerling et al., 2007). Concomitantly, the 
same mutant plants were more resistant to the obligate biotrophic oomycete Hpa, but 
more susceptible to the necrotrophic fungi B. cinerea and A. brassicicola 
(Kemmerling et al., 2007).  
Intriguingly, silencing of NbSERK3/BAK1 in N. benthamiana resulted in a clear 
hyper-susceptibility to the adapted bacterium Pta 11528 and the non-adapted 
bacterium Pto DC3000 (Heese et al., 2007). In addition, SERK3/BAK1 silencing in 
tomato led to loss of Verticillium resistance mediated by the LRR-RLP Ve1 (Fradin 
et al., 2009). Several non-mutually-exclusive hypotheses could explain the strong 
impact of SERK3/BAK1 silencing on disease resistance in N. benthamiana and 
tomato without an apparent impact on cell death control as observed in Arabidopsis. 
First, the silenced gene may not correspond to the true functional ortholog of 
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AtBAK1 and therefore not be involved in cell death control. Second, the silencing 
fragment may affect the expression of additional SERK paralogs those function 
and/or identity is currently unknown. Thirdly, the hypothetical R protein guarding 
the BAK1-BKK1 complex integrity and/or activity may not be present in N. 
benthamiana and tomato. Thus, silencing of SERK3/BAK1 in these plants does not 
result in observable cell death phenotypes.   
Another issue in interpreting the role of BAK1 and BKK1 in disease resistance is 
that the impact of BR signalling in defence is still unclear (Divi et al., 2010). 
Consequently, conclusions on disease susceptibility of bak1 mutants always need to 
be carefully weighed as these lines exhibit defects in hormone signalling, innate 
immunity and cell death.  
As bak1-5 mutant plants are strongly impaired in PTI but not BR signalling, and 
bak1-5 bkk1-1 mutants are fully viable not showing any cell-death related 
phenotypes (see Chapter 5) I used these mutant lines to test the role of BAK1 and 
BKK1 in defence signalling. Bak1-5 and bak1-5 bkk1-1 mutants were as susceptible 
as fls2 efr double receptor mutants to the highly virulent bacterial pathogen Pto 
DC3000 and the non-adapted strain Pta 6605 (Figure 4.9 A and D). Intriguingly, 
bak1-5 single mutant leaves supported nearly as much growth of two weakly 
virulent bacterial strains Pto DC3000 ΔAvrPto/ΔAvrPtoB and Pto DC3000 COR- as 
observed with the isogenic Pto DC3000 strain in Col-0 leaves (Figure 4.9 C-D). This 
super-susceptibility of plants carrying a single mutation in a central regulator of PTI 
signalling underscores the tremendous contribution of PTI to general plant defences. 
Importantly, bak1-5 fls2 efr and bak1-5 bkk1-1 mutants were more susceptible than 
bak1-5 and fls2 efr mutants to the weakly virulent strain Pto DC3000 COR- (Figure 
4.9 C). This suggests a partial redundant role of BAK1 and BKK1 in FLS2- and 
EFR-independent plant defence signalling pathways. It is therefore tempting to 
speculate that BAK1 and BKK1 are involved in the perception of other bacterial 
PAMP(s). This hypothesis may be extended to include oomycete PAMP(s) as bak1-
5 bkk1-1 double mutants support some growth of two Hpa isolates Cala2 and Emoy2 
that are normally resisted by the R proteins RPP2 and RPP4, respectively (Holub, 
2007). However, an alternative explanation might be that BAK1 and BKK1 are 
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involved in effector-triggered immunity (ETI). Yet, results presented in Chapter 7 
showing that bak1-5 bkk1-1 plants display a reduced responsiveness to a crude 
elicitor extract from Hpa-infected Arabidopsis plants rather supports the initial 
hypothesis. Therefore it is tempting to speculate that BAK1 and BKK1 are involved 
in the perception of multiple unknown PAMP(s) via the interaction with yet 
unidentified PRR(s). 
Overall, I was able to demonstrate the importance of BAK1 and BKK1 in basal and 
non-host resistance in Arabidopsis to hemibiotrophic bacteria and the obligate 
biotrophic oomycete Hpa. 
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Chapter 5: bak1-5 is not impaired in cell death control or 
brassinosteroid signalling 
 
Excursion: Brassinosteroid: perception, signalling and action 
 
 
The main plant steroid hormones are collectively called brassinosteroids (BR) and 
are a class of structurally related molecules that are produced via the mevalonate and 
isoprenoid pathway (Clouse and Sasse, 1998). BRs are growth promoting hormones 
that are involved in nearly all aspects of plant development, such as cell expansion, 
vascular patterning, flowering time, photomorphogenesis, senescence and sterility 
(Mussig, 2006, Domagalska et al., 2007; Ibanes et al., 2009; Clouse, 2002).  
Genetic screens in Arabidopsis isolated many dwarf BR insensitive mutants. The 
main locus BRI1 encodes an RK belonging to subfamily Xa with 25 extracellular 
LRRs, a single transmembrane spanning domain and a functional intracellular dual-
specific kinase domain (Li and Chory, 1997; Friedrichsen et al., 2000; Oh et al., 
2009). The perception of BRs is mediated by the extracellular LRR domain of BRI1 
(He et al., 2000). Brassinolide (BL), the most bioactive BR (Thompson et al., 1982), 
binds directly to the island domain of BRI1 situated between LRR21 and LRR22 
(Kinoshita et al., 2005). BRI1 forms constitutive homodimers and is under negative 
regulation by its C-terminal domain (Wang et al., 2005; Russinova et al., 2004). BL 
binding to the extracellular domain of BRI1 leads the activation of the intracellular 
kinase domain presumably by releasing autoinhibition (Wang et al., 2005). The 
BRI1 activation triggers the dissociation of the BRI1 kinase inhibitor 1 (BKI1) from 
the plasma membrane (Wang et al., 2005). Furthermore, BRI1 forms hetero-
complexes with BAK1 (Nam and Li, 2002; Li et al., 2002; Russinova et al., 2004). 
Also other members of the SERK-family such as SERK1 and BKK1 are able to 
interact with BRI1 in vivo (Karlova et al., 2006; He et al. 2007; Jeong et al., 2010). 
SERK1, BAK1 and BKK1 are positive regulators of BL-signalling and play partially 
redundant roles (He et al., 2007; Albrecht et al., 2008). The interaction of BRI1 and 
BAK1 is enhanced by BL application and this is dependent on BRI1 kinase activity 
(Wang et al., 2008). BAK1 and BRI1 undergo bidirectional phosphorylation 
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believed to be important for full BRI1 activation (Wang et al., 2008). BL application 
also leads to the phosphorylation of several homologous cytoplasmic RLKs (Tang et 
al., 2008). Three BR-signalling kinases (BSKs) interact directly and constitutively 
with BRI1 and are phosphorylated by BRI1 but not BAK1 (Tang et al.; 2008). This 
trans-phosphorylation by BRI1 is believed to lead to the activation and release of 
BSK family members from the complex. BSK1 interacts with BSU1 (BRI1 
suppressor 1) and is hypothesised to activate BSU1 by phosphorylation (Kim et al., 
2009). BSU1 is a kelch-repeat-containing phosphatase and a positive regulator of 
BR signalling (Mora-Garcia et al., 2004). BSU1 in turn is able to inactivate BIN2 
(BR insensitive 2) by dephosphorylating a crucial tyrosine residue in BIN2 (Kim et 
al., 2009). This dephosphorylation leads most likely to the proteasome mediated 
degradation of BIN2 (Peng et al. 2008). BIN2 is a GSK3-like kinase and a negative 
regulator of BR signalling (Li and Nam, 2002). In the absence of BR, BIN2 
normally phosphorylates the two transcription factors BZR1 (BRZ resistant 1) and 
BES1 (bri1-EMS-suppressor 1) (Wang et al., 2002; Yin et al., 2002; He et al., 2002). 
This phosphorylation leads to the inhibition of BZR1 and BES1 by degradation, 
cytoplasmic retention and/or reduced affinity to the target gene promoter sequences 
(Kim and Wang, 2010). Interestingly, BES1 and BZR1 regulate a different subset of 
BR-responsive genes whereby BES1 is a transcriptional activator (Yin et al., 2002) 
and BZR1 a transcriptional repressor (He et al., 2005). Overall, over 500 genes have 
been reported to be differentially expressed after exogenous BR application and a 
large set of them is co-regulated by auxin (Nemhauser et al., 2004). BR and auxin 
signalling display an intimate inter-dependency that is believed to occur mainly at 
the promoter level of common target genes (Nemhauser et al., 2004). This 
transcriptional reprogramming leads to cell expansion and growth as a final outcome 
of BR signalling.  
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5.1. Objectives 
 
BAK1 is not only implicated in PTI signalling. Actually, BAK1 was originally 
indentified as an interacting protein of BRI1, the main BR receptor, in the yeast two 
hybrid system (Nam and Li, 2002), and as being able to suppress the phenotype of 
weak bri1-5 mutant allele upon over-expression (Li et al., 2002). These initial 
studies showed that BAK1 is a positive regulator of BR signalling by interacting 
with BRI1 in vivo (Nam and Li, 2002; Li et al., 2002; Wang et al. 2005, 2008). Bak1 
null mutants are hypersensitive to BR synthesis inhibitor brassinazole (BRZ) 
(Nagata et al., 2000), BL hyposensitive and display morphological phenotypes 
 
Figure 5.1.: Current model of the brassionsteriod signaling pathway in Arabidopsis 
The signaling components in active and inactive status are shown in pink and blue, 
respectively. Phosphorylation confers positive effects (yellow circles) and negative 
effects (red circles).  
a) In the absence of BR, BKI1 interacts with inactive forms of BRI1, leading to 
block of BRI1 binding to BAK1. BRI1-bound BSKs are kept in inactive status. 
Consequently, BSU1 is inactive. Active BIN2 constitutively phosphorylates 
BZR1 and BZR2/BES1, leading to nuclear exporting and cytoplasmic retention 
by the 14-3-3 proteins, loss of DNA-binding activity, and proteasomal 
degradation of BZR1 and BZR2/BES1.  
b) In the presence of BR, BR binds to BRI1, which induces association with BAK1 
and disassociation of BKI1. By sequential transphosphorylation between BRI1 
and BAK1, BRI1 is fully activated and phosphorylates BSKs. Then the 
phosphorylated BSKs are released from the receptor complex and bind to BSU1, 
presumably to enhance BSU1 activity. Activated BSU1 inhibits BIN2 that in turn 
allows for accumulation of unphosphorylated BZR1 and BZR2/BES1 in the 
nucleus. Active BZR1 and BZR2/BES1 bind to genomic DNA to regulate BR-
target gene expression, thereby modulating growth and development of plants. 
Figure and legend adapted from Kim and Wang 2010.
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similar to weak bri1 mutant alleles (Nam and Li, 2002; Li et al., 2002). Furthermore, 
the absence of BAK1 aggravates, while the over-expression of BAK1 rescues the 
cabbage-like rosette phenotype of weak but not of strong bri1 alleles (Nam and Li, 
2002; Li et al., 2002). Kinase activity of BAK1 is required for its function in BR 
signalling as over-expression of a kinase-inactive variant dramatically enhances the 
growth retardation of weak bri1 alleles (Wang et al., 2008; Li et al., 2002). This is 
mostly likely due to a dominant negative effect on endogenous BAK1 and other 
SERK-family members as some of them play redundant roles in BR-signalling 
(Albrecht et al., 2008). For example, SERK1 plays a partially redundant role in BL 
signalling as serk1 bak1 double mutants are less sensitive to exogenous BL 
application and have shorter hypocotyls than bak1 single mutants (Karlova et al., 
2006; Albrecht et al., 2008).  
Interestingly, BKK1/SERK4 plays a partially redundant role in BAK1-dependent 
cell death control. Bak1 null mutants displayed a BR-independent spreading lesion 
phenotype after pathogen infection (Kemmerling et al., 2007). This logically leads to 
an enhanced susceptibility to nectrophic pathogens such as A. brassicicola and B. 
cinerea (Kemmerling et al., 2007). In contrast bak1 null mutants were more resistant 
to the obligate biotrophic oomycete pathogen Hpa race Noco2 (Kemmerling et al., 
2007). This inducible loss of cell death control of bak1 single mutants is 
dramatically enhanced in strong bak1 bkk1 double mutant alleles, which display 
constitutive cell death leading to seedling lethality under sterile conditions within 2 
weeks of germination (He et al. 2007). Weak allele double mutant combinations are 
viable but display early senescence under non-stress conditions (He et al., 2007; 
Jeong et al., 2010). In addition, BIR1 seems to be implicated in BAK1-dependent 
cell death control (Gao et al., 2009). bir1 mutants are lethal when grown at ambient 
temperature but fully viable at 27oC. This constitutive cell death is partially reversed 
by a second site mutation in SOBIR1 (suppressor of bir1-1) encoding a RLK 
belonging to subfamily XI (Gao et al., 2009). SOBIR1 is also known as SRRLK 
(small RNA generating RLK) and EVR (evershed) as it is involved in the generation 
of bacterial-induced small RNAs and foral organ abscission, respectively (Katiyar-
Agarwal et al., 2007; Leslie et al., 2010).  Importantly, BIR1 interacts with SERK1-
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4 in vivo but not with SOBIR1, suggesting that the effect of SOBIR1 on 
BIR1/BAK1-dependent cell death control might be indirect (Gao et al., 2009). 
Here, I demonstrate that cell death control is not impaired in bak1-5 or bak1-5 bkk1-
1 mutant plants. I also show that bak1-5, in contrast to previously published bak1 
null mutant alleles, is not generally impaired in BR signalling and is fully 
responsiveness to exogenous BL application.   
 
5.2. Results  
 
5.2.1. bak1-5 is not impaired in cell death control 
 
BAK1 was previously shown to be implicated in cell death control resulting in 
increased resistance to biotrophic pathogens of bak1 mutants (Kemmerling et al., 
2007). I made similar observations as bak1-4 mutants were more resistant to three 
different isolates of the biotrophic oomycete pathogen Hpa (see Chapter 4). 
However, I did not observe this increased resistance in the case of bak1-5 (see 
Chapter 4). In contrary, bak1-5 mutant plants seemed to support more growth of this 
biotrophic pathogen, which suggests that cell death control is not compromised in 
this mutant. In order to test this initial observation more thoroughly I crossed bak1-4 
or bak1-5 with the null mutant bkk1-1 (He et al., 2007). Twenty out of seventy 
individuals (X2=0.476, p=0.49) from a bak1-4 x bkk1-1 F2 segregating population 
died after 2 weeks in sterile conditions (Figure 5.1 A), confirming previous 
observations of bak1-4 bkk1-1 seedling lethality (He et al., 2007). In contrast, none 
of bak1-5 x bkk1-1 F2 segregating seedlings (n=76) died under the same conditions, 
and I could isolate fully viable double mutants that completed their life cycle (Figure 
5.1 A-B). To test for more subtle or development-regulated defects I grew plants in 
soil under non-sterile conditions. Weak allele combinations of bak1 bkk1 show early 
senescence and spreading lesion phenotypes under these conditions (He et al., 2007; 
Jeong et al., 2010). Consistently with the growth under sterile conditions, soil-grown 
bak1-5 bkk1-1 plants did not show any cell death or early senescence-related 
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phenotypes and looked similar to wild-type plants (Figure 5.1 B). The bak1-5 allele 
is therefore not associated with loss of cell death control.  
 
5.2.2. bak1-5 is not impaired in brassinosteroid signalling 
 
All bak1 null mutants are compromised in BR signalling and are hyposensitive to 
exogenous BL application (Nam and Li, 2002; Li et al., 2002; Kemmerling et al., 
2007). Therefore, I performed a detailed phenotypic analysis comparing the impact 
of the novel bak1-5 allele on BR signalling with the impact of the strong bak1-4 null 
allele. Classically, the bak1-4 loss-of-function allele displayed a semi-dwarf 
cabbage-like rosette when grown under short-day conditions similar to weak bri1 
mutant plants (Figure 5.2 A). Surprisingly, bak1-5 plants displayed a morphology 
comparable to wild-type despite being slightly smaller under these conditions 
(Figure 5.2 A). I made similar observations under long-day conditions; bak1-4 plants 
displayed a slightly stunted growth when compared to Col-0 or bak1-5 plants 
(Figure 5.2 B).  
As morphology does not always correlate with defects in other BR responses (Wang 
et al., 2002; Albrecht et al., 2008), I compared the effect of exogenous treatments 
Figure 5.2. Cell death control is not compromised in bak1-5. 
A. bak1-5 bkk1-1 seedlings are fully viable. Picture of representative individuals 
of 2.5 week-old seedlings of Col-0, bak1-4, bak1-5, bkk1-1, bak1-4 bkk1-1 
and bak1-5 bkk1-1. Scale bar represents 2cm. 
B. bkk1-1 bak1-5 does not show any early senescence phenotypes. Picture of 
representative individuals of six-week-old Col-0, bak1-4, bak1-5, bkk1-1 and 
bak1-5 bkk1-1 plants grown under short-day conditions. Scale bar represents 
5cm. 
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with BL or BRZ on bak1-4 and bak1-5 plants. First, I tested the sensitivity of roots 
towards different BL concentration. As previously reported (Nam and Li, 2002; Li et 
al., 2002) bak1-4 showed a reduced responsiveness to BL induced root growth 
inhibition (Figure 5.2 C). In contrast bak1-5 roots were at least as inhibited as wild-
type roots and even showed a slight tendency to being hypersensitive (Figure 5.2 C). 
Next, I quantitatively investigated the BR-responsiveness of etiolated seedlings 
grown under different BR regimes. As expected, bak1-4 hypocotyls were much 
smaller than wild-type and were hypo-sensitive to the growth inhibition effect of BL 
(Figure 5.2 D). In contrast, although bak1-5 hypocotyls were slightly smaller than 
wild-type, they displayed a wild-type-like responsiveness to BRZ and BL (Figure 
5.2 D).  
To test for subtle changes in BR sensitivity in the bak1-4 and bak1-5 seedlings, we 
performed BL marker gene analysis by quantitative real-time RT-PCR. For this 
purpose, I investigated the expression pattern of two well-characterised BL marker 
genes, SAUR-AC1 (At4g38850) as an auxin co-regulated gene, and EXP8 
(At2g40610) as a BL-specific gene (Goda et al., 2004). In order to fully capture the 
signalling capability of either bak1 allele, I included a pre-treatment with BRZ to 
reduce any hormone level adaptation within genotypes that may have altered BR 
signalling capacity as previously reported for bzr1-1D (Wang et al., 2002). BL 
treatment on its own did not reveal any significant differences between the 
genotypes for EXP8 expression (Figure 5.2 E, left). However, the induction of 
SAUR-AC1 by BL was clearly impaired in bak1-4 but less so in bak1-5 (Figure 5.2 E, 
right). Interestingly, BRZ pre-treatment prior to BL treatment revealed a clear 
impairment of bak1-4 in BL-induced gene expression for both marker genes (Figure 
5.2 E). On the contrary, bak1-5 showed an induction of SAUR-AC1 comparable to 
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Figure 5.3. bak1-5 is not impaired in brassinosteroid signalling. 
A. bak1-5 plants have a wild-type-like morphology under short day conditions. 
Picture of representative individuals of five-week-old Col-0, bak1-4 and 
bak1-5 plants grown under short-day conditions. Scale bar represents 5 cm. 
B. bak1-5 plants have a wild-type-like morphology under long-day conditions. 
Picture of representative individuals of six-week-old Col-0, bak1-4, bak1-5 
plants grown under long-day conditions. Scale bar represents 5 cm. 
C. bak1-5 is slightly hyper-sensitive in the BL-induced root growth inhibition. 
Relative root growth of 7-day-old Col-0, bak1-4 and bak1-5 seedlings grown 
without or with different concentration of BL.  Root growth is represented 
relative to untreated control. Results are average ± s.e (n ≥ 10). 
D. bak1-5 shows a wild-type-like BL-induced hypocotyl growth inhibition in 
etiolated seedlings. Hypocotyl length of 5-day-old etiolated Col-0, bak1-4 and 
bak1-5 seedlings grown without or with 100 nM BRZ or 100 nM BL. Results 
are average ± s.e. (n ≥ 30). 
E. bak1-5 shows a wild-type-like BL marker gene induction. Col-0, bak1-4 and 
bak1-5 seedlings were pre-treated for 16 H with 2.5 μM BRZ or not before 
treatment with 100 nM BL or not for 3 H. Gene expression of EXP8 (left) and 
SAUR-ACI (right) was measured by qPCR. Results are average ± S.E. (n=3). 
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wild-type (Figure 5.2 E, left), and the induction of EXP8 appeared higher in bak1-5 
than wild-type under this treatment regime (Figure 5.2 E, right).  
Defects in BR sensitivity are often revealed when mutations in potential BR 
signalling components or biosynthetic genes are combined with weak bri1 alleles 
(Kim and Wang, 2010). To test if the bak1-5 mutation affects BR sensitivity in such 
assays, I crossed bak1-4 or bak1-5 with bri1-301 that carries a point mutation in the 
kinase domain of BRI1 (Xu et al., 2008). As previously reported (Nam and Li, 2002), 
the bak1-4 mutation increased the cabbage-like rosette phenotype of bri1-301 under 
short-day growth conditions and aggravated the stunted growth in long-day growth 
conditions (Figure 5.3 A-B). In contrast, the bak1-5 mutation did not aggravate the 
bri1-301 phenotype to the same extent in these conditions. The bri1-301 rosette 
morphology was only slightly altered in bri1-301 bak1-5 in short-day growth 
condition (Figure 5.3 A). Furthermore, bri1-301 bak1-5 double mutant plants 
developed much bigger inflorescences compared to bri1-301 bak1-4 mutants in long 
day growth conditions (Figure 5.3 B). Next I performed quantitative hypocotyl 
growth assays on BL- or BRZ-containing media. As expected, the bak1-4 allele also 
severely enhanced the BRZ hypersensitivity and BL hyposensitivity of bri1-301 in 
this assay (Figure 5.3 C).  Surprisingly, but as noted before for BL-induced root 
growth inhibition and marker gene expression in bak1-5 (Figure 5.2 C and E), 
etiolated bri1-301 bak1-5 seedlings appeared slightly hyper-responsive to BL when 
compared to bri1-301 (Figure 5.3 C).  
Overall, my results clearly demonstrate that bak1-5 is still fully sensitive to BR, and 
may display a slight increase in BL sensitivity under certain experimental conditions.  
This phenotype is in stark contrast with the hypo-sensitivity generally associated 
with bak1 loss-of-function alleles. 
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5.3. Discussion 
 
5.3.1. bak1-5 is not impaired in cell death control 
 
In contrast to previously described bak1 null alleles (Kemmerling et al., 2007; He et 
al., 2007) bak1-5 is not compromised in cell death control (Figure 5.1). In addition, 
bak1-5 mutants are hyper-susceptible to adapted and non-adapted bacterial 
Figure 5.4. bak1-5 does not aggravate bri1-301 BL-related phenotypes. 
A. bak1-5 does not aggravate the bri1-301 cabbage-like rosette under short-day 
conditions. Picture of representative individuals of six-week-old bri1-301, 
bri1-301 bak1-4 and bri1-301 bak1-5 plants grown under short-day 
conditions. Scale bar represents 5 cm. 
B. bak1-5 does not significantly enhance the bri1-301 growth retardation under 
long-day conditions. Picture of representative individuals of six-week-old 
bri1-301, bri1-301 bak1-4 and bri1-301 bak1-5 plants grown under long-day 
conditions. Scale bar represents 5 cm. 
C. bri1-301 bak1-5 is slightly hyper-responsive to BL-induced hypocotyl 
elongation of etiolated seedlings. Hypocotyl length of 5-day-old bri1-301, 
bri1-301 bak1-4 and bri1-301 bak1-5 etiolated seedlings grown without or 
with 100 nM BRZ or 100 nM BL. Results are average ± s.e. (n ≥ 16). 
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pathogens (see Chapter 4). Furthermore, bak1-5 bkk1-1 double mutants are not only 
fully viable (Figure 5.1.), but are also more susceptible to the obligate biotrophic 
pathogen Hpa (see Chapter 4). This is in stark contrast with phenotypes observed for 
bak1 and bkk1 null alleles that do not express any full length BAK1 or BKK1 
protein (Kemmerling et al., 2007; He et al., 2007). This loss of cell death control is 
hypothesised to be due to the constant de-repression of a RK controlling cell death 
that would be normally under the negative regulation of BAK1 and BKK1 (He et al., 
2007; Kemmerling and Nurnberger, 2008). However, I would like to suggest an 
alternative model based on several observations. The constitutive cell death 
observed in bak1-4 bkk1-1 is partial dependent on salicylic acid and is light-
dependent (He et al., 2007; He et al., 2008). Bir1-1 cell death phenotype is partially 
reverted by high temperatures and mutations in PAD4 and EDS1 (Gao et al., 2009). 
These components are classically associated with R protein-mediated HR (Dodds 
and Rathjen, 2010). It is therefore conceivable that the integrity and/or activity of a 
multimeric complex containing BAK1, BKK1 and BIR1 may be “guarded” by an R 
protein. The absence of BAK1 and BKK1, or BIR1 would trigger constitutive cell 
death and explain the mutant seedling lethality even in sterile conditions. 
Interestingly though, the kinase activity of BAK1 seems to be important for cell 
death control, as kinase-dead variants of BAK1 cannot rescue the bak1-4 bkk1-1 
lethality (Wang et al., 2008). Following this line of thought, it is not surprising that 
bak1-5 plants are not compromised in cell death control as they are still expressing 
full length BAK1 protein variant. In addition, BAK1-5 kinase activity cannot be 
impaired per se as bak1-5 plants are not compromised in BR signalling (Figure 5.2, 
5.3) a phenotypic characteristic generally associated with the expression of kinase 
dead BAK1 variants (Nam and Li, 2002; Li et al., Wang et al., 2008). 
 
5.3.2. bak1-5 is not impaired in BR signalling 
 
My detailed phenotypic analysis clearly demonstrates that bak1-5 is not impaired in 
BR signalling even though bak1-5 mutants are slightly smaller than WT (Figure 5.2. 
and 5.3.). In contrast bak1-5 mutants might be even hypersensitive to the 
 137
exogenously applied BR (Figure 5.2. C-E). This is somehow reminiscent of bzr1D 
mutants harbouring a missense substitution that stabilizes the transcription factor 
BRZ1 and thereby relieving it from its constitutive negative regulation (Wang et al. 
2002: He et al., 2002). The stabilization of brz1D leads to constitutive BR signalling 
and triggers a negative feedback loop that down-regulates BR biosynthesis genes 
such as CPD (Wang et al., 2002). Consequently, soil-grown bzr1D plants display a 
reduced rosette size reminiscent of BR hyposensitive mutants (Wang et al., 2002). 
However, when brz1D mutants are treated with BRZ or crossed with mutants 
compromised in BR perception (bri1) or production (det2) its positive role in BR 
signalling becomes apparent (Wang et al., 2002). If bak1-5 indeed renders plants BR 
hypersensitive, why does it not revert the bri1-301 rosette phenotype? This could be 
explained by the current model that BAK1 is a signal enhancer of BR signalling 
rather than an integral signalling component (Wang et al. 2008). Therefore, in 
contrast to brz1D, bak1-5 requires a signalling-competent BRI1 to exert is function. 
In addition, the fact that it is not known if BAK1 is required for all or only a subset 
of BR responses makes it difficult to fully explain the impact of bak1-5 on BR 
signalling. Nevertheless, I tried to test the possible BR hypersensitivity of bak1-5 
further measuring CPD expression levels. Unfortunately, I did not obtain any 
consistent results either for bak1-4 or bak1-5 seedlings (data not shown). I also 
crossed bak1-5 to det2 and I am currently waiting to obtain F2 seeds for segregation 
and phenotypic analysis (data not shown).   
Based on the results presented in Chapters 4 and 5, I conclude that BAK1 is in 
principle able to differentially regulate PTI- and BR-signalling. bak1-5 mutants are 
strongly impaired in PTI-signalling but display BR signalling capacity at least 
comparable to wild-type.  
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Chapter 6: BAK1-5 is a hypo-acitve kinase displaying an enhanced 
interaction with different ligand-binding receptors 
 
Corrigendum: During the writing and the final analysis of this thesis chapter I 
identified a mutation in the expression clone of BAK1 used for in vitro studies. 
This only influences results presented in 6.2.5. and 6.2.7. The corrected versions 
including newer results with a corrected clone are presented under 6.2.10 and 
discussed in 6.3. I decided to include previous results as they reflect the 
research process during my PhD and therefore should be reproduced within 
this research PhD thesis.  
 
6.1. Objectives 
 
BAK1 is known to interact with the ligand-binding receptors BRI1, FLS2, EFR and 
PEPR1/2 (Chinchilla et al. 2009, Postel et al. 2009, Roux et al. submitted). Initially 
BAK1 was identified as an interactor of BRI1, the BR receptor, in the yeast two- 
hybrid system (Nam and Li, 2002). The authors went on to show that BAK1 also 
interacts with BRI1 in vivo using either double tagged lines expressing BAK1:MYC 
under the control of the CaMV 35S promoter and BRI1:GFP under the control of its 
own regulator sequence or single transgenic lines expressing BAK1:GFP under the 
control of its own promoter in combination with an endogenous anti-BRI1 antibody 
(Nam and Li, 2002). Similarly, Li and colleagues also used wild-type double 
transgenic lines expressing both BAK1:GFP and BRI1:FLAG under the strong 
CaMV 35S promoter (Li et al. 2002). Using these double tagged lines it was later 
shown that the BRI1-BAK1 interaction is enhanced after ligand addition and this 
enhanced interaction is dependent on BRI1 but not BAK1 kinase activity (Wang et 
al., 2008). Furthermore, in these double transgenic lines the BRI1 and BAK1 
phosphorylation status on Thr/Ser residues is enhanced after BL treatment in a 
mostly BRI1 kinase dependent manner (Wang et al., 2008). BAK1 and BRI1 
undergo bidirectional phosphorylation in vitro whereby the phosphorylation of BRI1 
by BAK1 increases its phosphorylation capacity of the artificial synthetic substrate 
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BR13 (Oh et al., 2000; Wang et al. 2008). Based on these results and phospho-
mimetic mutant analysis of BAK1 and BRI1, it was suggested that BRI1 and BAK1 
undergo bidirectional phosphorylation in vivo leading to an enhanced BR-signalling 
out-put via enhanced BRI1 kinase activity (Wang et al., 2005; Wang et al., 2008). In 
this model BAK1 plays a role as signal enhancer for BRI1 but has no intrinsic 
signalling specificity on its own. It is not known if this model can be extended to 
other RK interacting with BRI1. 
The knowledge of molecular events surrounding the BAK1 FLS2 interaction is 
much less well defined. FLS2 was initially found to interact with BAK1 in a ligand-
dependent manner in bak1-4 transgenic plants expressing BAK1:MYC under the 
control of its own promoter or BAK1:GFP under the control of CaMV 35S promoter 
in combination with the use of anti-FLS2 antibodies (Chinchilla et al., 2007; Heese 
et al., 2007). BAK1 and FLS2 form heteromeric complexes and are phosphorylated 
immediately after ligand addition in Arabidopsis cell cultures (Schulze et al. 2010). 
Interestingly, the general kinase inhibitor K-252a did not block heteromerization 
suggesting that kinase activity is not required for complex formation. However, it is 
not known if the observed phosphorylation of either partner is due to the intrinsic 
predicted kinase activity of FLS2 and/or BAK1 or rather due to third party kinases. 
Furthermore, nothing is known about the directionality of the phosphorylation 
events in this system.  
In the case of EFR and PEPR1/2 even less is known. BAK1 interacts with EFR in a 
ligand-dependent manner in efr transgenic lines expressing EFR:GFP under its own 
promoter and after transient over-expression of tagged proteins in N. benthamiana 
(Roux et al. submitted). In the case of PEPR1/2 the interaction with BAK1 was only 
shown in the yeast two-hybrid system (Postel et al., 2009). 
As shown in Chapter 4 and 5 the bak1-5 mutation has a differential impact on three 
BAK1-dependent signalling pathways. bak1-5 is not impaired in cell death control 
(see Chapter 5). In addition, it displays a wild-type like morphology and is fully BR 
responsive (see Chapter 5). On the contrary EFR- and FLS2-dependent PTI 
signalling is strongly impaired in bak1-5. A simple hypothesis to explain the 
differential impact of bak1-5 on the three signalling pathways would be that BAK1-
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5 interacts differentially with the ligand-binding receptors. For example, bak1-5 
would still be able to interact with BRI1, but would loss its ability to form ligand-
dependent complex with FLS2 or EFR. However, here I show that bak1-5 is still 
able to interact with BRI1, FLS2 and EFR using three independent approaches. 
Interestingly, bak 1-5 shows an enhanced interaction with all three receptors when 
compared to the wild-type BAK1 protein. Next, I show that bak 1-5 is a hypo-active 
kinase in vitro that is able to trans-phosphorylate BRI1 and EFR. I also demonstrate 
that BAK1 performs an unidirectional trans-phosphorylation of EFR in vitro and that 
the two non-RD kinases FLS2 and EFR posses a reduced kinase activity when 
compared to the strong RD kinase BRI1. I also demonstrate that bak1-5 kinase 
activity is required for the suppression of EFR-dependent PTI signalling. Finally, I 
describe novel in vitro phosphorylation sites on BAK1/bak1-5 using MS/MS 
analysis. 
 
6.2. Results 
 
6.2.1. Currently available C-terminal tagged BAK1 transgenic lines are unable 
to complement bak1-4 PTI phenotypes 
 
At the start of this PhD project no anti-BAK1 antibodies were available. In order to 
confirm bak1-5-related phenotypes and to test the impact of the single amino acid 
change in bak1-5 on hetero-complex formation with the ligand-binding receptors I 
generated transgenic bak1-4 lines expressing BAK1 or BAK1-5 C-terminally tagged 
with either GFP or 3xHA. Interestingly, previously published transgenic bak1-4 
lines expressing BAK1:GFP or BAK1:MYC were only used for BAK1-FLS2 
interaction studies but were not shown to complement bak1-4 related PTI signalling 
defects.  
I tested if transgenic bak1-4 T3 lines expressing BAK1:HA3 or bak1-5:HA3 under the 
control its own regulatory sequence (data not shown) could complement the delay 
and reduction in the flg22-induced ROS burst of bak1-4 plants or phenocopy the 
strong impairment thereof in bak1-5, respectively (see Chapter 4). As shown for two 
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independent lines the expression of BAK1:HA3 in bak1-4 was unable to complement 
the impairment of flg22-induced ROS burst of bak1-4 (Figure 6.1 A). In contrast, the 
Figure 6.1. Currently available C-terminal tagged BAK1 transgenic lines are 
unable to complement bak1-4 PTI phenotypes. 
A. Expression of BAK1:HA3 is not able to complement the impairment in flg22-
triggered ROS-burst of bak1-4 plants. ROS burst in leaves of Col-0, bak1-4, bak1-
5, bak1-4 pBAK1::BAK1:HA3 T3 line #13-4 and #9-4, bak1-4 pBAK1::BAK1-
5:HA3 T3 line #23-5 and  #13-5 after treatment with 100 nM flg22. Results are 
average ± s.e. (n=8). 
B. Expression of BAK1:GFP is not able to complement the impairment in flg22-
triggered ROS-burst of bak1-4 plants. ROS burst in leaves of Col-0, bak1-4, bak1-
5, bak1-4 pBAK1::BAK1:GFP T3 line #3 and #5, bak1-4 pBAK1::BAK1-5:GFP 
T3 line #18 and #5 after treatment with 100 nM flg22. Results are average ± s.e. 
(n=8). 
C. Neither the expression of BAK1:Myc nor BAK1:GFP is able to complement the 
impairment in flg22-triggered SGI of bak1-4. SGI of Col-0, bak1-4, bak1-5, bak1-
4 pBAK1::BAK1:Myc T4, bak1-4 pBAK1::BAK1:GFP T3 and bak1-4 
pBAK1::BAK1-5:GFP T3 in the presence of 60 nM flg22 or 60 nM elf18. Fresh 
weight is represented relative to untreated control. Results are average ± s.e (n=6). 
D. Expression of BAK1:GFP and BAK1-5:GFP can rescue the bak1-4 growth 
retardation. Picture of representative individuals of four-week-old Col-0, bak1-4, 
bak1-5, bak1-4 pBAK1::BAK1:GFP T3 and bak1-4 pBAK1::BAK1-5:GFP T3 
plants grown under short-day conditions. Scale bar represents 5 cm. 
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expression of BAK1-5:HA3 in bak1-4 was able to further reduce the flg22-triggered 
ROS burst in leaves of two independent transgenic lines phenocopying bak1-5 plants 
(Figure 6.1 A). Next, I tested transgenic bak1-4 T2 lines expressing BAK1:GFP or 
BAK1-5:GFP (data not shown). As observed for bak1-4 expressing BAK1-5:HA3 
the flg22-triggered ROS burst was nearly totally abolished in leaves of two 
independent bak1-4 BAK1-5:GFP lines (Figure 6.1 B). In the case of BAK1:GFP a 
partial complementation of the bak1-4 phenotype could be observed for one 
transgenic bak1-4 BAK1:GFP line but not the other (Figure 6.1 B). I tested if this 
inability of complementing bak1-4 related PTI phenotypes was specific to my 
constructs and/or to the bioassay used. Neither the expression of BAK1:GFP nor 
BAK1:MYC (Chinchilla et al., 2007) could complement the flg22-insensitivity of 
bak1-4 seedlings in the SGI assay (Figure 6.1 C). Interestingly the expression of 
either BAK1 epitope fusion protein actually led to a partially insensitivity of bak1-4 
seedlings to elf18 (Figure 6.1 C). Consistently with previous results bak1-4 BAK1-
5:GFP seedlings phenocopied bak1-5 seedlings and were insensitive to both flg22- 
and elf18-induced SGI (Figure 6.1 C). 
Previous reports showed that the (over-) expression of BAK1:GFP leads to bigger 
plants with elongated petioles and leaves complementing the impairment of bak1 
null-mutant alleles in BR signalling (Li and Nam, 2002; Li et al., 2002). Therefore, I 
tested if our BAK1:GFP lines were able to complement the growth retardation of 
bak1-4. Indeed the expression of BAK1:GFP or BAK1-5:GFP in the bak1-4 
background gave rise to plants with elongated petioles, as well as with longer and 
narrower leaves (Figure 6.1 D). Overall, the expression of BAK1:GFP is able to 
rescue the partial BR insensitivity of bak1-4 plants but not its impairment in FLS2- 
and EFR-dependent signalling.  
 
6.2.2. BAK1-5 displays an increased affinity to the ligand-binding receptors 
FLS2, EFR  and BRI1 after transient expression in N.benthamiana 
 
While generating stable transgenic Arabidopsis lines I initially preformed interaction 
studies in the heterologous plant expression model system N. benthamiana after 
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Agrobacterium-mediated transient expression of epitope-tagged fusion proteins 
(Goodin et al., 2008). I started by the co-expression of FLS2:MYC with either 
BAK1:HA3 or BAK1-5:HA3. When I immunoprecipitated FLS2:MYC using anti-
Figure 6.2. BAK1-5 shows an enhanced interaction with ligand-binding RKs FLS2, 
BRI1 and EFR after transient co-expression in N. benthamiana. 
A. BAK1-5:HA3 shows an enhanced interaction with FLS2:Myc in N. benthamiana. 
Co-immunoprecipitation of leaves expressing FLS2:Myc with either BAK1:HA3 
or BAK1-5:HA3. Leaves were treated or not with 100 nM flg22 for 5 min. Total 
proteins (T) were subjected to immunoprecipitation (IP) with anti-FLS2 antibody 
and IgG beads followed by immunoblot analysis using either anti-FLS2 or anti-
HA antibodies.  
B. BAK1-5:GFP shows an enhanced interaction with EFR:HA3 in N. benthamiana. 
Co-immunoprecipitation of leaves expressing EFR:HA3 with either BAK1:GFP or 
BAK1-5:GFP. Leaves were treated or not with 100 nM elf18 for 5 min. Total 
proteins (T) were subjected to immunoprecipitation (IP) with GFP-Trap beads 
followed by immunoblot analysis using either anti-GFP or anti-HA antibodies. 
The asterisk indicates an unspecific background band. 
C. BAK1-5:GFP shows an enhanced interaction with BRI1:HA3 in N. benthamiana. 
Co-immunoprecipitation of leaves expressing BRI1:HA3 with either BAK1:GFP 
or BAK1-5:GFP. Leaves were treated or not with 100 nM BL for 3 H. Total 
proteins (T) were subjected to immunoprecipitation (IP) with GFP-Trap beads 
followed by immunoblot analysis using either anti-GFP or anti-HA antibodies. 
The asterisk indicates an unspecific background band.  
D. BAK1:GFP or BAK1-5:GFP does not interact with CERK1:HA3 in N. 
benthamiana. Co-immunoprecipitation of CERK1:HA3 with either BAK1:GFP or 
BAK1-5:GFP after transient expression in N. benthamiana leaves. Leaves were 
treated or not with 100 μg/mL chitin for 5 min. Total protein (T) was subjected to 
immunoprecipitation with GFP-Trap beads followed by immunoblot analysis 
using anti-GFP or anti-HA antibodies. The asterisk indicates an unspecific band. 
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FLS2 antibodies I was able to observe a slight interaction with BAK1-5:HA3 even 
before ligand addition (Figure 6.2 A). Consistently with previous reports BAK1:HA3 
only interacted with FLS2 after flg22 treatment and to similar levels as BAK1-
5:HA3 (Figure 6.2 A). We recently reported that EFR interacts with BAK1 in a 
ligand-dependent manner (Roux et al., submitted). So we tested the interaction 
between EFR:HA3 and BAK1:GFP or BAK1-5:GFP after co-expression in N. 
benthamiana. When I immunoprecipitated BAK1:GFP or BAK1-5:GFP I could 
observe an interaction with EFR:HA3 only after elf18 treatment (Figure 6.2 B). 
While pulling-down similar amounts of BAK1:GFP and BAK1-5:GFP much more 
EFR:HA3 co-immunoprecipitated with BAK1-5:HA3 than with BAK1::GFP after 
elf18 treatment (Figure 6.2 B). Next I tested the interaction of BRI1:HA3 with 
BAK1:GFP or BAK1-5:GFP. Interestingly, more BRI1:HA3 co-immunoprecipitated 
with BAK1-5:GFP before and after ligand addition when pulling-down similar 
amounts of BAK1:GFP or BAK1-5:GFP using GFP-trap beads (Figure 6.2 C). The 
constitutive interaction between BAK1:GFP/BAK1-5:GFP and BRI1:HA3 was most 
likely due to the presence of endogenous BR produced by N. benthamiana. 
Importantly, BAK1-5 still retained its interaction specificity as it did not interact 
with CERK1, a LysM-RLK involved in BAK1-independent chitin perception (Miya 
et al., 2007; Wan et al., 2008). When pulling-down either BAK1:GFP or BAK1-
5:GFP using GFP-trap beads before or after chitin treatment neither of the two 
proteins co-immunoprecipitated with CERK1:HA3 (Figure 6.2 D). 
In conclusion transient over-expression in N. benthamiana epitope-tagged BAK1-5 
shows an increased affinity to the ligand-binding receptors FLS2, BRI1 and EFR but 
not to the un-related RLK CERK1. 
 
6.2.3. BAK1-5 displays a slightly increased affinity to the ligand-binding 
receptors FLS2 and BRI1 in stable transgenic bak1-4 plants expressing C-
terminally tagged BAK1 variants 
 
I tested if the enhanced interaction of BAK1-5 with the ligand-binding receptors was 
also observable in stable Arabidopsis transgenic lines. At this point, I was unaware 
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that the expression of BAK1:HA3, BAK1:GFP or BAK1:MYC in bak1-4 was unable 
to complement the impairment in FLS2-dependent signalling. 
I immunoprecipitated BAK1:HA3 or BAK1-5:HA3 from total protein extracts of 
previously described transgenic plants using anti-HA beads. Consistently with 
previous results I observed a ligand-dependent interaction of BAK1:HA3 with FLS2 
(Figure 6.3 A). I was unable to detect an increased interaction between BAK1-5:HA3 
and FLS2 when immunoprecipitating BAK1-5:HA3 (Figure 6.3 A). Interestingly, 
when I performed the reciprocal IP using anti-FLS2 antibodies I was able to observe 
a slight interaction between FLS2 and BAK1-5:HA3 but not BAK1:HA3 without 
ligand addition (Figure 6.3 B). FLS2 interacted with BAK1:HA3 only after ligand 
addition and this with similar strength when compared to BAK1-5:HA3 (Figure 6.3 
Figure 6.3. BAK1-5 shows a slight enhanced interaction with ligand-binding RK 
FLS2 and BRI1 in stable transgenic bak1-4 plants expressing C-terminally tagged 
BAK1 variants. 
A. FLS2 does hardly show an enhanced interaction with BAK1-5:HA3 in stable 
transgenic bak1-4 plants. Co-immunoprecipitation of FLS2 with either 
BAK1:HA3 or BAK1-5:HA3 in bak1-4 pBAK1::BAK1:HA3 T2 or bak1-4 
pBAK1::BAK1-5:HA3 T2 plants treated with or not with 100 nM flg22 for 5min, 
respectively. Total proteins (T) were subjected to immunoprecipitation (IP) with 
anti-HA antibodies beads followed by immunoblot analysis using either anti-
FLS2 or anti-HA antibodies. 
B. BAK1-5:HA3 shows a slight ligand-independent interaction with FLS2 in stable 
transgenic bak1-4 plants. Co-immunoprecipitation of BAK1:HA3 or BAK1-5:HA3 
with FLS2 in bak1-4 pBAK1::BAK1:HA3 T2 or bak1-4 pBAK1::BAK1-5:HA3 T2 
plants treated with or not with 100 nM flg22 for 5min, respectively. Total proteins 
(T) were subjected to immunoprecipitation (IP) with anti-FLS2 antibodies and 
IgG beads followed by immunoblot analysis using either anti-FLS2 or anti-HA 
antibodies. 
C. BAK1-5:HA3 shows an enhanced interaction with BRI1 in stable transgenic bak1-
4 plants. Co-immunoprecipitation of BAK1:HA3 or BAK1-5:HA3 with BRI1 in 
bak1-4 pBAK1::BAK1:HA3 T2 or bak1-4 pBAK1::BAK1-5:HA3 T2 plants treated 
with or not with 100 nM BL for 3 H, respectively. Total proteins (T) were 
subjected to immunoprecipitation (IP) with anti-HA antibodies beads followed by 
immunoblot analysis using either anti-FLS2 or anti-HA antibodies. 
 146
B). Finally, I also tested the interaction between BRI1 and BAK1:HA3/BAK1-5:HA3 
by immunoprecipitating BRI1 with anti-BRI1 antibodies. The interaction between 
BRI1 and BAK1:HA3 was constitutive and slightly enhanced by ligand addition 
(Figure 6.3 C). Consistently, the amount of BAK1-5:HA3 interacting with BRI1 was 
much higher with and without BL treatment. Interestingly, co-immunoprecipitated 
BAK1-HA3 and BAK1-5-HA3 migrated as a doublet with the upper band migrating 
much slower than the corresponding protein in the total protein extract (Figure 6.3 
C). This suggests the interaction of BAK1 with BRI1 leads to post-translational 
modification of BAK1, such as phosphoryaltion. 
In summary, BAK1-5 displays a slightly enhanced interaction with FLS2 and BRI1 
in transgenic bak1-4 plants expressing epitope-tagged BAK1 or BAK1-5. 
 
6.2.4. BAK1-5 displays an increased affinity to the ligand-binding receptors 
FLS2 and BRI1 in Arabidopsis  
 
During the course of my PhD study a novel anti-BAK1 antibody became available 
(Schulze et al. 2010), which recognized an epitope outside of the region containing 
the BAK1-5 mutation. This enabled me to perform interaction studies between 
BAK1/BAK1-5 and FLS2 or BRI1 under native conditions using specific antibodies. 
First, I investigated the interaction with FLS2 by immunoprecipitating BAK1 or 
BAK1-5 using the newly available anti-BAK1 antibodies. As previously reported, 
BAK1 interacted with FLS2 in a ligand specific manner (Figure 6.4 A). FLS2 co-
immunoprecipitated with BAK1-5 from non-elicited seedlings and the amount of 
BAK1-5 in complex with FLS2 after flg22 treatment was greater than in the case of 
BAK1 (Figure 6.4 A). I observed similar results when performing reciprocal 
immunoprecipitation experiments using specific anti-FLS2 antibodies (Figure 6.4 B). 
BAK1-5 formed a strong ligand independent complex with FLS2 and showed an 
enhanced interaction after flg22-treatment when compared with wild-type BAK1 
protein (Figure 6.4 B). Finally, I tested the interaction of BRI1 with BAK1 or 
BAK1-5 using anti-BRI1 antibodies (Figure 6.4 C). I was able to confirm the in 
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planta BRI1-BAK1 interaction previously only reported using transgenic lines 
expressing epitope-tagged BRI1 and/or BAK1 proteins (Nam and Li, 2002; Li et al., 
2002; Wang et al., 2008). As observed in N. benthamiana and in stable transgenic 
lines, BAK1-5 showed an enhanced interaction with BRI1 independent of BL-
treatment (Figure 6.4 C). 
In conclusion, BAK1-5 displays an enhanced interaction with the two ligand-binding 
RKs FLS2 and BRI1 in native conditions.  
 
6.2.5. BAK1-5 is a hyper-active kinase  
 
I demonstrated that BAK1-5 has an increased affinity with the three ligand- binding 
RKs BRI1, FLS2 and EFR. However, BAK1-5 does not show a preferential 
interaction for any of these three RKs. Therefore, this enhanced interaction of 
BAK1-5 per se cannot explain the differential regulation of three BAK1-dependent 
 
Figure 6.4. BAK1-5 shows an enhanced interaction with ligand-binding RK FLS2, 
and BRI1 in native conditions. 
A. FLS2 shows a ligand-independent interaction with BAK1-5 in A. thaliana. Co-
immunoprecipitation of BAK1 or BAK1-5 with FLS2 in Col-0 or bak1-5 plants 
treated or not with 100 nM flg22 for 5 min, respectively. Total proteins (T) were 
subjected to immunoprecipitation (IP) with anti-BAK1 antibodies and IgG beads 
followed by immunoblot analysis using either anti-FLS2 or anti-BAK1 antibodies. 
B. BAK1-5 shows a ligand-independent interaction with FLS2 in A. thaliana. Co-
immunoprecipitation of BAK1 or BAK1-5 with FLS2 in Col-0 or bak1-5 plants 
treated or not with 100 nM flg22 for 5 min, respectively. Total proteins (T) were 
subjected to immunoprecipitation (IP) with anti-FLS2 antibodies and IgG beads 
followed by immunoblot analysis using either anti-FLS2 or anti-BAK1 antibodies. 
C. BAK1-5 shows an enhanced interaction with BRI1 in A. thaliana. Co-
immunoprecipitation of BAK1 or BAK1-5 with BRI1 in Col-0 or bak1-5 treated or 
not with 100 nM BL for 1.5 H, respectively. Total proteins (T) were subjected to 
immunoprecipitation with anti-BRI1 antibodies and IgG beads followed by 
immunoblot analysis using either anti-BRI1 or anti-BAK1 antibodies. The asterisk 
indicates an unspecific band.
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signalling pathways observed in bak1-5. Since the bak1-5 mutation corresponds to a 
C408Y amino acid change just before the catalytic loop of the kinase domain (see 
Chapter 4), the bak1-5 phenotype could be due to altered kinase activity.  
To test potential differences in BAK1-5 kinase activity, I expressed the cytoplasmic 
domains (CD: residues 256 to 615) of BAK1 and BAK1-5 in Escherichia coli (E. 
coli), as well as the respective kinase-dead mutant variants (D416N) (indicated as 
BAK1* and BAK1-5*, respectively) as N-terminally tagged glutathione-S-
transferase (GST) -fusion proteins and purified them using glutathione beads. In 
agreement with previously published results (Li et al., 2002; Li and Nam, 2002; 
Figure 6.5. BAK1-5 is a hyperactive kinase in vitro. 
A. BAK1-5 CD has an increased trans-phosphorylation capacity. In vitro kinase 
assay incubating equal amounts of GST control or N-terminal GST-tagged 
BAK1, BAK1-5, BAK1* and BAK1-5* CD with artificial substrate myelin 
basic protein (MYBP).  Autoradiogram, upper panel; Coomassie colloidal blue 
stained membrane, lower panel. 
B. BAK1-5 CD is a hyperactive kinase on Ser and Thr residues. 0.25 μg of 
heterologously-expressed N-terminal GST-tagged BAK1, BAK1-5, BAK1* and 
BAK1-5* CD were subjected to immunoblot analysis with anti-phosphoThr 
antibodies. Immunoblot, upper panel; Coomassie colloidal blue stained 
membrane, lower panel. 
C. BAK1-5 CD is a hyperactive kinase on Tyr residues. 0.75 μg of heterologously-
expressed N-terminal GST-tagged BAK1, BAK1-5, BAK1* and BAK1-5* CD 
were subjected to immunoblot analysis with anti-phospho-Tyr antibodies. 
Immunoblot, upper panel; Coomassie colloidal blue stained membrane, lower 
panel. 
D. BAK1-5 CD does not trans-phosphorylate the epitope tag MBP or GST. In vitro 
kinase assay incubating equal amounts of N-terminal GST-tagged BAK1 or 
BAK1-5 with epitope tagges MBP or GST.  Autoradiogram, right panel; 
Coomassie colloidal blue stained membrane, left panel. 
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Wang et al., 2008), I detected a strong auto-phosphorylation of BAK1-CD when 
incubated with radioactive [32P]-γ-ATP in vitro (Figure 6.5 A). The kinase-dead 
BAK1*-CD had no auto-phosphorylation activity (Figure 6.5 A). Intriguingly, 
heterologously expressed BAK1-5 CD showed a mobility shift on SDS-PAGE 
compared to BAK1 CD or kinase dead BAK1-5*-CD (Figure 6.5 A-C), indicative of 
a potential hyper-phosphorylation in E. coli during recombinant protein production 
as previously observed in the case of hyper-active kinase variant BRI1(T872A) CD 
(Wang et al., 2005). Although I could not observe a significant increase in the auto-
phosphorylation activity of BAK1-5 CD when compared to BAK1 CD in vitro using 
radio-active labelled [32P]-γ-ATP, BAK1-5 CD hyper-phosphorylated the artificial 
substrate myelin basic protein (MYBP) in this assay (Figure 6.4 A). The absence of 
increased auto-phosphorylation activity in in vitro radioactive kinase assays was also 
previously observed with BRI1(T872A) CD (Wang et al. 2005). Therefore, I probed 
purified BAK1 CD and BAK1-5 CD in immunoblots with specific anti-phospho-
threonine(Thr)/serine(Ser) antibodies (α P-T). Indeed, BAK1-5 CD showed a major 
increase in the auto-phosphorylation activity on Thr- and Ser-residues (Figure 6.4 B). 
Importantly, the kinase-dead variants BAK1* CD and BAK1-5* CD had no 
detectable Thr/Ser-phosphorylation signal demonstrating that the observed signal 
resulted exclusively from auto-phosphorylation (Figure 6.5 B).  
I was interested whether this increased auto-phosphorylation activity was restricted 
to Thr/Ser residues, as BAK1 was recently shown to also auto-phosphorylate on 
Tyrosine (Tyr) residues in vitro (Oh et al. 2009). Interestingly, Tyr auto-
phosphorylation was also increased in BAK1-5 CD as observed on immunoblots 
with anti-phospho-Tyr antibodies (α P-Y) (Figure 6.5 C). 
Finally, I tested if any of the observed phosphorylation of BAK1 or BAK1-5 occurs 
on the epitope-tags used in this study. Neither BAK1 nor BAK1-5 CD trans-
phophorylated the maltose binding protein (MBP) or GST-protein in radio active 
kinase assays using [32P]-γ-ATP (Figure 6.5 D). 
These results clearly indicated that BAK1-5 has increased kinase activity in vitro. 
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6.2.6. The RD kinase BRI1 and the two non-RD kinases EFR and FLS2 have 
different kinase activities in vitro 
 
Ultimately, I wanted to study the trans-phophorylation events between 
BAK1/BAK1-5 CD and the CDs of the respective ligand-binding RKs. Therefore, I 
first analyzed FLS2 and EFR kinase activities and compared them with the kinase 
activity of BRI1 in vitro. For this purpose, I expressed in E. coli the CDs of EFR 
(residues 682 to 1031), FLS2 (residues 840 to 1173) and BRI1 (residue 814 to 1196) 
as fusion proteins with an N-terminal MBP tag. As controls, I also constructed the 
respective kinase-dead variants EFR* CD (D849N), FLS2* CD (D997N) and BRI1* 
CD (D1009N). Having all three kinases in the same expression system enabled us to 
directly compare their kinase activities in vitro using radioactive [32P]-γ-ATP. As 
previously reported (Oh et al. 2000), BRI1 CD had a very strong auto- and trans-
Figure 6.6. The RD kinase BRI1 and the two non-RD kinases EFR and FLS2 have 
different kinase activities in vitro. 
A. Differential kinase activity of the RD kinase BRI1 and the non-RD kinases 
FLS2 and EFR. In vitro kinase assay incubating equal amounts of MBP control 
or N-terminal MBP-tagged EFR, EFR*, FLS2, FLS2*, BRI1 and BRI1* CD 
with artificial substrate myelin basic protein (MBP). Autoradiogram, upper 
panel; Coomassie colloidal blue stained membrane, lower panel. 
B. FLS2 is an inactive kinase in vitro. In vitro kinase assay using His or N-terminal 
His-tagged FLS2, FLS2*, BRI1 and BRI1* CD. Note that ten times more FLS2 
and FLS2* CD was loaded compared to BRI1 and BRI1* CD. Autoradiogram, 
upper panel; Coomassie colloidal blue stained membrane, lower panel 
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phosphorylation capacity using the artificial substrate MYBP (Figure 6.6 A). In 
contrast, EFR CD possessed only minor auto-phosphorylation capacity and 
negligible trans-phosphorylation ability on MYBP (Figure 6.6 A). Notably, these 
activities were abolished in BRI1* CD and EFR* CD (Figure 6.6 A), demonstrating 
that the observed phosphorylations are indeed due to the intrinsic kinase activities of 
these protein.  
Surprisingly, I was unable to detect any FLS2 CD phosphorylation in vitro (Figure 
6.6 A), indicating that FLS2 is an extremely weak kinase. The later result is in 
disagreement with previous reports that revealed phosphorylation activities in vitro 
for FLS2 (Gomez-Gomez et al., 2001; Lu et al., 2010; Xiang et al., 2008). As Zhou 
and colleagues (2008) used a N-terminally His tagged FLS2 fusion protein to report 
FLS2 kinase activity, I also generated His:FLS2 CD. Again, as observed with 
MBP:FLS2 CD, I was unable to observe any phosphorylation activity (Figure 6.6 B). 
Under the same conditions, His:BRI1 CD displayed a strong kinase activity (Figure 
6.6 B).  
Consequently, it appears that in comparison to BRI1 that is an extremely strong 
kinase, EFR is a moderately good kinase, while FLS2 is almost kinase-inactive in 
vitro. 
 
6.2.7. Differential trans-phosphorylation capacities of BAK1, BAK1-5, BRI1 
and EFR 
 
As FLS2 CD did not posseses any detectable phosphorylation capacity in vitro, I 
focused my trans-phosphorylation studies with BAK1 and BAK1-5 on the 
comparison between the non-RD kinase EFR and the RD kinase BRI1. 
I first confirmed in our experimental conditions that BAK1 CD was able to trans-
phosphorylate BRI1* CD, and reciprocally that BRI1 CD was able to trans-
phosphorylate BAK1* CD (Figure 6.7 A). Next, I asked if the increased auto- and 
trans-phosphorylation capacities of BAK1-5 CD (Figure 6.5) would translate into an 
increased trans-phosphorylation of the biologically relevant substrate BRI1* CD. 
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Indeed, BAK1-5 CD hyper trans-phosphorylated BRI1* CD (Figure 6.7 A). 
Interestingly, BAK1* CD slightly inhibited BRI1 CD auto-phosphorylation, when 
compared to the empty vector control GST (Figure 6.7 A). In contrast, BAK1-5* CD 
hardly influenced BRI1 CD auto-phosphorylation activity and therefore was still 
strongly trans-phosphorylated by BRI1 CD (Figure 6.7 A).   
Figure 6.7. Differential transphosphorylation capacities of BAK1, BAK1-5, BRI1 
and EFR. 
A. BRI1 and BAK1 undergo bi-directional trans-phosphorylation in vitro. In vitro 
kinase assay incubating equal amounts of N-terminal MBP-tagged BRI1 or 
BRI1* CD with N-terminal GST-tagged BAK1, BAK1*, BAK1-5, BAK1-5* 
CD or GST control, respectively. Autoradiogram, upper panel; Coomassie 
colloidal blue stained membrane, lower panel. 
B. Uni-directional trans-phosphorylation of EFR by BAK1 in vitro. In vitro kinase 
assay incubating equal amounts of N-terminal MBP-tagged EFR or EFR* CD 
with N-terminal GST-tagged BAK1, BAK1*, BAK1-5, BAK1-5* CD or GST 
control, respectively. Autoradiogram, upper panel; Coomassie colloidal blue 
stained membrane, lower panel.  
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Next, I investigated the in vitro trans-phosphorylation events surrounding EFR CD. I 
found that BAK1 CD was able to trans-phosphorylate EFR* CD to a level 
comparable to the EFR CD auto-phosphorylation (Figure 6.7 B). This is in contrast 
to the BAK1-BRI1 trans-phosphorylation events in which BAK1 CD trans-
phosphorylation of BRI1* CD is minimal in comparison to BRI1 CD auto-
phosphorylation (Figure 6.7 B). Another striking difference was the inability of EFR 
CD to trans-phosphorylate BAK1* CD (Figure 6.7 B). This could be due to the 
inhibition of EFR CD (auto)-phosphorylation by BAK1* CD. However, EFR CD 
was still unable to trans-phosphorylate BAK1-5* CD, which hardly influenced EFR 
CD auto-phosphorylation (Figure 6.7 B). Importantly, BAK1-5 CD was able to 
hyper trans-phosphorylate EFR* CD and significantly enhanced the phosphorylation 
status of EFR CD (Figure 6.7 B).  
 
6.2.8. The kinase activity of BAK1-5 is required for the bak1-5 phenotype 
 
I tested if the kinase activity of BAK1-5 is required for the bak1-5 phenotype. As 
bak1-5 has the strongest differential phenotype with elf18 response when compared 
to bak1-4, I concentrated on EFR-dependent responses to address this question.  
I created stable transgenic lines in the bak1-4 background expressing BAK1, BAK1*, 
BAK1-5 and BAK1-5* under the native regulatory sequence of BAK1 (Figure 6.8 A). 
The wild-type allele of BAK1 was able to rescue the reduced and delayed elf18-
induced ROS burst of bak1-4 (Figure 6.8 B). As previously shown (see Chapter 4), 
expression of BAK1-5 in bak1-4 recapitulated the bak1-5 phenotype (Figure 6.8 B). 
Interestingly, the expression of the kinase inactive BAK1* in bak1-4 led to a further 
decrease in elf18-induced ROS burst (Figure 6.8 B), revealing a dominant-negative 
effect of BAK1* and demonstrating the importance of BAK1 kinase activity for 
downstream signalling. Strikingly, the expression of BAK1-5* in bak1-4 led to a 
similar dominant-negative effect as BAK1* but did not fully suppress elf18-induced 
ROS burst as observed in bak1-5 or when BAK1-5 was expressed in bak1-4 (Figure 
6.8 B).  
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These two observations demonstrate that BAK1-5 requires its kinase activity to 
quench EFR-dependent signalling. More importantly, it strongly suggests that the 
differential impact of the bak1-5 mutation on different signalling pathways is linked 
to phosphorylation.  
 
 
6.2.9. Mapping of in vitro phosphorylation sites on BAK1 and BAK1-5 
 
I demonstrated that BAK1-5 is a hyper-active kinase in vitro and its kinase activity 
is required for full suppression of elf18-induced ROS burst (Figure 6.8 B). In order 
to obtain a more qualitative insight in the change of the phosphorylation status of 
BAK1-5 compared to BAK1 I in collaboration with Jan Seklar and Alex Jones 
performed exhaustive phosphorylation site mapping by tandem mass-spectrometry 
(MS/MS). The CDs of BAK1, BAK1-5, BAK1* and BAK1-5* were used in 
nonradioactive autophosphorylation assays and subjected to in gel digestion using 
one or a combination of the following proteases: trypsin, AspN and elastase. The use 
of different proteases clearly increased the sequence coverage and the amount of 
Figure 6.8. BAK1-5 requires its kinase activity for surpression of elf18-induced 
ROS burst. 
A. Expression of BAK1, BAK1-5, BAK1* and BAK1-5* in transgenic plants in 
the bak1-4 background. Immunoblot of total proteins from Col-0, bak1-4 
pBAK1::BAK1, bak1-4 pBAK1::BAK1*, bak1-4 pBAK1::BAK1-5, 
pBAK1::BAK1-5* and bak1-4 using anti-BAK1 antibodies. Immunoblot, upper 
panel; Coomassie colloidal blue stained membrane, lower panel. 
B. The kinase activity of BAK1-5 is required for the suppression of elf18-induced 
ROS burst. ROS burst in leaves of Col-0, bak1-4, bak1-5, bak1-4 
pBAK1::BAK1, bak1-4 pBAK1::BAK1-5 bak1-4, pBAK1::BAK1* and bak1-4 
pBAK1::BAK1-5* treated with 100 nM elf18. Results are average ± s.e. (n=8).
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identified phosphorylation sites, especially in the C-terminus which is deprived of 
Arg and Lys usually defining trypsin protease specificity. We obtained near total 
sequence coverage of ≥ 97% for both kinase dead mutant cytoplasmic domains 
missing only a single 4 aa long-peptide. In the case of BAK1-5 an additional 17 aa 
long-peptide was missing containing three potential phosphorylation sites. 
Surprisingly, in the case of BAK1 we were unable to obtain any peptides with good 
quality scores covering the activation loop. Less stringent database search 
algorithms consistently suggested that the Thr at position 449 in the activation loop 
is mutated to an Ala (Figure 6.9 A). This was totally unexpected as previous DNA 
sequence analysis of the corresponding expression vector did not 
reveal any point mutation of the corresponding codon (Figure 6.9 B). Nevertheless, 
the evidence clearly suggested that the analysed BAK1 protein is a mutant variant 
BAK1(T449A) which has been previously shown to posses reduced kinase activity 
(Wang et al., 2008). This fact impeded a comprehensive comparative analysis of the 
phosphorylation status in a qualitative and quantitative manner. However, a 
Figure 6.9. The BAK1 CD carries a previously un-identified mutation at position 
T449 creating an Alanine substitution. 
A. Fragmentation spectra identified the threonin at position 449 to substituted by 
an alanin. The depicted spectrum was obtained using error tolerant search 
parameters and has an Mascot Ion Score of ≥ 93. The highlighted T-30 indicates 
a mass loss of 30 Dalton corresponding to a T to A substitution.  
B. Absence of T449A corresponding base-pair change in the sequence of the 
BAK1 CD expression vector. The obtained assigned sequence chromatogram 
(ASC) corresponding to the peptide sequence depicted in A is shown. The 
codon corresponding to T449 is boxed.  
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summary of the identified phosphorylation sites is shown in Table 6.1 and the 
corresponding spectra can be found in the Appendix V.II. Phosphorylation sites 
were assigned initially using SEQUEST (Eng et al., 1994), Mascot (Perkins et al., 
1999) and/or X! Tandem scores. In addition the MS/MS fragmentation spectra of all 
phosphopeptides were inspected visually to confirm predicted phosphosite 
assignment.  
We were able to identify all previously published in vitro and in vivo 
phosphorylation sites (Wang et al., 2008; Karlova et al., 2009) except for the 
ambiguously identified site T589/S595 (Table 6.1). In addition we obtained good 
evidence for several previously unpublished sites including two Tyr-phosphorylation 
sites confirming previous result obtained by immunoblot analysis using anti-
phospho-Tyr anti-bodies (Figure 6.5 C). We found two sites in the N-terminal lobe 
(T355, T357), three in the P+1 loop (Y463, S465, T466) and three additional sites in 
the C-terminus (S602, T603, Y610) (Table 6.1). In the case of the two neighbouring 
sites S602 and T603 we cannot exclude that these two predicted sites are actually 
only one phosphosite. In addition, we found weak evidence for Y443, which was 
only identified on doubly phosphorylated peptides (Table 6.1).  
Interestingly, three of the previously published phosphosites (S286, T312, T455) 
were also identified as being phosphorylated in BAK1* or BAK1-5* making them 
potential targets of E. coli kinases (Table 6.1).  
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Table 6.1. Identification of in vitro phosphorylation sites of BAK1(T449A) or BAK1-
5 by MS/MS analysis. 
a underlined residues have been identified previously as in vitro and/or in vivo 
 phoshporylation sites (Karlova et al. 2009, Wang et al. 2008). The “*” indicates 
 residues which were found to be phosphorylated in the kinase dead variants 
 BAK1* or BAK1-5* CD. 
 b identified peptide sequence including amino acid residues before and after,
 respectively  the corresponding residues in the primary protein sequence. 
 Carbamylation of cystein residues is indicated by a preceding “c”, 
 phosphorylation of serine, threonine or tryosin residues in denoted by a preceding 
 “p” 
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Corrigendum: 
 
6.2.10. BAK1-5 is a hypo-active kinase able to trans-phosphorylate BRI1 and 
EFR in vitro 
 
As soon as I identified the missense substitution of the in vitro expression clone of 
BAK1 CD, I in collaboration with Yasuhiro Kadota re-transformed the expression 
vector and confirmed the presence of the wild-type plasmid in individual E. coli 
BL21 clones (data not shown). We re-purified all four proteins, BAK1, BAK1-5, 
BAK1* and BAK1-5* after heterologous expression in E.coli. To test for the overall 
phosphorylation status we performed cold kinases assays in combination with 
immunoblot analysis using anti-phospho-Thr/Ser or anti-phospho-Tyr antibodies 
(Figure 6.10. A-B). BAK1 CD displayed an even more dramatic mobility shift on 
SDS-PAGE than BAK1-5 CD suggesting a compromised kinase activity of BAK1-5 
CD in vitro. This was indeed confirmed by immunoblot analysis as the signal 
corresponding to BAK1-5 CD was considerably lower than this of BAK1 CD for 
either phospho-Thr/Ser (α P-T) or phospho-Tyr (α P-Y) sites, respectively (Figure 
6.10. A-B). We than tested if BAK1-5 CD was still able to trans-phosphorylate BRI1 
or EFR CD in vitro. Therefore, we performed radioactive kinase assays using [32P]-
γ-ATP. When we incubated BAK1 with BRI1* CD we could see a clear trans-
phosphorylation of BRI1* CD (Figure 6.10. C). Similarly, BAK1-5 CD was able to 
trans-phosphorylate BRI1* CD albeit to a lower level. Both BAK1* and BAK1-5* 
CD were trans-phorylated by BRI1 CD to similar degree (Figure 6.10 C). Therefore, 
BAK1/BAK1-5 CD undergo a bi-directional trans-phosphorylation with BRI1 CD in 
vitro. Next, we investigated the trans-phosphorylation events between EFR CD and 
BAK1/BAK1-5 CD. Both BAK1 and BAK1-5 CD were able to trans-phosphorylate 
EFR* CD (Figure 6.10 D). However, the trans-phosphorylation activity of BAK1-5 
CD on EFR* CD was considerably lower when compared to BAK1 CD. 
Interestingly, the trans-phosphorylation of EFR* CD by BAK1 CD was much 
stronger than the auto-phosphorylation of EFR CD (Figure 6.10. D). This relatively 
low activity of EFR CD was also reflected by its inability to trans-phosphorylate 
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BAK1* or BAK1-5* CD (Figure 6.10. D). Therefore, BAK1/BAK1-5 CD undergo 
unidirectional phosphorylation with EFR CD in vitro.  
These results confirm previous observations on the difference in phosphorylation 
directionality between BAK1/BRI1 and BAK1/EFR shown in 6.7. In addition, they 
illustrate that BAK1-5 has a reduced kinase activity and is able to trans-
phosphorylate either ligand-binding receptor in vitro.  
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Figure 6.10. BAK1-5 is a hypo-active kinase able to transphosphorylate BRI1 and 
EFR in vitro. 
A. BAK1-5 CD is a hypo-active kinase on Ser and Thr residues. 0.25 μg of 
heterologously-expressed N-terminal GST-tagged BAK1, BAK1-5, BAK1* and 
BAK1-5* CD were subjected to immunoblot analysis with anti-phosphoThr 
antibodies. Immunoblot, upper panel; Coomassie colloidal blue stained 
membrane, lower panel. 
B. BAK1-5 CD is a hypo-active kinase on Tyr residues. 0.75 μg of heterologously-
expressed N-terminal GST-tagged BAK1, BAK1-5, BAK1* and BAK1-5* CD 
were subjected to immunoblot analysis with anti-phospho-Tyr antibodies. 
Immunoblot, upper panel; Coomassie colloidal blue stained membrane, lower 
panel. 
C. BRI1 and BAK1 undergo bi-directional trans-phosphorylation in vitro. In vitro 
kinase assay incubating equal amounts of N-terminal MBP-tagged BRI1 or 
BRI1* CD with N-terminal GST-tagged BAK1, BAK1*, BAK1-5, BAK1-5* 
CD or GST control, respectively. Autoradiogram, upper panel; Coomassie 
colloidal blue stained membrane, lower panel. 
D. Uni-directional trans-phosphorylation of EFR by BAK1 in vitro. In vitro kinase 
assay incubating equal amounts of N-terminal MBP-tagged EFR or EFR* CD 
with N-terminal GST-tagged BAK1, BAK1*, BAK1-5, BAK1-5* CD or GST 
control, respectively. Autoradiogram, upper panel; Coomassie colloidal blue 
stained membrane, lower panel.  
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6.3. Discussion 
 
In recent years, the importance of the regulatory RLK BAK1 became apparent, as it 
is involved in several independent signalling pathways, namely BR responses, innate 
immunity, and cell death control (Chinchilla et al., 2009). It was however unclear 
whether the regulatory role and the importance of BAK1 in these different biological 
processes is similar. The results presented in Chapters 4 and 5 clearly suggest that 
BAK1 is able to differentially regulate these different signalling pathways as bak1-5 
mutant plants are strongly impaired in PTI-signalling but display a wild-type-like 
behaviour in respect to BAK1-dependent cell death control and BR-signalling. In 
this chapter I explored the underlying biochemical mechanisms of this observed 
phenomenon. Intriguingly, BAK1-5 displayed an enhanced interaction with the three 
different ligand-binding RKs FLS2, EFR and BRI1 (Figure 6.2-6.4). Interestingly, 
BAK1-5 is a hypo-active kinase in vitro that is able to trans-phosphorylate the two 
ligand-binding RKs EFR and BRI1 (Figure 6.10). Importantly, BAK1-5 requires its 
kinase activity to suppress EFR-dependent PTI-signalling as bak1-4 plants 
expressing kinase dead BAK1-5* were only partially able to suppress elf18-
triggered ROS burst (Figure 6.8). Therefore, BAK1-5 differentially regulates PTI- 
and BR-signalling in a phosphorylation dependent manner. 
In addition, I was able to show a significant difference in the kinase activities of the 
two RD-kinases BRI1 and BAK1 compared with the two non-RD kinases FLS2 and 
EFR in vitro (Figure 6.6 and 6.10). Furthermore, whereas BRI1 and BAK1 
underwent a bidirectional phosphorylation, only a unidirectional phosphorylation 
originating from BAK1 could be observed in the case of EFR and BAK1 (Figures 
6.8 and 6.10).  
 
6.3.1. Phosphorylation-dependent differential regulation of BAK1-dependent 
signalling pathways 
 
My initial (clearly) over simplified working hypothesis for the differential regulation 
of PTI- and BR-signalling in bak1-5 was based on a potential differential interaction 
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of BAK1-5 with the different ligand-binding RKs. However, this hypothesis did not 
hold true as BAK1-5 displays an enhanced interaction with all three ligand-binding 
RKs tested, namely FLS2, EFR and BRI1 (Figure 6.2-4). Surprisingly, I found that 
BAK1-5 is a hypo-active kinase in vitro (Figures 6.10). This reduced kinase activity 
of BAK1-5 might be sufficient to support BR-signalling but not PTI-signalling. Yet, 
several observations do not support this hypothesis: (i) There is no direct correlation 
between the in vitro kinase activity of BAK1 mutant variants and their ability to 
complement either the compromised flg22-triggered SGI of bak1-4 bkk1-1 or the 
growth retardation phenotype of bri1-5 (Wang et al., 2008). BAK1(T449A) is able 
to complement both phenotypes but has a reduced kinase activity compared to 
BAK1(T450A) that is not able to complement either phenotype (Wang et al., 2008). 
Interestingly, BAK1-5 posses a stronger kinase activity than BAK1(T449A) (data 
not shown) further substantiating this observation. (ii) Plants expressing the hypo-
active kinase variant BAK1(Y610F) are blocked only in BR signalling but not flg22-
triggered SGI (Oh et al. 2010) thereby displaying an opposite phenotype to bak1-5 
plants even though both BAK1 variants are compromised in their overall kinase 
activity. Therefore, the quantitative kinase output of BAK1 is not the determining 
factor per se that enables BAK1 to function in PTI- or BR-signalling (Table 6.2). 
(iii) In bak1-5 plants PTI signalling is not simply more strongly impaired than in 
bak1-4 loss of function mutants but rather differentially regulated. This is 
exemplified in the differential MPK activation in bak1-5 plants whereby MPK3 and 
6 but not MPK4 are fully activated 15 mins after ligand-treatment (Figure 6.5). (iv) 
BAK1-5 requires its kinase activity to fully suppress efl18-triggered ROS-burst in 
vivo (Figure 6.8). Altogether, this leads to the new hypothesis that BAK1-5 
differentially regulates PTI- and BR-signalling pathways by discriminative auto-
phosphorylation and/or trans-phosphorylation of the main-ligand binding receptors. 
Therefore, the qualitative kinase output of BAK1 defines its signal competence in 
respect to PTI- or BR- signalling pathways.  
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 BAK1 BAK1-5 (C408Y) 
BAK1 
(Y610F)2
BAK1 
(T450A)1
BAK1 
(T449A)1 
BAK1* 
(D418N)3
PTI WT --- WTb -b WTb  -- 
BR WT WT -- - WT --- 
Cell- 
death WT WT WT WT WT - 
kinase 
activitya WT - -/-- -- --- ---- 
 
Table 6.2.: The quantitative kinase out-put of BAK1 is not correlated with its ability to 
full-fill its function in PTI or BR signaling  pathways. 
The number of “- “ indicates the severity of impairment of BAK1’s specific function 
a in vitro kinase activity of BAK1 variants, relative impairment partially approximated 
b Impairment in PTI signaling was only measured as the respective BAK1 variant’s ability to 
rescue bak1-4 bkk1-1 impairment in flg22-triggered SGI 
1 ref. Wang et al. 2008 
2 ref. Oh et al. 2010 
3 ref. Li et al. 2002, Wang et al. 2008 and present study 
 
6.3.2. The differential regulation of BAK1-dependet signalling pathways 
 
The current paradigmatic model based on BRI1 and BAK1, implies that BAK1 is a 
mere signalling enhancer required for optimal activity of BRI1 and subsequent 
signalling (Gendron and Wang 2007; Wang et al., 2008). Upon BR binding, trans-
phosphorylation of BRI1 in the preformed homodimer induces BRI1 kinase activity, 
a prerequisite for heteromerization with BAK1. Trans-phosphorylation of BAK1 on 
residues in the kinase domain activates BAK1, which then trans-phosphorylates 
BRI1 on residues within the intracellular juxta-membrane and C-terminal regions 
increasing BRI1 kinase activity (Wang et al., 2008). Ligand-activated BRI1 can 
signal without BAK1, but its signalling output is increased by BAK1. In contrast 
little is known about the molecular events surrounding the BAK1 and FLS2/EFR 
interactions. It is known that the heterocomplex formations are ligand-inducible 
(Chinchilla et al. 2007; Heese et al., 2007; Roux et al., submitted) and that at least in 
the case of FLS2 happens quasi instantaneously with ligand addition (Schulze et al., 
2010). Another important difference between the interaction of BRI1-BAK1 and 
FLS2/EFR-BAK1 is that the former requires BRI1 but not BAK1 kinase activity for 
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full interaction in vivo (Wang et al., 2008) whereas the later is totally kinase 
independent (Milena Roux, unpublished).  In both cases BAK1 kinase activity does 
not influence the interaction status. So, for me it was intitially counterintuitive that 
BAK1-5, having a reduced kinase activity in vitro, displays an enhanced interaction 
with the ligand binding RKs in co-immunoprecipitation experiments even without 
ligand addition (Figure 6.2-4). These initially counterintuitive observations might be 
unified in the following hypotheses. BAK1-5 might be a de-regulated kinase in vivo 
and thereby be constitutively active albeit with a sensus stricto lower activity than 
wild-type BAK1. The position of the BAK1-5 muatation (C408Y) clusters with 
potentially orthologous mutations in the mammalian RKs ALK1 (F1245C) and 
EGFR (L833V) (George et al., 2008; Mosse et al., 2008) at the interface between the 
β6 and β9 strands in the active kinase conformation structure (Kannan and Neuwald, 
2005). Interestingly, the interface between the β6 and β9 strands is involved in the 
correct positioning of the activation segment and of residues in the catalytic loop and 
is a hotspot for oncogenic mutations (Dibb et al., 2004). Therefore, the C408Y 
mutation might interfere with the proper positioning of the core catalytic residues 
leading to reduced kinase activity in vitro as observed for BAK1-5 (Figure 6.10). 
However, residues in the β6 strand are also known to be involved in kinase auto-
inhibition either by its C-terminal tail or in case of several mammalian RTKs by its 
juxta-membrane region (Kobe et al., 1996; Hubbard 2004; Dibb et al., 2004; Bose 
and Zhang, 2009). The C408Y mutation potentially not only reduces kinase activity 
sensus stricto but in addition might interfere with auto-inhibition in vivo. FLS2 and 
BAK1 are assumed to assemble in preformed complex in close proximity in the 
plasma membrane as their interaction occurs quasi instantaneously with ligand 
addition (Schulze et al., 2010). A deregulated but still active BAK1-5 might stabilize 
these preformed complexes leading to the enhanced interaction in vivo observed in 
co-immunoprecipitation experiments (Figure 6.2-4).  Similarly, a deregulated 
BAK1-5 might stabilize a complex with BRI1 leading to a more frequent interaction 
in vivo and thereby to an increased immunoblot signal in co-immunoprecipitation 
experiments (Figure 6.2-4). This would also explain the slight BR hypersensitivity 
of bak1-5 observed in some bioassays (see Chapter 5).  
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Alternatively, the hypo-active kinase BAK1-5 might form a dead-locked and thereby 
stabilized complex with the ligand-binding receptors. In the case of PRRs this could 
quell the kinase activity of the receptor and down-stream signalling activation.  
In order to test these different hypotheses I attempted to investigate the kinase 
acitivty or phosphorylation status of BAK1, BAK1-5 and the respective ligand-
binding receptors BRI1 and FLS2 in vivo. I combined immunoprecipitation of the 
protein of interested using endogenous antibodies against the native proteins with 
immunoblot analysis with anti-phospho-Thr/Ser antibodies. Unfortunately, no signal 
specific to the immunoprecipitated protein could be observed (data not shown). 
Similarly, I did not succeed in performing isoelectric focusing in combination with 
immunoblot analysis using antibodies against the protein of interest (data not shown). 
Finally, I also tried to combine immunoprecipitation of the protein of interest with in 
vitro kinase assays using MYBP as artificial substrate. This was unsuccessful most 
likely due to precipitation of proteins due to high salt concentrations (data not 
shown). In future studies I will try to adapt the protocols accordingly. 
Intriguingly, the expression of BAK1:GFP and BAK1:HA3 was able to rescue the 
BR-related growth phenotype of bak1-4 but not the compromised flg22-triggered 
ROS burst and SGI (Figure 6.1, data not shown). On the contrary BAK1:GFP and 
BAK1:HA3 seemed to have a slight dominant negative effect on the responsiveness 
of bak1-4 to elf18 in SGI assay (Figure 6.1, data not shown). This suggests that the 
C-terminal tag on BAK1 does not block BRI1-specific responses but interfers with 
FLS2-and EFR-dependent signalling. This is not due to a compromised interaction 
of BAK1:GFP and BAK1:HA3 with FLS2 or EFR (Figure 6.2-3, 7.1, data not 
shown), but might be due to imposed structural changes on the C-terminal tail of 
BAK1. This differential complementation of bak1-4 phenotypes by C-terminally 
tagged BAK1 variants is in accordance with the differential regulation of PTI- and 
BR-signalling in bak1-5 mutant plants (see Chapter 4 and 5). The enhanced 
interaction of BAK1-5 with FLS2 and EFR (Figure 6.2-4) does not explain per se 
the inhibition of PTI signalling observed in bak1-5. However this inhibition requires 
the kinase activity of BAK1-5 (Figure 6.9). Therefore, I would like to suggest that in 
contrast to BR-signalling, in which BAK1 is potentially only a signal enhancer 
 166
(Wang et al., 2008), BAK1 might be an intrinsic component of PTI-signalling. The 
differential auto-phosphorylation of BAK1-5 could theoretically already lead to a 
differential interaction surface for potential downstream signalling components. 
Alternatively or concomitantly, BAK1-5 could trans-phosphorylate specific residues 
on EFR and FLS2 that would affect interactions with positive and/or negative 
regulators such as BIK1 and related proteins (Zhang et al., 2010; Lu et. al. 2010). 
Phosphorylation of specific phosphosites in the juxta-membrane region and C-
terminal tail of mammalian RTKs and Ser/Thr RKs are known to regulate signal 
complex composition, sub-cellular localization, receptor degradation, and therefore 
the initiation, amplitude, complexity and/or duration of the signal (Birchmeier et al., 
2003; Lemmon and Schlessinger, 2010).  Importantly, neither FLS2 nor BAK1-5 
protein levels were reduced in bak1-5 (Figure 6.4) showing that BAK1-5 does not 
affect its own or the expression level of FLS2. Similarly, BAK1:GFP and 
BAK1:HA3 might be unable to phosphorylate specific residues in their C-terminal 
tail and/or bind to specific PTI down-stream signalling partners.  
In this respect it is also noteworthy that BAK1 was recently shown to be a dual 
specificity kinase that also auto-phosphorylates on Tyr residues in vitro (Oh et al., 
2009) (Figure 6.10). As in mammals, these phosphorylated Tyr residues could 
represent docking sites in the C-terminal tail and recruit specific interaction partners 
(eg. SH2 domain-containing proteins) dictating signalling specificity (Pawson, Cell 
2004; Bae et al., Cell 2009; de la Fuente van Bentem and Hirt, 2009; Lemmon and 
Schlessinger, 2010).  
 
6.3.3. Differential regulation of RD and non-RD kinases 
 
The differential impact of bak1-5 on BRI1-dependent and FLS2/EFR-dependent 
signalling could also be related to a more general differential regulation of RD 
versus non-RD kinases. RD kinases carry an arginine (Arg) before the conserved 
catalytic core Asp, and are in general activated by phosphorylation in the activation 
loop. The phospho-groups interact with a positively-charged pocket containing the 
Arg and most likely re-orient residues within the catalytic loop, ATP-binding pocket 
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and/or facilitate peptide substrate binding (Nolen et al., 2004).  In contrast, non-RD 
kinases do not require phosphorylation of the activation loop to adopt an active 
confirmation. They are rather regulated by different mechanisms such as relief of 
auto-inhibition by C-terminal extensions (Kobe et al., 1996), Tyr phosphorylation in 
the P+1 loop (Mayans et al., 1998), or are constitutively active kinases due to 
intrinsic structural properties (Nolen et al., 2001).  
Interestingly, the RD-kinase BRI1 was far more active in vitro in our conditions than 
the non-RD kinases EFR and FLS2 showing strong auto- and trans-phosphorylation 
capacities (Figure 6.6, 7, 10). EFR did possess some degree of auto-phosphorylation 
(Figure 6.6), but no trans-phosphorylation capacity either towards the artificial 
kinase substrate MBP (Figure 6.6), or towards the physiologically-relevant BAK1 
kinase domain (Figure 6.10). Surprisingly, I was unable to detect any in vitro kinase 
activity for FLS2 CD (residues 840 to 1173) neither as N-terminal MBP-tag nor His-
tag fusion protein, especially in comparison to the strong BRI1 kinase activity 
(Figure 6.7). This is in contradiction with previous reports (Gomez-Gomez et al, 
2001; Xiang et al., 2008; Lu et al., 2010). Initially, a N-terminal GST-tag fusion of 
FLS2 (residues 840 to 1173) was reported to be kinase active in vitro (Gomez-
Gomez et al., 2001; Gohre et al., 2008) and this activity was abolished by a single 
substitution corresponding to the fls2-17 mutation leading to the change of a highly 
conserved Gly into an Arg (G1064R) in the subdomain IX (Gomez-Gomez et al., 
2001). This result indicated that FLS2 kinase activity is required for flg22 binding as 
fls2-17 mutants showed a reduced flg22-binding capacity (Gomez-Gomez et al. 
2001). However, this conclusion was later refuted as no full-length FLS2 protein 
could be detected in fls2-17 extracts (Robatzek et al., 2007). Next, in vitro kinase 
activity of a N-terminal His-tag fusion of FLS2 (residues 840 to 1173) was reported 
(Xiang et al., 2008). Yet, the important control of a kinase inactive variant was 
omitted, and a recent publication by the same research group reported that 
recombinant FLS2 possesses only weak kinase activity impeding analysis of trans-
phosphorylation events in vitro (Zhang et al., 2010). This is in agreement with 
another recent report showing only residual kinase activity of FLS2 CD (residues 
832 to 1173); although once again no control with kinase inactive variant was 
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presented (Lu et al., 2010). Notably, close sequence analysis of the FLS2 kinase 
domain revealed a low conservation of the otherwise highly conserved Gly-rich loop 
[GxGxxG] in subdomain I, which is involved in the correct positioning of the 
substrate ATP (Bossemeyer 1994). Particularly, the replacement of the second 
invariant Gly by a Ser (S879) in FLS2 is predicted to lead to a dramatic reduction in 
kinase activity, as mutation of the corresponding Gly in the model Ser/Thr kinase 
cAPK reduces the kinase activity by 50-fold (Taylor et al., 1999).  
Strikingly, in contrast to the situation with BRI1 and BAK1, no trans-
phosphorylation of BAK1 by EFR (or FLS2) could be observed in vitro (Figure 6.7, 
10, data not shown). Yet, BAK1 is capable of trans-phosphorylating EFR in vitro 
(Figure 6.10). Of course, I cannot exclude that FLS2 and EFR kinase domains are 
only fully activated in vivo after extracellular ligand binding via conformation 
changes mediated by the trans-membrane domain, which is missing in the in vitro 
system. 
Consistently with their low activity in in vitro kinase assays, no phosphosites could 
be identified by mass spectrometry on recombinant EFR or FLS2 CDs (data not 
shown). Interestingly, even in the case of the well-studied non-RD kinase XA21, all 
studied phosphorylation sites were initially found by targeted mutagenesis and not 
by mass spectrometry analysis (Xu et al., 2006; Chen et al., 2010).  
Nevertheless, the kinase activities and some potential phosphosites of FLS2 and 
EFR seem important for downstream signalling. A kinase-dead version of EFR 
(EFR*) is unable to confer elf18-triggered ROS burst when transiently expressed in 
N. benthamiana (data not shown). A K898M mutation in the FLS2 kinase domain 
abolished MPK3 and MPK6 activation by flg22 after transient over-expression in 
fls2 mutant protoplasts (Asai et al. 2002); however controls for protein expression 
and kinase activity were missing. Targeted mutagenesis of potential phosphosites in 
FLS2 revealed that T867, T1040 and T1072 are required for its full functionality 
(Robatzek et al., 2007). However, it was not investigated if these sites are required 
for kinase activity, are auto-phosphorylation sites, or whether they represent trans-
phophorylation targets of BAK1.  
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Overall, the striking difference between the kinase activities of the two RD kinases 
BRI1 and BAK1 compared to the non-RD kinases EFR and FLS2 suggests a 
different regulatory mechanism between these two kinase classes. Interestingly, a 
highly conserved Thr residue in the intracellular juxta-membrane domain reveals a 
differential regulation of the overall kinase activity of RD and non-RD kinase by a 
single site. Accordingly, T705 of the non-RD kinase XA21 is essential for in vitro 
auto-phosphorylation, interaction with downstream signalling components, and for 
XA21-mediated resistance (Chen et al., 2010). Similarly, a mutation of the 
corresponding residue in FLS2 (T867) compromised its function in planta (Robatzek 
et al., 2006). However, in the case of the RD kinase BRI1 the phosphorylation of the 
corresponding Thr (T880) is not required for its function (Wang et al., 2005). 
Another difference between RD and non-RD RK seems to be the requirement of 
kinase activity for complex formation with the RD-RLK BAK1. We found that the 
kinase activity of neither interaction partner is required for the ligand-induced 
interaction of FLS2 or EFR with BAK1 (Milena Roux, unpublished). Optimal 
ligand-dependent heteromerization could even be induced between double mutant 
combinations of FLS2* or EFR* with BAK1* (Milena Roux, unpulished). These 
results obtained after transient over-expression in N. benthamiana nicely 
complement previous pharmalogical studies in A. thaliana cell cultures (Schulze et 
al., 2010). Treatment of cell cultures with the broad-range kinase inhibitor K252a 
did not block FLS2-BAK1 complex formation, but totally inhibited phosphorylation 
of either of the interaction partners. Ligand-dependent conformational changes thus 
seem sufficient to trigger heteromerization between the non-RD kinases EFR and 
FLS2 with BAK1. Therefore, the interaction of EFR and FLS2 with BAK1 is a 
requirement for rather than a consequence of detectable phosphorylation. This 
situation is in stark contrast with the absolute requirement of the BRI1 kinase 
activity for the ligand-induced complex formation with BAK1 in planta (Wang et al., 
2008).  
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Chapter 7: Towards the identification of novel PAMPs inducing 
BAK1-dependent responses and BAK1-interacting proteins using 
BAK1-5 
 
7.1. Objectives  
 
Relatively little is know about the immediate downstream events after 
oligomerization between FLS2/EFR and BAK1. Only recently it was shown that the 
membrane-associated cytoplasmic kinase BIK1 and related PBL proteins positively 
regulate PTI-signalling. BIK1 and PBL proteins form constitutive complexes with 
FLS2 and EFR (Zhang et al., 2010a; Lu et al., 2010). They are phosphorylated 
within minutes of flg22 or efl18 treatment and released from the complex; both 
events requiring kinase active BAK1. Whether BAK1 directly interacts with BIK1 is 
still controversial (Zhang et al., 2010; Lu et al., 2010). Another BAK1-interacting 
protein is BIR1, a LRR-RLK belonging to the subfamily Xa. Interestingly, bir1 
mutants show constitutive cell death under normal growth conditions suggesting an 
involvement in BAK1-dependent cell-death control (Gao et al., 2009).  
Also, the knowledge of the molecular identity of PRRs upstream of BAK1 is scarce. 
It is known that in Arabidopsis the recognition of at least three “orphan” PAMPs, 
namely HrpZ, lipopolysaccharides and peptidoglycans is BAK1-dependent (Shan et 
al., 2008). Furthermore, the hyper-susceptibility of bak1-5 fls2 efr and bak1-5 bkk1-
1 to bacterial and oomycete pathogens suggests the existence of additional yet 
unknown PAMPs, which recognition is dependent on BAK1 and/or BKK1 (see 
Chapter 4). Interestingly, BAK1-5 displayed an enhanced interaction with the two 
known PRRs FLS2 and EFR (see Chapter 6). By extrapolating this knowledge to yet 
unknown BAK1-dependent PRRs BAK1-5 seems to be the perfect tool to identify 
new PRRs by MS/MS analysis. 
Here, I present recent progresses in identifying novel BAK1/BAK1-5-interacting 
proteins. First, in a proof of concept experiment I identified FLS2 as a major flg22-
dependent BAK1 interaction partner by MS/MS analysis. Furthermore, I show that 
BAK1 exists in complex with other SERK family members. I also show that BAK1 
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interacts with close homologs of BIR1, and that BAK1 is involved in the perception 
of yet unknown PAMPs from bacteria, fungi and oomycetes.  
 
 
7.2. Results and Discussion 
 
7.2.1. Identification of FLS2 as a BAK1 interactor by MS/MS analysis 
 
BAK1 was initially identified as flg22-dependent FLS2 interaction partner by 
immunoprecipitation of FLS2 from flg22-treated Arabidopsis cell culture followed 
by MS/MS analysis of co-immunoprecipitated proteins (Heese et al., 2007). 
Interestingly, BAK1-5 displayed an enhanced interaction capacity with the ligand-
binding receptor FLS2 even without ligand addition (see Chapter 6). Therefore I 
attempted to exploit this intrinsic property of BAK1-5 to identify novel BAK1 
interaction proteins especially PRRs. As a proof of concept experiment in 
collaboration with Frederikke Gro Malinovsky I tested if we were able to identify 
FLS2 as a BAK1 interaction partner by MS/MS analysis of co-immunoprecipitated 
proteins, either after flg22 treatment of wild-type BAK1 expressing plants or 
exploiting the enhanced affinity of BAK1-5 (see Chapter 6). In order to obtain 
enough protein for MS/MS analysis we performed large-scale immunoprecipitations 
on 30-45 ml of 3 mg/ml protein using 10-20 g of 2 to 3 week-old seedlings as 
starting material for total protein extraction. In the initial experimental set-up we 
used mock treated bak1-4 seedlings as negative control, seedlings of bak1-4 
pBAK1::BAK1-GFP T2 lines treated with flg22 or mock treated seedlings of bak1-4 
pBAK1::BAK1-5-GFP T2 lines. We immunoprecipitated BAK1-GFP or BAK1-5-
GFP from total protein extracts using GFP-trap beads. We also incubated total 
protein from the negative control bak1-4 with the same amount of GFP-trap in order 
to control for non-specific interactions. As shown in Figure 7.1 A we were able to 
immunoprecipitate some BAK1-GFP or BAK1-5-GFP, respectively, under this 
“large-scale” conditions. However we were not able to deplete all fusion protein 
from the total protein extract as significant amounts remained in the flow-through 
(Figure 7.1 A). Next, we investigated the amount of FLS2 in the immunoprecipitates 
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by immunoblot analysis using anti-FLS2 antibodies. FLS2 was clearly enriched in 
the immunoprecipitate of BAK1-GFP but absent in the negative control and the 
BAK1-5-GFP immunoprecipitate (Figure 7.1 B). The remnant of the 
immunoprecipitates was separated by SDS-PAGE and proteins visualized using 
colloidal commassie blue staining (Figure 7.1 C). A protein migrating at similar size 
to BAK1-GFP and BAK1-5-GFP was clearly enriched in the immunoprecipitates of 
transgenic plants expressing BAK1-GFP or BAK1-5-GFP, respectively, but absent 
in the negative control (Figure 7.1 C). No other specific bands could be observed 
that would be absent in the negative control. As we only wanted to identify FLS2 as 
a BAK1-interacting protein in this pilot experiment only proteins bigger than 64 kDa 
were subjected to in-gel tryptic digestion followed by MS/MS analysis. We 
Figure 7.1. Identification of FLS2 as a flg22-dependent BAK1-GFP interacting 
protein by MS/MS analysis. 
A. Partial enrichment of BAK1-GFP or BAK1-5-GFP by large-scale 
immunoprecipitation. Immunoprecipitation from total protein extracts of bak1-4 
plants (lane 1), bak1-4 pBAK1::BAK1-GFP T2 plants treated with 100 nM flg22 
for 5 min (lane 2) or bak1-4 pBAK1::BAK1-5-GFP T2  plants mock-treated 
(lane 3) using anti-GFP trap beads. Immunoblot analysis of total protein (T), 
flow through after immunoprecipitation (FT) and 1/100 of the 
immunoprecipitate (IP) by anti-GFP antibody. 
B. Large-scale co-immunoprecipitation of FLS2 only after flg22-treatment. 
Immunoprecipitation as described above. Immunoblot analysis of total protein 
(T) and immunoprecipitate (IP) by anti-FLS2 antibody. 
C. Identification of FLS2 as BAK1-GFP interacting protein by MS/MS analysis. 
Colloidal commasie stain gel of all immunoprecipitated proteins using GFP-trap 
as described above with graphical depiction of the BAK1 protein sequence 
coverage obtained by MS/MS analysis. * indicates the band identified as BAK1 
or BAK1-5, respectively.  Φ indicates the area from where FLS2 peptides were 
recovered. 
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identified 26 peptides covering 40% of the BAK1 sequence in the bak1-4 
pBAK1::BAK1-GFP sample (Figure 7.1 C and Table 7.1). In the case of bak1-4 
pBAK1::BAK1-5-GFP we were able to identify only 8 peptides covering 19% of the 
BAK1-5 sequence (Table 7.1). No peptides matching either BAK1 or BAK1-5 were 
present in the negative control bak1-4 (Table 7.1). We defined potential BAK1 
interacting partners as follows: proteins that are identified by at least two 
independent peptides with a quality score (Mascot Ion score) greater than 25 and 
that have no matching peptides identified in immunoprecipitates of the negative 
Table 7.1 Proteins specifically identified in the immunopreciptates of BAK1-GFP 
and/or BAK1-5-GFP. 
a peptides matching the indicated protein and potential other proteins without 
 exclusively matching peptide 
b number of specific peptides only matching the indicated protein 
1 denotes immunoprecipitates of bak1-4 plants mock treated 
2 denotes immunoprecipitates of bak1-4 pBAK1::BAK1-GFP plants treated with flg22 
3 denotes immunoprecipitates of  bak1-4 pBAK1::BAK1-5-GFP plants mock treated 
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control. The summary of all identified proteins matching these criteria is shown in 
Table 7.1 and the respective peptides with Mascots scores can be found in the 
Appendix VII.I.  
Interestingly, by applying these criteria we were able to identify FLS2 as an flg22-
dependent interaction partner of BAK1 as we recovered 7 peptides in the BAK1-
GFP sample covering 8% of the FLS2 sequence (Figure 7.1 C and Table 7.1). 
However, we were not able to recover any peptides matching FLS2 in the 
immunoprecipitate of the mock treated BAK1-5-GFP sample. This might be due to 
the overall low recovery of fusion protein in these large-scale experiments (Figure 
7.1 A). Nevertheless, we identified several other specific BAK1/BAK1-5 interacting 
proteins that will be discussed in more detailed in the following section. 
 
7.2.2. Identification of BAK1/BAK1-5-interacting proteins by MS/MS analysis 
 
In order to obtain more robust data and identify new potential PRRs I performed two 
additional large-scale immunoprecipitation experiments followed by MS/MS 
analysis. For each experiment I used different transgenic bak1-4 lines (bak1-4 
pBAK1::BAK1-HA3 T2, bak1-4 pBAK1::BAK1-5-HA3 T2, bak1-4 pBAK1::BAK1-
GFP T2 or bak1-4 pBAK1::BAK1-5-GFP T2) expressing either 3xHA or GFP C-
terminal epitope tagged fusion proteins. Using two different tags I was able to 
control for potential tag-specific BAK1-unspecific interaction partners. In the 
experimental set-up we included the negative control bak1-4 not expressing any 
fusion protein, an untreated control and a general crude elicitor extract treatment 
from different bacterial pathogens. After extracting total proteins I 
immunoprecipitated C-terminally tagged BAK1 or BAK1-5 using either HA-beads 
or GFP-trap beads, respectively. The immunoprecipitates were separated by SDS-
PAGE and proteins visualized using colloidal commassie blue stain (data not shown). 
All proteins were subjected to in-gel tryptic digestion followed by MS/MS analysis. 
The maximal sequence coverage of BAK1 or BAK1-5 in any of these samples was 
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Table 7.2 Proteins specifically identified in the immunoprecipitates of BAK1-GFP, 
BAK1-5-GFP, BAK1-HA3 and BAK1-5-HA3. 
a peptides matching the indicated protein and potential other proteins without unique 
 matching peptide   
b number of specific peptides 
1 denotes first repeat using bak1-4 pBAK1::BAK1- HA3 or bak1-4 pBAK1::BAK1-5-HA3 
plants 
2 denotes second repeat using bak1-4 pBAK1::BAK1-GFP or bak1-4 pBAK1::BAK1-5-
GFP plants 
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20%. I could not observe any difference in the identified proteins between BAK1 
and BAK1-5 and therefore summarized all potential interacting proteins as 
BAK1/BAK1-5 interactors in Table 7.2. Respective peptides and Mascot Ion Score 
can be found in the Appendix VII.II. When considering all three independent 
experiments I was able to identify 26 potential BAK1/BAK1-5 interacting proteins  
(Table 7.1 and 7.2). I identified two chaperones, the HSP90 protein shepherd (SHD) 
and the HSP70 protein luminal binding protein 2 (BiP2), that are most likely 
Figure 7.2. Identification of SERK1 and BKK1 as BAK1 interacting proteins by 
MS/MS analysis. 
Alignment of SERK-family members. Blue or red indicates non-specific or specific, 
respectively, amino acid sequences identified by the MS/MS analysis. See text for 
experimental details. 
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involved in the proper folding of BAK1 (Saijo, 2010). In addition, I identified 
several RLKs that were of great interest for us. 
The SERK-family members are highly similar at the amino acid level reaching from 
66% to 89% identity in a pair-wise comparison (Hecht et. al., 2001; Albrecht et al., 
2005) making it very difficult to obtain specific peptides (Figure 7.2). Nevertheless 
careful peptide sequence analysis identified SERK1 and BKK1 as interaction 
partners of BAK1. I obtained one specific peptide for SERK1 and one peptide 
matching either SERK1 or SERK2, which is allocated to SERK1 in the absence of 
specific peptides for SERK2 (Table 7.2 and Figure 7.2). In the case of BKK1 I found 
four specific peptides representing different trypsin cleavage products of the same 
amino acid sequence (Table 7.2 and Figure 7.2). This suggests that SERK-family 
members form oligomeric complexes and do not function in isolation. Recent 
findings of cooperative functional interactions of SERK-family members in BR- and 
PTI signalling support this hypothesis (Chinchilla et al., 2009; Roux et al. submitted). 
 I also identified two LRR-RLKs from the subfamily Xa as BAK1 interaction 
partners (Table 7.1 and 7.2). Phylogenetic analysis showed that they form an out-
group within subfamily Xa containing the known BAK1-interacting protein BIR1 
(Figure 7.3 A) (Goa et al., 2008). I identified two specific peptides matching 
At3g28450.1 the closest homologe of BIR1 (Table 7.1, 2 and Figure 7.3 B). 
Furthermore, I identified eight specific peptides for the third member of the out-
group At1g27190.1 and one additional peptide being shared with its closest homolog 
At1g69990.1 (Table 7.1, 2 and Figure 7.3 B). I did not identify any BIR1-specific 
peptides in any of the three repeats suggesting that other family members of this out-
group are the main BAK1 interaction partners in my experimental conditions. 
In addition I identified several metabolism-related enzymes as potential BAK1 
interaction partner (Table 7.1 and 7.2). However, I was unable to identify any 
peptides matching BRI1 which is in agreement with results from other laboratories 
(R. Karlova and S. de Vries, personal communication). Consistently, I did not 
identify proteins displaying the expected topology of potential PRRs. 
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7.2.3. Progress on the identification of PAMPs inducing BAK1/BKK1-
dependent responses 
 
I previously showed that bak1-5 plants are hyper-susceptible to bacterial pathogens 
and that leaves of fls2 efr bak1-5 and bak1-5 bkk1-1 support even more bacterial 
growth than leaves of fls2 efr (see Chapter 4). In addition, seedlings of bak1-5 bkk1-
1 are hyper-suceptible to oomycete pathogens (see Chapter 4). This suggests that 
BAK1 and/or BKK1 are required for the perception of unknown PAMPs by yet 
unidentified PRRs. Therefore, in collaboration with Fredderikke Gro Malinovsky I 
tested if fls2 efr bak1-5 and/or bak1-5 bkk1-1 plants are impaired in the perception of 
PAMPs present in crude elicitor extracts from individual pathogens available at The 
Sainsbury Laboratory. Initially, we screened for a reduction in the elicitor-induced 
Figure 7.3. Identification of BIR1 homologs as BAK1 interacting proteins by 
MS/MS analysis. 
A. The identified BAK1-interactors are members of LRR-RLK subfamily Xa and 
form a sub-clade containing BIR1 (boxed). Phylogenetic tree of LRR-RLK sub-
family Xa. 
B. Alignment of BIR1 and its three closest homologs. Blue or red indicates non-
specific or specific, respectively, amino acid sequences identified in the MS/MS 
analysis. See text for experimental details.
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ROS-burst as readily recordable read-out. Applying crude elicitor extracts from the 
bacterial pathogens Pto DC3000, Pta 6605, the oomycete pathogens Albugo 
laibachii Alem1, A. candida 20DD5, Hpa Emoy2 and two fungal pathogens Botrytis 
cinerea and A. brassicicola on Col-0 leaf discs we only obtained reproducible ROS-
burst production with extract from Pta 6605 (Figure 7.4 A, data not shown). Most of 
the measurable ROS-burst was dependent on FLS2 and EFR as ROS production was 
markedly reduced in the fls2 efr double mutant leaves (Figure 7.4 A). However, it 
was even further decreased in leaves of fls2 efr bak1-5 and bak1-5 bkk1-1 plants 
(Figure 7.4 A and B).  
As several crude elicitor extracts did not induce any reproducible ROS-burst we 
used a subset of these to test for PTI-gene induction by qPCR in a series of 
preliminary experiments. We treated Col-0 or bak1-5 seedling for 30 or 180 min 
with crude extracts isolated from plants effected with A. laibachii Alem1, A. candida 
Figure 7.4. Identification of (potentially) novel BAK1-dependent PAMP (extracts) 
from P. tabaci 6605. 
A. BAK1 and BKK1 are involved in the perception of FLS2- and EFR-
independent PAMP(s). Graphical depiction of P. tabaci crude elicitor extract-
triggered ROS-burst in leaves of Col-0, fls2 efr, fls2 efr bak1-5 and bak1-5 
bkk1-1 plants. Table summarizing total ROS-burst production after 40 min in 
RLU ± s.e. (n=16). 
B. Reduced and delayed Pta 6605crude elicitor extract-triggered ROS-burst in 
bak1-5 bkk1-1 leaves. Kinetics of P. tabaci crude elicitor extract-triggered 
ROS-burst in leaves of Col-0, fls2 efr, fls2 efr bak1-5 and bak1-5 bkk1-1 
plants. Results are given as average ± s.e. (n=16)
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20DD5 or Hpa Emoy2 or from A. brassicicola grown on V8 plates. As shown in 
Figure 7.5 all extracts induced the expression of the PTI marker gene At2g17780 
after 30 min in Col-0 and bak1-5. The gene induction was transient and the 
expression level was reduced already after 180 min for some of the extracts (Figure 
7.5). Nevertheless, the expression level of At2g17780 at 30 min was always lower in 
bak1-5 seedlings compared to wild-type (Figure 7.5 A).  To confirm these initial 
results in collaboration with Milena Roux I focused on extracts from Hpa Emoy2 as 
bak1-5 bkk1 are hyper-susceptible to this pathogen (see Chapter 4). In the new 
experimental set-up we included extracts from non-infected plants as non pathogen 
related control. We treated seedlings of Col-0, bak1-5, bkk1-1 and bak1-5 bkk1-1 
with extracts from mock or Hpa Emoy2-inoculated plants for 30 or 180 min. We did 
not observe any significant difference in the expression level of the PTI marker gene 
At1g51890 after 30 min between the mock control and treatment (Figure 7.5 B). 
However, the expression of At1g51890 was markedly induced after 180 min only in 
samples from seedling treated with Emoy2 crude elicitor extract (Figure 7. 5 B). 
This induction clearly required functional BAK1 and BKK1 as the expression level 
of At1g51890 was reduced in the single mutants bak1-5 and bkk1-1 and even lower 
in the double mutant bak1-5 bkk1-1 (Figure 7.5B).   
All together, this demonstrates the presence of yet unknown PAMPs which are 
perceived by BAK1- and/or BKK1-dependent PRRs. 
 181
 
 
7.2.4. Progress on the identification of BAK1/BKK1-dependent PRRs 
 
Next, in collaboration with Yasuhiro Kadota I wanted to identify the corresponding 
BAK1- and/or BKK1-dependent PRR(s) responsible for perception of PAMPs 
present in the crude elicitor preparations tested as shown in Figure 7.4 and 7.5. We 
focused our initial efforts on the crude elicitor extract of Pta 6605. Firstly it induced 
a reproducible lower ROS-burst in leaves of fls2 efr bak1-5 and  bak1-5 bkk1-1 
compared to fls2 efr (Figure 7.4). Secondly, this extract was readily available in 
large quantities needed for elicitation of sufficient amount of seedlings.  As most of 
the recognition of the P. tabaci 6605 crude elicitor extract was dependent either on 
Figure 7.5. BAK1 and BKK1 play a partial redundant role in the recognition of 
several crude elicitor extracts of non-bacterial pathogens. 
A. Identification of BAK1-dependent crude elicitor extracts of non-bacterial 
pathogens. Expression analysis of At2g17780 by qPCR in Col-0 and bak1-5 
seedlings treated with crude elicitor extracts of A. laibachii Alem1, A. candida 
20DD5, A. brassicicola or Hpa Emoy2 for 30 or 180 min, respectively. Results 
are average ± s.e. (n=3). 
B. Partially redundant roles of BAK1 and BKK1 in the recognition of yet 
unidentified PAMP(s) from Hpa Emoy2. Expression analysis of At1g51890 by 
qPCR analysis in seedlings of Col-0, bak1-5, bkk1-1 and bak1-5 bkk1-1 not 
treated, mock treated or treated with Hpa Emoy2 crude elicitor extract for 30 or 
180 min. Results are average ± s.e. (n=3)
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FLS2 or EFR (Figure 7.4) we used the fls2 efr bak1-5 triple mutant plants in order to 
avoid identifying only FLS2 or EFR as inducible BAK1-5 interaction partners. For 
the identification of potential novel PRRs we treated fls2 efr bak1-5 seedlings either 
with water or with Pta 6605 crude elicitor extract for 5 min at the same 
concentration used in ROS-burst experiments (Figure 7.4). As we performed 
immunoprecipitation experiments with the newly available anti-BAK1 antibodies 
(Schulze et al. 2010), we also included bak1-4 as a negative control. We incubated 
total protein extracts with anti-BAK1 antibodies and anti-rabbit IgG beads. 
Immunoprecipitated proteins were separated by SDS-PAGE, visualized by colloidal 
commasie blue stain, and subjected to in-gel trypsin digestion followed by MS/MS 
analysis. Unfortunately, we only obtained a maximal sequence coverage of 8% of 
BAK1-5 including only two specific peptides (Table 7.3). This relatively low 
recovery rate of BAK1-5 made it difficult to evaluate the identified co-
immunoprecipitated proteins (Table 7.3 and Appendix VII.III). Additional 
experiments are needed to investigate the low recovery rate and to evaluate the 
significance of the identified proteins.  
Interestingly, we recovered two BKK1 specific peptides in the bak1-4 sample 
proving that the anti-BAK1 antibody also recognizes BKK1 in planta as previously 
suggested by peptide competition experiments on immunoblots (Schulze et al. 2010). 
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Table 7.3. Proteins immunoprecipitated using anti-BAK1/BKK1 antibodies. 
a peptides matching the indicated protein and potential others without unique matching 
 peptide   
b number of specific peptides 
1 denotes immunoprecipitates of bak1-4 plants mock treated 
2 denotes immunoprecipitates of fls2 efr bak1-5 plants mock treated 
3 denotes immunoprecipitates of fls2 efr bak1-5 plants treated with P.tabaccrude elicitor 
extract 
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Chapter 8: Conclusion and Outlook 
 
8.1. A novel model of action for BAK1 in PTI-signalling 
 
In contrast to previous models, I found that BAK1 is able to dictate specificity of 
downstream signalling as the kinase hypo-active BAK1-5 nearly totally blocked 
FLS2- and EFR-mediated PTI signalling but hardly influenced BRI1-mediated BR 
signalling, as well as cell death control. Based on these results and the recent work 
from Chinchilla and colleagues (Schulze et al., 2010), I propose a model for the 
mechanisms underlying EFR/FLS2 heteromerization with BAK1, and the role of 
BAK1 in the establishment of PTI signalling. EFR and FLS2 most likely exist in 
close proximity with BAK1 at the plasma membrane in loose preformed complexes. 
Conformational changes triggered by ligand-binding lead to the stabilization of the 
complex. This interaction is kinase-independent, but may lead to the activation of 
the EFR/FLS2 kinase activity by BAK1 via trans-phosphorylation events. 
Phosphorylation of specific residues on EFR/FLS2 and/or BAK1 leads to the 
recruitment of downstream signalling components that dictate the specificity of the 
signalling output. In this model, BAK1 is not a simple enhancer of the kinase 
activity of the ligand-binding RKs, but is an integral part of the signalling pathway. 
Future studies need to carefully address the role of kinase activity of non-RD kinases 
for PTI signalling and final defence outcomes. Therefore, careful qualitative and 
quantitative analyses guided by mass-spectrometry of the phosphorylation status of 
BAK1, BAK1-5, FLS2 and EFR in vitro and in vivo will shed more light onto the 
complex regulatory mechanisms of these two model non-RD kinases by the 
regulatory RLK BAK1. These studies are however technically challenging, as unlike 
BRI1, the kinase activity of EFR is very weak and that of FLS2 is practically 
negligible at least in vitro. In addition, the analysis by quantitative proteomics of 
EFR/FLS2-BAK1 complexes in bak1-5 compared to wild-type, combined with 
bak1-5 and bak1-5 bkk1-1 suppressor screens will help to identify novel key 
regulators of PTI. Such approaches are currently undertaken in the laboratory. 
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8.2. Discovering new PRRs and enhancing plant disease resistance 
 
The identification of BAK1 as a PTI-signalling component could become a seminal 
discovery in plant science. It was recently shown that the interfamily heterologous 
expression of EFR in solanaceous plants leads to broad-spectrum disease resistance 
against bacteria (Lacombe et al., 2010). It is conceivable that this might represent a 
novel strategy to contain plant diseases in the field, especially if several different 
PRRs are stacked within the same plant. Stacking of a combination of R-proteins 
and PRRs might even further enhance disease resistance. However, the number of 
currently known PRRs is limited. Nonetheless, many orphan PAMPs are known.  
Several of these orphan PAMPs are perceived by BAK1-dependent PRRs. 
Importantly, this observation is not restricted to model plants such as Arabidopsis 
and N. benthamiana (Chinchilla et al., 2009), but has been recently reported in the 
case of Ax21-perception in rice also (Pamela Ronald, personal communication). 
Therefore, the requirement of BAK1 and orthologous proteins for signalling in 
response to PAMP perception seems to be evolutionary conserved. A concise 
strategy to identify novel BAK1-interacting proteins in several plant species and/or 
cultivars using either yeast-two hybrid or proteomic approaches might lead to the 
identification of novel PRRs. Those could be used for PRR stacking and crop 
improvement. 
A complementary approach is to manipulate currently known PRRs. For example, 
random mutagenesis of the extracellular domain might generate novel or more 
efficient PAMP binding sites.  Alternatively, the manipulation of the intracellular 
kinase domain might be suited to create more responsive and/or efficient PRRs. The 
close examination of oncogenic mutations in mammalian RKs or kinases in general 
will aid the structure function analysis as cancer is often caused by deregulated or 
hyper-active growth-promoting kinases.  
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8.3. From the idea of linear signal transduction pathways to the idea of 
cytoplasmic states 
 
Signal transduction is often perceived as a linear signal cascade. Ligand binding to 
the extracellular domain of a RK activates the intracellular kinase domain, 
phosphorylation and other post-translational modifications relay the signal to the 
nucleus and thereby induce an appropriate transcriptional reprogramming. The 
activation of de-activating enzymes such as phosphatases leads to the down-
regulation of signalling. This sequential and binary view of signal transduction is a 
clear over-simplification. For example, it is apparent that PTI is under constant 
negative regulation by phosphatases and protein degradation mechanisms as 
treatment with either calyculin A or CHX induces responses reminiscent of PAMP 
treatment (Felix et al., 1994; Navarro et al., 2004). This means that kinases involved 
in PTI signalling possess a residual basal kinase activity that has to be controlled by 
constant de-phosphorylation. Both processes happen within a single cell at the same 
time. Therefore, ligand binding does not simply lead to the activation of the 
intracellular kinase domain, but changes the cytoplasmic state (Dehmelt and 
Bastiaens, 2010). This concept integrates the idea that “protein network reaction 
states are maintained by dynamic processes, and information transfer occurs by 
switching from one dynamically maintained state to another” (Dehmelt and 
Bastiaens, 2010). This means that not only activity of a signalling component 
defines the final signalling outcome but also its location and interactions. For 
example, it is known that mammalian RKs are endocytosed and are able to signal 
from the endosomes (Murphy et al., 2009). Even though endosmal signalling 
involves RKs with the same activity as plasma membrane-localized RKs, endosomal 
localized RKs are able to initiate a different set of responses via the interaction with 
a different set of signal transduction components (Murphy et al., 2009). BAK1-5 
might not simply switch on or off a certain signalling pathway but rather influence 
several cytoplasmic states and interactions of signalling networks, giving rise to the 
complex phenotypical traits associated with bak1-5. Future studies need to address 
these complexities and ideally lead to the development of tools that not only identify 
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the activity but also localization and interactions of a single protein at a given 
moment within an individual cell.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 188
Appendices 
 
Appendix I: Phospho-peptide spectra 
 
Appendix I.I: BAK1(T450A) 
 
 
pS290: ELQVASDNFpSNKNILGR 
pS286: ELQVApSDNFSNK 
 189
 
 
pT466: GTIGHIAPEYLSpTGK 
pY463: GTIGHIAPEpYLSTGK 
pT312: LADGpTLVAVKR 
 190
 
pS604: DSTpSQIENEYPSGPR 
pT603: DSpTSQIENEYPSGPR 
pS602: DpSTSQIENEYPSGPR 
 191
 
 
 
 
 
 
 
 
 
 
 
 
 
 
pS612: DSTSQIENEYPpSGPR 
pY610: DSTSQIENEpYPSGPR 
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Appendix I.II: BAK1-5 
 
 
 
 
pT312: .LADGpTLVAVKR 
pS290: ELQVASDNFpSNKNILGR 
pS286: ELQVApSDNFSNKNILGR 
 193
 
 
 
pT449: LMDYKDpTHVTTAVR 
pT357: LRGFcCMTPpTER 
pT355: LRGFcCMpTPTER 
 194
 
 
 
pS465: GTIGHIAPEYLpSTGK 
pY463: GTIGHIAPEpYLSTGK 
pT455: GpTIGHIAPEYLSTGK 
 195
 
 
 
pS603: DSpTSQIENEYPSGPR 
pS602: DpSTSQIENEYPSGPR 
pT466: GTIGHIAPEYLSpTGK 
 196
 
 
 
pY443/pT449: LMDpYKDTHVpTTAVR 
pS286/pS290: ELQVApSDNFpSNKNILGR 
pS612: DSTSQIENEYPpSGPR 
 197
 
 
 
pT455/pS465: GpTIGHIAPEYLpSTGK 
pT446/pT449: DpTHVpTTAVR 
pY443/pT450: LMDpYKDTHVTpTAVR 
 198
 
 
 
 
 
 
 
 
 
 
 
 
 
 
pT455/pT466: GpTIGHIAPEYLSpTGK 
pT455/pY463: GpTIGHIAPEpYLSTGK 
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Appendix II: Peptides and mascot ion scores of BAK1-interacting 
proteins 
 
Appendix II.I.  
 
AT4G33430.1 
Peptide sequence Best Mascot Ion score 
AANILLDEEFEAVVGDFGLAK 76.9 
DYKDTHVTTAVR 54.5 
ELQVASDNFSNK 66.9 
ELQVASDNFSNKNILGR 67.1 
ERPESQPPLDWPK 39.3 
ERPESQPPLDWPKR 50.9 
GFCMTPTER 37.5 
GLAYLHDH 33.6 
GLAYLHDHCDPK 52.7 
GNAEGDALSALK 30.5 
GRLADGTLVAVK 35.2 
GRLADGTLVAVKR 59.6 
GTIGHIAPEYLSTGK 63.6 
IAPEYLSTGK 46.3 
LADGTLVAVK 63.7 
LADGTLVAVKR 74.7 
LANDDDVMLLDWVK 74.4 
LLVYPYMANGSVASCLR n.d. 
LMDYKDTHVTTAVR 107 
MLEGDGLAER 64.5 
NAEGDALSALK 68 
 200
RLADGTLVAVK 47.1 
STSQIENEYPSGPR 54.7 
Overall 107 
 
AT5G46330.1 
Peptide sequence Best Mascot Ion score 
FSGQIPALFSK 37.5 
GQLEDGTVIAVK 60.6 
IENSSESSLPDLDSALK 82.2 
ILGFAWESGK 33.2 
IPAELGNLVQLQALR 75.3 
LESLTYLSLQGNK n.d. 
LLSVLDLSNNK n.d. 
Overall 82.2 
 
AT1G27190.1 
Peptide sequence Best Mascot Ion score 
FLNALILSDNK 57.5 
LSGSIPSQLSR 35.4 
LSLAGNDLSGTIPSELAR n.d. 
SKDDSDWIGLLR 78.4 
Overall 78.4 
 
AT3G28450.1 
Peptide sequence Best Mascot Ion score 
FSVANNDLSGR 63.1 
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IAETFDENIR 27.5 
Overall 82.2 
 
AT5G42020.1 
Peptide sequence Best Mascot Ion score 
ARFEELNNDLFR n.d. 
EAEEFAEEDKKVK 47.2 
EALEWLDENQNSEKEEYDEK 62.8 
FEELNNDLFR 55.6 
GRLSQEEIDR 33.9 
IINEPTAAAIAYGLDK 90.1 
IINEPTAAAIAYGLDKK 74.4 
ITPSWVGFTDSER n.d. 
KFEDKEVQKDR n.d. 
KLVPYQIVNK 31.8 
LADKLEGDEKEKIEAATK n.d. 
LSQEEIDR 64.5 
MKETAEAYLGK 66.4 
MKETAEAYLGKK 42.5 
NGHVEIIANDQGNR 75.6 
RALSSQHQVR 31.5 
SGGAPGAGGESSTEEEDESHDEL 89.1 
TVFDVKR 29.7 
VEIESLFDGVDLSEPLTR n.d. 
VEIIANDQGNR 61.9 
Overall 90.1 
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AT3G06810.1 
Peptide sequence Best Mascot Ion score 
AASIYTGVYSR 39.2 
FAADNVSGFPTNPSQFK n.d. 
IADGPDEVHLGTIGK 25.2 
IDNLVFHPSEDR 44.6 
LLVLEAADHLDK 52.7 
LPNVAPER 28.1 
RELAATENKHNLSGK 33.3 
Overall 52.7 
 
AT3G16460.1 
Peptide sequence 
Best 
Mascot 
Ion score
LEGAGSEAGTLWDDGAFDGVR n.d. 
LTAEGGETGAVWDDGSHDDVKK 65.4 
NGSQVVFGDER 39.8 
SGFQISAPEATGK 73.5 
SLSTQEVITALTFTTNK n.d. 
SSTTPVPSTPLK 51.7 
VYVGQGQDGVAAVK 80.4 
Overall 80.4 
 
AT1G33680.1 
Peptide sequence 
Best 
Mascot 
Ion 
score 
AEEEVIAIPVQPSDHKR 44.2 
EVNGSVSHDEIGDESK 60.4 
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EVNISGSQNEGEDDSKETNDVVAQK 49.6 
IQLIPQNEGDASK 25.1 
Overall 60.4 
 
AT2G18020.1 
Peptide sequence Best Mascot Ion score 
ASGDYAIVIAHNPDSDTTR 36.8 
GVVTEIIHDPGR 50.9 
Overall 50.9 
 
AT1G68560.1 
Peptide sequence Best Mascot Ion score 
IYGSDITTLR 35.5 
TIATSATHYNGVR 58.3 
Overall 58.3 
 
AT1G5550.1 
Peptide sequence Best Mascot Ion score 
DTQEVKLEQGLK 59.7 
SVSGSGVASSYSK 69.5 
YNVWASTPNGNKK 44.4 
Overall 69.5 
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AT2G42520.1 
Peptide sequence Best Mascot Ion score 
ELASQIHDEAK 46.9 
VGSSTDLIVQR 54.2 
VGYGGPPSGSR 46.9 
Overall 54.2 
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Appendix II.II. 
 
AT4G33430.1 
Peptide sequence Best Mascot Ion score 
AANILLDEEFEAVVGDFGLAK 37.9 
ADGTLVAVKR 35.8 
DTHVTTAVR 41.3 
ELQVASDNFSNK 74.6 
ELQVASDNFSNKNILGR 78.1 
ERPESQPPLDWPK 53.8 
ERPESQPPLDWPKR 33.5 
GFCMTPTER 49.5 
GGFGKVYK 38.7 
GLAYLHDHCDPK 45.8 
GRLADGTLVAVK 52.6 
GRLADGTLVAVKR 53.6 
GTIGHIAPEYLSTGK 77.2 
IENEYPSGPR 52.8 
ITGAIAGGVAAGAALLFAVPAIALAWWR 28 
LADGTLVAVK 84.7 
LADGTLVAVKR 86.5 
LMDYKDTHVTTAVR 84.6 
LNNNSLSGEIPR 48.4 
MLEGDGLAER 52.1 
MSEVVR 37.4 
NAEGDALSALK 83.6 
NSLADPNK 29.7 
Overall 86.5 
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AT1G71830.1 
Peptide sequence Best Mascot Ion score 
AANILLDEEFEAVVGDFGLAK 37.9 
ADGTLVAVKR 35.8 
AFDLAR 24.5 
DTHVTTAVR 41.3 
ELQVASDGFSNK 68.2 
GFCMTPTER 49.5 
GGFGKVYK 38.7 
GRLADGTLVAVK 52.6 
GRLADGTLVAVKR 53.6 
GTIGHIAPEYLSTGK 77.2 
LADGTLVAVK 84.7 
LADGTLVAVKR 86.5 
LMDYKDTHVTTAVR 84.6 
LRGFCMTPTER 22.2 
MLEGDGLAEK 57.5 
MSEVVR 37.4 
Overall 86.5 
 
AT2G13790.1 
Peptide sequence Best Mascot Ion score 
AANILLDEEFEAVVGDFGLAK 37.9 
GFCMTPTER 49.5 
GGFGKVYK 38.7 
GRLADGNLVAVK 33 
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GRLADGNLVAVKR 53.6 
GTIGHIAPEYLSTGK 77.2 
LADGNLVAVK 84.7 
LADGNLVAVKR 86.5 
LANDDDIMLLDWVK 73.4 
LRGFCMTPTER 22.2 
MLEGDGLAER 52.1 
MSEVVR 37.4 
Overall 86.5 
 
AT1G27190.1 
Peptide sequence Best Mascot Ion score 
ADLPDGSALAVK 42.6 
ADLPDGSALAVKR 35.8 
IACSCVVSRPK 66.3 
NSLIDPSSR 34.6 
RLSACGFGEK 36.2 
Overall 66.3 
 
AT3G13930.1 
Peptide sequence Best Mascot Ion score 
AAALALR 25.3 
ADVEDFLASGSK 89.6 
DYTPSSDTGPAAPEAK 72.4 
GLSTIGEEVR 48.8 
GYIETPESMLL 51.1 
IFASPLAR 33.5 
 208
ISKPSSAPSEDR 43.3 
ISVNDLVIK 60.7 
KGLSTIGEEVR 42.2 
KLAEDNNVPLSSIK 85.6 
LAEDNNVPLSSIK 72 
SQLNSFQEASGGK 55.5 
SQLNSFQEASGGKR 104 
VEKPASAPEAK 40.9 
VIDGAIGAEWLK 28.3 
Overall 104 
 
AT3G25230.1 
Peptide sequence Best Mascot Ion score 
ALEIDPNNR 29.5 
FTLGQGQVIK 32.8 
LEDGTVVGK 29.6 
LQDGTVFLK 26.6 
SDGVEFTVK 27.1 
TVSEVTDDNKVVK 63.8 
VACNLNDAACK 33.1 
VGEEKEIQQGLK 41.2 
VGEEKEIQQGLKK 27.8 
VLELESTNVK 75.6 
Overall 75.6 
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AT4G31990.1 
Peptide sequence Best Mascot Ion score 
AENLMLER 32 
IADVIQEK 35.2 
IGAINVVCSSADAATR 69.8 
ISLAGLSLAK 47.6 
LAAALIER 60.2 
NLGLYAER 27.4 
QELYDSLVSK 32.4 
TEELQPYVLNVVK 81.2 
VATIQGLSGTGSLR 38.4 
VVISSPTWGNHK 36.9 
Overall 81.2 
 
AT1G20260.1 
Peptide sequence Best Mascot Ion score 
FVMQGAYDTR 58 
QIYPPINVLPSLSR 31.8 
TLDQFYSR 49.6 
TPVSLDMLGR 54 
TVSGVAGPLVILDK 39.4 
Overall 58 
 
AT1G23190.1 
Peptide sequence Best Mascot Ion score 
LSGTGSEGATIR 90.9 
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SMPTSAALDVVAK 65.5 
YDYENVDAGK 32.5 
Overall 90.9 
 
AT1G32500.1 
Peptide sequence Best Mascot Ion score 
FAQQTNAGQLTR 46.9 
GIDLETAR 34.5 
SSQIEPISTQQR 57.5 
Overall 57.5 
 
AT3G02090.1 
Peptide sequence Best Mascot Ion score 
HVGSDLTQR 44 
IDAVDASTVK 31.8 
IDAVDASTVKR 61.7 
IPTAELFAR 50.3 
TILGPAQNVK 34 
VTTLPNGLR 25.2 
Overall 61.7 
 
AT3G4800.1 
Peptide sequence Best Mascot Ion score 
FSDVDEVIK 34.1 
LAFTGSTDTGK 34.6 
TAEQTPLTAFYAGK 56.8 
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TAFDEGPWPK 32.4 
YGLAAGVFTK 41.8 
Overall 86.5 
 
AT4G24190.1 
Peptide sequence Best Mascot Ion score 
EESSDDVTDPPKVEEK 34 
ELISNASDALDK 48.8 
GNLASENVDDVK 29.6 
IMQSQTLSDANK 55.8 
LADTPCVVVTSK 36.3 
Overall 55.8 
 
AT4G34200.1 
Peptide sequence Best Mascot Ion score 
GGVIDEDALVR 47.1 
ILNDETFAK 45.6 
STGDGSKPTILVAEK 79.4 
TLAVLGFGK 55.6 
VIAHDPYAPADR 32.2 
Overall 79.4 
  
AT5G01410.1 
Peptide sequence Best Mascot Ion score 
GGVIMDVVNAEQAR 67.2 
IPFVCGCR 34.6 
 212
IREGAAMIR 32.2 
LAAPYDLVMQTK 32.1 
MSDPQMIKEIK 29.7 
NMDDDEVFTFAK 78.7 
TKGEAGTGNIIEAVR 87.3 
VGLAQMLR 56.4 
Overall 87.3 
 
AT5G63570.1 
Peptide sequence Best Mascot Ion score 
AGSGVATLGLPDSPGVPK 37.3 
FVNSGTEACMGVLR 60.2 
IIGGGLPVGAYGGR 36.5 
NLMPGGVNSPVR 41.6 
SVGGQPVLIDSVK 52.3 
Overall 60.2 
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Appendix II.III.  
AT4G33430.1 
Peptide sequence 
Best 
Mascot Ion 
score 
ELQVASDNFSNK 77.3 
ERPESQPPLDWPKR 31.9 
GTIGHIAPEYLSTGK 72.6 
LADGTLVAVK 74.3 
Overall 77.3 
 
AT2G13790.1 
Peptide sequence 
Best 
Mascot Ion 
score 
ELLVATDNFSNK 62.3 
ERPEGNPALDWPK 38.9 
GTIGHIAPEYLSTGK 72.6 
Overall 72.6 
 
AT3G50590.1 
Peptide sequence 
Best 
Mascot Ion 
score 
ILSQQGGEAVYPLPR 37.9 
LPLITVVDTK 49.5 
LPLITVVDTKDQLK 38.7 
Overall 49.5 
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AT3G19820.1 
Peptide sequence 
Best 
Mascot Ion 
score 
GQFVEYIPTR 32.9 
VEPLVNMGQISR 54.8 
Overall 54.8 
 
AT2G02740.1 
Peptide sequence 
Best 
Mascot Ion 
score 
APEFVALESGAFK 109 
FFNLSVQNK 50.9 
YGGDYEWSR 64.6 
Overall 109 
 
AT5G06450.1 
Peptide sequence 
Best 
Mascot Ion 
score 
GTLVLEFLGTR 92.8 
NLCLFLR 39.3 
TSGWSLSSVK 44.3 
Overall 92.8 
 
AT5G24710.1 
Peptide sequence 
Best 
Mascot Ion 
score 
ENSAIYILGR 34.7 
VSGSAPQLITIGADK 34.3 
Overall 34.7 
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